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Abstract 
Currently, the discharge of pollutants to the environment is considered one of the biggest problems 
challenging chemists and environmental scientists. These pollutants come from different sources and 
might be carcinogenic, toxic or radioactive compounds which can cause serious health hazards to 
humans, animals and plants. Intensive thermodynamic studies by Danil de Namor and  co-workers in 
the Thermochemistry Laboratory indicated that  functionalisation of calix[4]pyrroles, cyclodextrines 
and  calix[n]arenes ( n=4,6 )  leads to the production of selective  macrocyclic receptors  for the removal 
of anions, toxic heavy metals and other pollutants from water. The objective of this thesis is to 
design, synthesise and characterise macrocyclic receptors with suitable functional groups for the 
selective removal of drugs and anions from water. The drugs selected for this study are diclofenac, 
sodium diclofenac, clofibric acid, carbamazepine, aspirin and ibuprofen. This selection is based on the 
fact that these drugs are extensively used and as a result these contaminate sewage, surface and ground 
water. Supramolecular chemistry is one of the most important areas of chemistry which offers many 
advantages due to the efficient, fast and economical way for removing pollutants from water.  In this 
thesis a large number of macrocycles based on calix[4]arene, calix[4]pyrrole resorc[4]arene and 
pyrogalol[4]arene have been synthesised and characterised by  1H NMR and microanalysis. From these 
receptors those based on cyclodextrin and calix[4]arene  derivatives have been selected for sodium 
diclofenac while for drugs containing carboxylic acids in their structure, a partially substituted 
calix[4]arene amine was selected for further investigations involving these drugs. These interactions 
were assessed in solution by several techniques such as 1H NMR titration, UV-Visible, conductivity, 
isothermal titration calorimetry. In the solid state, thermogravimetry and differential scanning 
calorimetry were explored. The extraction of these pharmaceuticals by some of these macrocycles 
under different conditions is reported. The importance of fundamental studies in searching for 
applications is demonstrated where the selectivity of the calix[4]arene amine for these drugs is shown 
in the extraction process. Modified silica with amino functional groups is explored for extracting 
aspirin from water. Preliminary research on the efficiency of pyrogallol[4]arene and resorcine[4]arene 
to work as molecular containers for selected drugs were tested by 1H NMR  Two novel calix[4]pyrroles 
were investigated for complexation with halides and phosphates showing their selectivity for 
phosphates relative to halides. Final conclusions are given as well as suggestions for further work 
particularly with the new oligomeric material which has been characterised by various techniques 
which are FTIR, XRD, SEM, BET analysis
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1.1 Supramolecular chemistry 
Supramolecular Chemistry1,2 is a branch of chemistry which was made up from early ideas resulting 
from the contributions on receptors by Ehrlich and Silverstin3, the coordination chemistry introduced 
by Werner4 and the lock-key mechanism suggested by Fischer5. Great interest has been focused on 
Supramolecular Chemistry since three scientists; Pederson6,7, Lehn8,9 and Cram10,11 were awarded 
the Nobel Prize in Chemistry in 1987 for their work on crown ethers, cryptands and spherands 
respectively. Supramolecular Chemistry is concerned with the reversible interactions between the 
receptor molecule (host) bearing multiple recognition sites consisting of holes and cavities in their 
structures for binding ions, radicals or neutral species (guests) leading to molecular aggregates with 
supermolecular structures12-14. These aggregation processes are attributed to the combination of non-
covalent forces which are ion-dipole, ion-ion, dipole-dipole, cation-π, anion-π, van der Waals, π-π 
interactions, and hydrogen bonding15-18. The perfect encapsulation of the guest in the cavity leads to 
excellent complexation with high stability constant values. Thus the re-organization of the 
conformation of the receptor molecule commonly leads to   maximum strength of complexation19. 
Also the external environment surrounding host-guest complexes can play a major role in 
complexation processes because of the weakness of the non-covalent forces, for example hydrogen 
bonded host-guest complexes are very sensitive to the polarity of the solvent surrounding 
supermolecule structures (Fig. 1.1). Danil de Namor and co-workers20-27 have made extensive 
thermodynamic studies on the effect of the medium on host-guest complexes. There are many 
applications of Supramolecular Chemistry in separation science, drug-delivery systems and 
molecular sensing and recognition28-33. 
 
Fig. 1.1 Dynamic elements of the host-guest complexation process 
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1.2 Pharmaceuticals, phosphate and halides in the environment 
1.2.1 Occurrence of pharmaceuticals in the aquatic environment 
In the last few years, contamination of water by a variety of pharmaceuticals has been gaining serious 
concern by environmental scientists34-36. There are many sources for the pharmaceuticals to enter the 
aquatic environment. These are as follows: (i) the use of various pharmaceuticals for treatment of 
human and animals which are excreted as unchanged compounds or as metabolites entering the 
aquatic environment as a result of inadequate treatment of wastewater in sewage treatment plants 
(STPs); (ii) the discarding of unused pharmaceuticals via toilet; (iii) the discharge of  residuals  of 
drugs manufacturers37-39. As a consequence of globally different regulations applied of drugs 
marketing and manufacturing, different concentrations levels in different countries have been 
diagnosed for many types of drugs in the analysed water samples and this come from that these 
samples were collected from different regions in different countries. Some of these samples were 
taken from the sewage treatment plants or from the water streams which are located near the effluents 
of the hospitals or near the drug manufactories which have the higher risk to the environment.40 
 Up to date,  few studies concerning the removal of these pollutants from water have been carried out. 
Currently a number of techniques are used to treat wastewater such as powdered activated carbon, 
ozonation, ultraviolet photolysis, zeolites, and reverse osmosis. However, powdered activated carbon 
is not effective to remove many organic pollutants at low concentration level and also cannot be 
recycled when the saturated point is reached. Oxidation by ozone is effective to remove most 
pharmaceuticals from water but the toxicity of ozone and by-products resulting from this process has 
implications on human health and the environment. Ultraviolet photolysis is not effective to remove 
most pharmaceuticals from water. Zeolites also show low efficiency to remove organic pollutants. 
Reverse osmosis is effective to remove most pharmaceuticals from water but this technology is 
economically undesirable41-43. 
 As in oxidation by ozone, less promising experimental work has been reported by Jiang and co-
workers44-46 using ferrate (VI) as oxidizing agent for the removal of ciprofloxacin, ibuprofen, 
sulfamethoxazole, diclofenac, carbamazepine and benzafibrate from water. The authors have 
revealed that ferrate (VI) effectively degrades ciprofloxacine, diclofenac and carbamazepine, but it 
is not effective to remove ibuprofen and benzafibrate. The limitations of this process were the doses 
of ferrate (VI) required to complete the oxidation process, the large number of pharmaceuticals that 
can resist the oxidation by ferrate (VI) and the undesirable oxidation products formed which can 
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cause high impact on the environment. For example, more than half a dozen of oxidation products 
were identified from the oxidation of ciprofloxacin by ferrate (VI) FeO4
2-. 
Molecularly imprinted techniques47 were also used in the production of molecularly imprinted 
polymers, MIPs, which are used for the removal of pharmaceuticals from water. MIPs are activated 
synthetic polymers obtained from the introduction of a number of specific functional groups into a 
polymer matrix which can enhance the specificity towards a template. These MIPs have gained much 
interest due to their usage in many applications involving solid phase extraction, sensing, drug 
delivery systems and chromatography. The implantation process of functional groups can be made 
by applying one of two subsequent strategies depending on the nature of the chemical interaction 
between the functional monomer and the template. Firstly, the non-covalently aggregation process 
resulting from the interaction between an analyte (template) and a functional monomer is to be fixed 
in a polymeric matrix containing a cross-linking material and an initiator in the appropriate solvent. 
In this method, non-covalent bonds drive the polymerization procedure and the template must be 
removed after polymerization while the monomer will remain bound covalently into the polymer 
structure. Secondly48, the covalently complex of a functional monomer with a template is co-
polymerised with a cross linker, an initiator and an appropriate solvent. The release of the template 
from the cross-linking polymer in both procedures leads to the formation of a polymer with cavities 
and specific recognition sites homogeneous in shape, size and functionality to those of the imprinted 
template (Fig. 1.2)49.  
 
 
Fig. 1.2 Schematic representation of molecularly imprinted polymer49 
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Geissen et al 50 have demonstrated that the MIP synthesised by polymerisation of 2-vinylpyridine 
monomer, ethylene glycol dimethacrylate as cross linker and azo-bis-isobutyronitrile as initiator in 
the presence of diclofenac as template in toluene removes selectively diclofenac from water in the 3-
8 pH range 
It has been emphasized that the use of a number of templates in the polymerization process can lead 
to produce molecularly imprinted polymers with multiple active sites with different and effective 
reactivity for the simultaneous removal of a number of materials without any reduction in their 
efficiency. 
C. Dai et al 51 have reported the use of the precipitation polymerisation process for the synthesis of 
multi-templates MIP using ketoprofen, naproxen, clofibric acid, diclofenac and ibuprofen as 
templates and demonstrated that these polymers are able to remove acidic pharmaceuticals effectively 
in the 3-7 pH range and the removal process was found to be kinetically fast.  
Many drawbacks still remain in the removal of drugs by MIPs including the incarceration of targeted 
materials in cavities which can make the long term clean-up process unrealistic or even economically 
disappointing due to the large quantity of organic solvents utilised. Also, the use of an excess amount 
of the monomer in the polymerisation process can lead to the presence of non-selective sites in the 
polymeric matrix and can increase the density of monoliths which can also decrease the selective 
interaction between the MIP and the targeted material. In addition to these drawbacks, the synthesis 
of MIPs is considered to be rather tedious52,53. 
Therefore, there is serious concern about the need to find an effective and economical method to   
remove these organic pollutants from water. Supramolecular Chemistry can therefore be a suitable 
strategy to overcome this problem. The reversible complexation of macrocylic receptors with 
different types of anions, cations and neutral species via cooperative interactions through non-
covalent bonds may be a fast and an economical way for the removal of these pollutants from water 
due to the possibility of recycling the host.  
1.2.2 Phosphate and halides in the environment 
The phosphate anion is a fundamental constituent in all living systems and plays crucial role in the 
production of energy required to drive the biological reactions. It is also presents in fertilizers, product 
metabolism, and traditional detergents. The presence of phosphates in a high concentration levels in 
the environment leads to growing algae and can cause negative impact on the environment whereas 
the variation of the concentration levels of phosphate in living cell reflects the biological activity and 
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healthiness of these systems. For example, it is difficult to control   phosphate levels in blood for 
patients with kidney failure54. Another issue of considerable environmental concern is that related to 
the presence of fluorides in water. Long-term exposure to high concentration levels of fluoride leads 
to a number of health problems such as skeletal fluorosis, which is a health disorder related to the 
building up of fluoride in the bones. This disease can cause joint stiffness and pain, and may result 
in weak bones or fractures in older adults. Over the years, many studies have looked at the possible 
link between fluoride and cancer. Most of the concern about cancer seems to be around osteosarcoma. 
One theory on how fluoridation might affect the risk of the osteosarcoma is based on the fact that 
fluoride is localised on the bones and can lead to cancer55-57. Probing and trapping these anions by 
artificial supramolecular receptors is still challenging and therefore, it will be one of the main targets 
in this project. 
1.3 Classification of Macrocyclic receptors 
Macrocyclic receptors can be divided into two classes; naturally occurring and synthetic 
macrocycles58 
 
1.3.1 Naturally occurring macrocycles 
Some of the macrocycles can be considered as naturally occurring receptors. Representative 
examples are valinomycin, chlorophyll, nigericin and cyclodextrin (CDs). Cyclodextrins (CDs) are 
biosynthetic cyclic oligosaccharides first obtained by Villers through the enzymatic degradation of 
starch13. CDs consist of six (α- cyclodextrin), seven (β-cyclodextrin), eight (γ-cyclodextrin) or more 
anhydrous glucopyranosyl units connected together through α-(1, 4)-D-glycosidic bonds with a 
truncated “cone” structure having a lipophilic internal cavity and a polar outer surface. The primary 
hydroxyl groups which involve C-6 (Fig. 1.3 a & b) are located on the narrow rim of the “cone” but 
the secondary hydroxyl group on C-2 and C-3 are located on the wider rim. These unique properties 
enabled CDs to embedding a variety of hydrophobic   molecules with an appropriate size in their 
hydrophobic cavities leading to inclusion complexes in equilibrium processes59-61. The inclusion 
complexes formed are used in a number of applications such as agriculture, food, separation sciences 
and the pharmaceutical industry. For example, CDs enhance the water solubility of low soluble drugs 
to increasing their bioavailability and stabilise drugs towards light and thermal decomposition62-66. 
The numerical values of the stoichiometry and the stability constants of these inclusion complexes 
can be determined by observing the changes in their physicochemical properties like solubility, 
chemical reactivity, UV-Vis absorbance, drug retention and chemical stability67. 
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Fig. 1.3 (a) Molecular structure of β- cyclodextrin (b) β-CD in a “cone” conformation59  
The difference of the number of glucose units and the size of cavities between the isolated CDs leads 
to differences in their chemical and physical properties (Table 1.1)68. There are a large number of 
cyclodextrin derivatives due to the possibility of introducing functional groups through the hydroxyl 
groups (18-OH in α-CD, 21-OH in β-CD and 24-OH in γ-CD) with different reactivities which can 
be modified by different methods. Substitution on the  CDs rims can give a high degree of binding 
properties towards  many lipophilic guest compounds69-72.  
Danil de Namor and coworkers73,74 have carried out a series of thermodynamic studies for 
cyclodextrins as hosts with different guests. CDs with different functional groups have shown to have 
a strong  effect on the receptor properties75-78. 
Table 1.1 Physicochemical properties of ,  and -cyclodextrins68 
 
Physico-chemical Properties     -Cyclodextrin  -Cyclodextrin   -Cyclodextrin 
Number of glucopyranose units              6             7       8 
Molecular weight (g mol-1)               972                1135         1297 
Solubility in water at 25 C (%, w/v)             14.5                1.85       23.2 
Outer diameter (Å)             14.6                15.4       17.5 
Cavity diameter (Å)        4.7–5.3              6.0–6.5        7.5–8.3 
Height of torus (Å)           7.9                7.9       7.9 
Cavity volume (Å3)               174               262          427 
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1.3.2 Synthetic macrocyclic receptors (crown ethers, cryptands, spherands,       
calixarenes, calixpyroles and pillarenes)  
Due to the importance of the field of Supramolecular Chemistry, a huge number of synthetic 
macrocycles has been synthesised such as crown ethers, cryptands, spherands, p-tert-
butylcalix[n]arene(n=4, 5, 6, 8), calix[n]pyrroles and pillarenes1,2,29. 
 Pederson4,5 in the early seventies reported the first synthesis of the macrocyclic known as Dibenzo-
18-crown-6 consisting of oxyethylene repeating units (-O-CH2CH2) containing a hole in its structure, 
large enough, to interact with alkali and alkaline-earth metal cations to form  host- guest complexes 
driven by ion-dipole interactions between the cation and the negative charge of the oxygen donor 
atoms of the receptor. He concluded that dibenzo macrocyclic crown ethers are good complexing 
agents for these metal cations, particularly those contining five to ten oxygen atoms, thus a strong 
binding affinity of dibenzo crown-5 towards the sodium cation was observed.  The enhancement of 
the interaction behaviour of these macrocycles towards targeted guests can be achieved by controling 
the size of the macrocyclic hole or by  introducing other donor atoms  like sulphur or nitrogen to 
generate crown ethers which have affinity to interact strongly and selectively with the targeted guest 
(Fig. 1.4).  
Pederson et al 79 reported the synthesis of crown thio-ethers and demonstrated that the binding affinity 
of these receptors was raised towards the silver cation but decreased towards the potassium cation 
which means that the introduction of a soft donor atom such as sulphur makes them selective for soft 
metal cations such as silver. 
 Thermodynamic studies by Izzat et al 80 related to thio-crown ethers revealed that complexation 
processes between  thio-crown ethers with  silver and mercury cations are enthalpicaly driven. This 
means that the energy required to drive the complexation process are provided as a heat (exothermic) 
from the interaction of the reactants leading to produce the most favourable stable state of the targeted 
complex. Also, significant contribution by the sulfur moiety in the complexation process was 
detected.  
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1-Aza-15-crown-5 Hexathia-18-crown-618-crown-6 Dibenzo-18-crown-6
 
Fig. 1.4 Chemical structures of different macrocyclic crown ethers. 
Generally the complexation of crown ethers with metal cations and the stability of the host-guest 
complexes formed  depend on different factors such as the size fittings between the host and the guest 
, cationic radii, energy of solvation  and polarity of the solvent81. 
 Danil de Namor et al 26 have reported the thermodynamic parameters of complexation of 12-crown-
4, 1-benzyl-1-aza-12-crown-4 and 1-aza-12-crown-4 (Fig. 1.5, Table 1.2) with the lithium cation in 
acetonitrile and propylene carbonate as dipolar aprotic solvents by using different lithium salts. They 
demonstrated the influence of the counter-ions of the lithium salts and the medium effect on the 
complexation process in order to increase the dissociation of these salts and enhance the ionic 
conductivity of electrolytic solutions for use in lithium batteries.  
 
                    
(a)                                   (b)                                                  (c) 
Fig. 1.5 Structures of (a) 12-crown-4, (b)1-benzyl-1-aza-12crown-4 and (c) 1-aza-12-crown-4 
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Table 1.2 Stability constants expressed as log Ks and derived standerd Gibbs energies (∆cG), 
enthalpies (∆cH), and entropies (∆cS) of complexation of crown ethers (12-crown-4 (12-C-4) and 
1-Benzyl-1-aza-12-crown-4 (1-BA-12-C4)) and lithium (using salts containing different anions) in 
acetonitrile (MeCN) and in propylene carbonate at 298.15 K  
In MeCN 
Electrolyte Receptor log Ks cG/kJ mol-1 cH/kJ mol-1 cS/Jmol-1K-1 
Li+AsF6 12-C-4 3.23   18.4   22.78   14.7 
Li+BF4 12-C-4 3.46   19.8   21.66   6.20 
Li+CF3SO3 12-C-4 3.52   20.1   21.35    4.60 
Li+ClO4 12-C-4 3.31   18.9   21.87      10.0 
Li+AsF6 1-A-12-C4 4.23   24.2   18.84      18.0 
Li+BF4 1-A-12-C4 4.24   24.2   19.91      14.4 
Li+CF3SO3 1-A-12-C4 4.23   24.2   18.69       18.5 
Li+AsF6 1-BA-12-C4 4.25   24.3   27.14    9.50 
Li+BF4 1-BA-12-C4 4.30   24.6   27.54     9.90 
Li+CF3SO3 1-BA-12-C4 4.31   24.6   27.44     9.30 
Li+ClO4 1-BA-12-C4 4.31   24.6   28.50    13.1 
Propylene 
Carbonate 
     
Li+AsF6 12-C4 2.81      16.0  15.9     5.70 
Li+BF4
 12-C4 2.79   15.9  17.71    6.10 
Li+CF3SO3
 12-C4 2.84   16.2  17.05    2.80 
Li+ClO4 12-C4 2.81   21.0  15.29      2.40 
Li+AsF6 1A-12-C4 3.67  21.1  14.78      20.9 
Li+BF4 1A-12-C4 3.69  22.1  14.63      21.7 
Li+CF3SO3 1A-12-C4 3.87  23.3  15.08      23.5 
Li+AsF6 1-BA-12-C4 4.08  25.1  24.59    4.30 
Li+BF4
 1-BA-12-C4 4.39  25.1  24.98      0.40 
Li+CF3SO3
 1-BA-12-C4 4.59  26.2  24.70      5.00 
Li+ClO4
 1-BA-12-C4 4.32  24.7  23.30      4.70 
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 Crown ethers have been mainly used as receptors to complex with metal cations. However Cram and 
coworkers82 have reported the complexation of 27-crown-9 with organic cations such as tert-butyl 
ammonium, guanidinium and arenediazonium salt and demonstrated that the complexation process 
was governed by hydrogen bond formation (Fig. 1.6) 
                                      
PF6. H2O
-
 
Fig. 1.6 Complextion reaction of guanidinium ion by 27-crown-9 
 Reinhoudt and co-workers83 have carried out thermodynamic studies on the complexation of                                                                 
18-crown-6 with nitromethane , acetonitrile and malonitrile as neutral guests by using 1H NMR in 
deuterated benzene and concluded that 18-crown-6 hosted these guests in solution with 
stoichiometric ratios of 1: 1 and 1: 2 [receptor: guest].  
Danil de Namor and co-workers84 have reported interesting solution  thermodynamic studies of 
complexation processes involving 18-crown-6 with different types of amino acids in methanol and 
demonstrated that 18-crown-6 is complexed with these amino acids and the complexation was 
enthalpically driven and controlled by  hydrogen bond formation and electrostatic interactions. The 
stability constants exepressed as log Ks, standard Gibbs energies cG, enthalpies cHand entropies 
cS are given in Table 1. 3 
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Table 1. 3 Thermodynamic parameters of complexation of amino acids with 18-crown-6 in methanol 
at 298.15 K 
Amino acid Log Ks cG/ kJ mol-1 cH/ kJ mol-1 cS/ J mol-1K 
DL-Alanine 3.59    20.49  45.94   85.4 
DL-Arginine 3.42    19.52  40.11   69.1 
DL-Asparagine 3.14    17.92  40.24   74.9 
DL-Aspartic acid 2.99    17.07  38.55  72.0 
DL-Cysteine 3.28    18.72  30.67   40.1 
DL-Glutamic acid 3.34    19.07  35.78    56.0 
Glycine 3.98    22.72  53.83   104.3 
DL-Histidine 3.03    17.29  39.26  73.7 
DL-Isoleucine 3.17   18.10  36.42   61.4 
DL-Leucine 3.35    19.12  42.47   78.7 
DL-Methionine 3.66   20.89  37.85   56.9 
DL-Phenylalanine 3.15   17.98  39.38   71.7 
DL-Proline 2.6  15.07  11.38     12.4 
DL-Serotonin 3.37   19.24  38.80   65.6 
DL-Thyronine 3.02  17.24  35.36   60.8 
DL-Tryptophan 3.06   17.74  41.36   81.0 
DL-Tyrosine 2.93  16.72  45.39   96.0 
DL-Valine 3.19   18.72  34.49   54.6 
 
Recently various crown ethers with different functional groups have been synthesised to enhance the 
complexation properties of these macrocyclic receptors85-87. Müllen and co-workers85 have 
synthesised benzo-21-crown-7 including dibenzocoronene tetracarboxdiimide chromophore (Fig. 
1.7) and the receptor has shown selectivity towards lead and potassium cations in acetonitrile. 
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C11H23
C11H23
 
Fig. 1.7 The structure of the receptor synthesised by Müllen and coworkers75. 
J-M. Lehn8,9 and co-workers have reported the first synthesis of macrocyclic receptors known as 
“cryptands” described as more rigid and selective for alkali metal cations than crown ethers. These 
receptors  contain a three dimensional cavity with mixed donor atoms such as oxygen and nitrogen 
in their molecular structure (Scheme 1.1).  The authors concluded that the direction of the nitrogen 
atom to the interior of the cavity may facilitate the complexation with cations. Also complexation 
with anions occurs when these macrocycles receptors are protonated88. The supermolecular structure 
of the complex resulting from the interaction between cryptand with the metal cation described 
initially by Lehn as “cryptate” but the term was extended to include all the cationic or anionic species 
imprisoned in the cage- like structure of this receptor 
Cryptand 222
LiAlH4
  
Scheme 1.1 Synthetic pathway of cryptands 222   
Danil de Namor and co-workers22,89 have extensively reported thermodynamic studies of the 
complexation of cryptand 222 with silver and alkali metal cations in a variety of solvents. These 
authors concluded that the cations are fully desolvated after complexation by showing a linear 
relationship between the complexation of cryptand 222 and univalent cations in dipolar aprotic 
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solvents and the solvation of these cations in these solvents in terms of Gibbs energies, enthalpies 
and entropies. Recently Sui and co-workers90 have reported the synthesis of a tri-aza-cryptand 
modified by boron-dipyrromethene fluorophore and they concluded that the receptor has a high 
binding affinity towards potassium over other metal cations. The efficiency of the receptor to 
complex with the potassium cation was studied by following the variation in the fluorescence 
emission spectrum of the receptor as a result of the addition of potassium to the receptor solution in 
acetonitrile (Fig. 1.8) 
                                                             
Fig. 1.8 Chemical structure of the tri-aza-cryptand receptor containing a fluorophore 
Other interesting receptors are those synthesised by Cram91-93 known as “spherands” (Fig. 1.9). 
These are  pre-organised  macrocyles with rigid cavities which   can interact strongly with lithium 
but to a lesser extent  with sodium. Due to their rigidity, these  must be pre-organaised for 
complexation during the synthesis. The host-guest complexes resulting  from the complexation of 
spherands with guests are called “spheraplex”. 
                                       
Me
                                       
  Fig. 1.9 Chemical structure of the spherands   
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Ogoshi et al 94  have reported in 2008 the synthesis and clasification of a new class of macrocycles 
called “ pillarenes”. These were obtained by the Lewis acid catalysed condensation reaction of 1-4-
dimethoxy benzene with paraformaldehyde and consist of hydroquinone units connected together by 
methylene bridges at the  2 and 5 positions (Scheme 1.2).  Pillarenes macrocycles have become very 
atractive due to their ease of preparation and modification , are  rigid with a π-rich cavity  and superior 
host–guest complexing properties. This type of macrocycles have been synthesised with different 
shapes,  different functional groups  with  attractive chelating behavior . The deprotection of alkoxy 
groups and the introduction of hydroxyl groups enabled the macrocyclic structure to have ten reactive 
hydroxyl groups which can be modified by the introduction of  different functional groups. Therefore 
this modification has led to the production of receptors with a large number of active sites which 
enhance the selectivity towards guests95-99.      
 
  
CH3
Dimethoxypillar[5]areneDimethoxybenzene Polymer
CH3
BF3O(C2H5)2
CH3
CH3CH3
CH3
OH(CH2O)nH
       
Scheme 1.2 Synthetic pathway of pillar[5]arene receptor 
Given that the research carried out in this thesis involves the use of calix[4]arenes, calix[4]pyrrole, 
resorcin[4]arene and pyrogallol[4]arene derivatives, an account on the two former receptors is now 
described. 
1.4 Calix[4]arenes 
These belong  to a class of macrocyclic receptors containing repeating phenolic units linked together 
by methylene bridges with rigid cone-like structures that can hold ionic and neutral species in their 
cavities. Calix[n]arenes were synthesised by Zinke in 1940 from the condensation of p-tert-butyl 
phenol with formaldehyde in basic medium (Scheme 1.3)  
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HCOH/ NaOH
Heat, 80 °C
n = 4, 6, 8
         
   p-tert-butyl phenol                                             p-tert-butyl  calix[n]arene (n=4, 6, 8) 
Scheme 1.3 Synthesis of p-tert-butylcalix[4]arene. 
The term calix[n]arene was given by Gutsche in 1987 to macrocyclic compounds which have a cup 
body structure similar to the Greek vase known as calyx crater (Fig. 1.10); calix means cup-like 
structure, crater is applicable due to the cavity arising from the connectivity between phenyl (arene) 
rings included in the structure and n between two brackets indicates the number of phenol groups in 
the macrocyclic structure100-106. 
            
                  (a)                                                                                  (b) 
Fig. 1.10 Images of (a) Greek Calyx Crater and (b) molecular modelling of p-tert-butyl calix[4]arene 
showing the similarity between the Greek vase and the calix[4]arene. 
 
The 1H NMR technique has been used to characterise and to recognise p-tert-butylcalix[4]arene from 
p-tert-butylcalix[6]arene and p-tert-butylcalix[8]arene. For p-tert-butylcalix[4]arene, there were five 
different resonances in the 1H NMR spectrum at room temperature as noticed for the first time by 
1.                                                                                                                                   Introduction 
 
17 
 
Kammerer and co-workers107. The resonance of the hydroxyl, aryl and tert-butyl protons are observed 
as singlets whereas the resonances of the methylene bridge protons are observed as a pair of doublets 
(Fig. 1.11). Ungaro and co-workers108 have identified these two doublets for the methylene bridge 
protons and demonstrated precisely that the higher field doublet resonance corresponds to the 
equatorial protons (close to the aryl group) and the downfield doublet arises from the axial protons 
(close to the hydroxyl groups). Gutsche and co-workers109 have revealed that the 1H NMR spectrum 
for the methylene bridge protons of p-tert-butylcalix[4]arene in a nonpolar solvents like CDCl3 and 
bromobenzene-d5 are  in a similar pattern with p-tert-butylcalix[8]arene and were observed as a pair 
of doublets but there were no doublet resonance noticed for the p-tert-butylcalix[6]arene which 
showed only a singlet at room temperature. The distinction between the p-tert-butylcalix[4]arene and 
p-tert-butylcalix[8]arene was illustrated by using pyridine-d5 as solvent,  p-tert-butylcalix[4]arene is 
able to  maintain its occurrence as a pair of doublets even at 0 °C whereas only one singlet peak was 
observed for the p-tert-butylcalix[8]arene even at -90 °C.  
 
Fig. 1.11 1H NMR spectrum for p-tert-butylcalix[4]arene in CDCl3 at 298 K (this work) 
1.4.1 Properties and conformations of p-tert-butylcalix[4]arene 
 Due to the presence of intramolecular hydrogen bonding between the four phenolic hydroxyl                                                                                                                                                                                                                                                                                                   
groups the structure of calix[4]arene is described as rigid with two cavities (Fig. 1.12) which are the 
upper hydrophobic cavity found between the aromatic rings which is considered as a container for 
Axial proton 
Equatorial proton 
proton 
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electron deficient species and the lower hydrophilic cavity or semi-cavity which is formed through 
the substitution of the phenolic hydrogens   by different functional groups 109,110. 
 
Wide rim
Narrow rim
Upper rim
Lower rim
narrow rim
wide rim
Fig. 1.12  The upper and lower rim of p-tert-butylcalix[4]arene  
 
 Due to the presence of four separated phenol rings by methylene bridges, these rings are flexible to 
rotate via the methylene bridges leading the calix[4]arene to adopt four different conformations 
recognised first by Cornforth111 and later coined by Gutsche as cone, partial cone, 1,2-alternate and 
1,3-alternate conformations resulting from different orientations of the phenolic rings in the space . 
In a “cone” conformation all phenol rings are oriented in one direction (up or down) (Fig. 1.13(a))    
and this is considered the more favourable conformation due to the formation of intramolecular 
hydrogen bonds between the hydroxyl groups.  In a partial ‘cone’ conformation, three of the phenol 
rings are oriented in the same direction (up or down) except one ring which is oriented in the opposite 
direction (Fig. 1.13 (b)), The 1,2-alternate conformation contains two adjacent phenolic rings 
oriented in the same direction while the others are oriented in the opposite direction (Fig. 1.13 (c)). 
The 1, 3-alternate conformation involves phenol neighbouring rings in the opposite direction up or 
down (Fig. 1.13 (d)). The parent p-tert-butylcalix[4]arene adopts a “cone” conformation in solution 
and in the solid state and the inter-conversion between these conformers can take place because of 
the possibility for the phenolic groups to rotate  via the methylene bridges105. 
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a b
dc
 
Fig. 1.13 Possible conformations of p- tert-butylcalix[4]arene: (a) Cone ,(b) Partial cone,(c) 1,2-
alternate ,(d)1,3-alternate. 
 
1H and 13C NMR spectra are used to distinguish between these sterioisomers especially 1H and 13C 
NMR patterns for the bridging methylene groups which are different for three out of four 
conformations. In a “cone” conformation the methylene bridge protons appear as a pair of doublets. 
The 1, 2-alternate conformation and the “partial cone” have similar patterns and appear as a pair of 
doublets and one singlet, it can be recognised in the aromatic part of the spectrum whereas a 1, 3-
alternate conformation appears as one singlet110. The 13C NMR spectrum for the bridge methylene 
carbon have been used by De Mendoza and co-workers112 to identify the possible conformations 
adopted by p-tert-butylcalix[4]arene and they demonstrated that the resonance near δ = 31 ppm is 
related to  the bridge methylene carbon when the connected phenyl groups are in the “syn” direction 
(both phenyl groups up or both phenyl groups down ) and near δ = 37 ppm when they are in opposite 
orientation (Fig. 1.14)  
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1H NMR Spectrum                                                                         13C NMR Spectrum 
 
(a)     (ppm)                                                                            (b)       (ppm) 
Fig. 1.14 Patterns of signals expected in the (a) 1H NMR and (b) 13C NMR spectra of the four 
conformational isomers of calix[4]arene110 
 
1.4.2 Lower Rim Functionalisation of calix[4]arenes 
There is a diverse number of calix[4]arene derivatives due to the flexibility of the upper (p-tert-butyl) 
and lower rim (phenolic hydroxyl groups) to be functionalised by different functional groups. This 
modification with additional functional groups increases the binding ability of parent calix[n]arenes 
to form complexes with cations, anions and neutral species.  There are a variety of functionalised 
calix[4]arenes which have been synthesised either by functionalisation of the phenolic rim or the 
upper rim. As far as functionalisation of the lower rim is concerned, alkylation of the phenolic groups 
is one of the easiest reactions which can occur at the lower rim. This involves functional groups such 
as esters, ketones, amines and amides which can be introduced into the phenolic hydrogens of 
calixarenes113-119.  
McKervey et al 113 have carried out the synthesis of   functionalised p-tert-butyl-calix[n]arene [n=4, 
5, 6] by ester groups and they reported the complexation processes of these receptors with alkali 
metal cations in non-aqueous media. These authors concluded that p-tert-butylcalix[4]arene 
containing ester groups showed high selectivity towards the sodium cation over other metal cations. 
It was aimed that the “cone” conformation of the receptor and the presence of tert-butyl group at the 
upper rim drive the ester group at the lower rim to form a cavity for coordination. Also, it was 
emphasised that the complexation of p-tert-butylcalix[6]arene was less towards sodium and have 
shown selectivity towards the potassium ion which means that the formation of a larger cavity leads 
to alter the ability of the receptor to interact with larger cations113-116. Arnaud-Neu et al 114 have 
reported the synthesis of a series of new receptors containing esters and ketones functionalities at the 
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lower rim of p-tert-butyl-calix[n]arenes [n=4, 5, 6] and found that these derivatives exhibited affinity 
to interact with alkali metal cations.  The effect of the cavity size on the complexation process was 
demonstrated. 
Danil de Namor and co-workers117,118 have carried out novel studies about the synthesis and 
characterisation of lower rim calix[4]arene derivatives (Fig. 1.15 a and b)  and the effect of these 
functional groups on cation and anion complexation processes . This was carefully followed by the 
change in the electrical behaviour of ionic solutions as a result of complexation using conductometric 
and potentiometric titrations. In fact they reported the effect of ester and ketone hydrophilic groups 
on the complexation behaviour of these functionalised receptors towards alkali, alkaline earth-metal, 
transition and heavy metal cations and they found that the calix[4]arene functionalised by ketone 
groups in acetonitrile was more selective for these cations than the ester derivatives especialy towards 
Ca2 (log Ks = 12.16, Table 1.4) 
 
                                                            
                                              
                                                     a                                     b 
Fig. 1.15 Lower rim functionalised p-tert-butylcalix[4]arene with (a) ester and (b) ketone groups 
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Table 1.4 Thermodynamic parameters for the complexation of (a) p-tert-butylcalix[4]arene tetraester  
and (b) p-tert-butylcalix[4]arene ketone with bivalent cations in acetonitrile using different 
techniques obtained by Danil de Namor and co-workers117 
Receptor (a )      log Ks             ∆cG° (kJ mol1)        ∆cH° (kJ mol1)           ∆cS°(JK1mol1)  
Ca 2+ 8.15b  46.23   53.8a  25  
 
 Sr 2+ 
 
5.35a 
 
 30.48  
 
 37.6a 
 
 24  
 
Ba 2+ 
 
4.34a 
 
 24.80  
 
 29.6a 
 
 16  
 
 Pb 2+ 
 
7.39a 
 
 42.18  
 
 59. 7a 
 
 59 
 
Cd 2+ 
 
4.08c 
 
 23.29  
 
 22.4c 
 
   3 
 
Hg2+ 
 
3.69 c 
 
 21.01 
 
 21.1 c 
 
 0.3 
 
Receptor (b)       log Ks          ∆cG°(kJ mol1)         ∆cH° (kJ mol1)             ∆cS° (J K1mol1) 
 
Mg2+ 
 
3.33c 
 
 19.01  
 
   48.1c 
 
   225  
 
Ca2+         12.16b 
 
 69.41  
 
 65.3b 
 
   14     
 
 Sr2+                 7.90d 
 
 45.10  
 
 49.8d 
 
 16  
 
 Ba2+ 
 
5.14a 
 
 29.34  
 
 36.9a 
 
 25   
 
 Pb2+ 
 
9.30b 
 
 53.09  
 
 62.7a 
 
 32  
 
Cd2+ 
 
6.60c 
 
 37.67  
 
 22.7c 
 
   50 
 
Hg 2+   5.90d  33.68  32.3d    5 
 
 
(a) Direct calorimetry, (b) competitive macrocalorimetry, (c) direct microcalorimetry, (d) competitive 
microcalorimetry titrations  
Stability constant values shown in Table 1.3 indicate that the selectivity of the ester derivative 
followed the sequence,  
 
                                        Ca2  Pb2  Sr2  Ba2  Cd2  Hg2 
 
While the ketone derivative showed different trend and followed the sequence 
                                      Ca2+ > Pb2+ > Sr2+ > Cd2+ > Hg2+ > Ba2+ 
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Considerable enhancement in the binding affinity towards alkali-metal cations were noticed when 
tetra-diethylamide functionalities were introduced in the lower rim of p-tert-butylcalix[4]arene (Fig. 
1.16 ) and have exhibited strong affinity to complex with alkali metal cations especially with sodium 
and potassium cations. The X-ray crystal structure indicated that the cation is properly accommodated 
in the polar cavity while a “cone” conformation is adopted by the receptor.  Also, the receptor has 
affinity to complex with alkaline-earth metal cations and the highest affinity was found for calcium 
over other alkaline-earth metal cations. The addition of the amide functionality leads to increasing 
the basicity of the receptor and has made it more basic than ester and ketone derivatives119. 
                                                                      
 Fig. 1.16 Chemical structure of 5, 11, 17, 23-tetra-tert-butyl-25, 26, 27, 28-tetrakis(N, N-
diethylaminocarbonyl) methoxy calix[4]arene 
 
The functionalisation of the calix[4]arene with phosphine oxide at the lower rim (Fig. 1.17) has led 
to increase the affinity of the receptor to bind with lanthanide metal cations and this modification was 
used to remove radioactive elements such as europium, Eu (III), thorium, Th (IV), plutonium, Pu 
(IV) and americium, Am (IV) from nuclear waste120                       
                                                                                  
Fig. 1.17 Chemical structure of p-tert-calix[4]aren functionalised with phosphine oxide 
 
Calixarine derivatives containing mixed functionalities like amide-bipyridine or amide phenantroline 
(Fig. 1.18) have also shown affinity to interact with lanthanide cations119. 
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CH3H3C
     
    
Fig. 1.18 Chemical structure of receptors used for the complexation of lanthanides cations 
 
It has been demonstrated that bis-calix[4]arene (Fig. 1.19 a) has affinity to bind  with methyl viologen 
(N-N-dimetyl-4,4-bipyridinium dichloride) (Fig. 1.19 b) which is commonly utilised as a herbicide 
and it is well known for its negative impact to human health and the environment. The complexation 
process revealed that the herbicide is completely incarcerated in the -rich rectangular cavity and the 
complexation process is promoted by cation- interaction between the positive charge of the hosted 
herbicide with the -system zoomed by two parallel anthracenes and the calix[4]arene skeleton. The 
receptor has the ability to act as a fluorescent chemosensor to this toxic material due to the presence 
of anthryl group in the receptor skeleton121. 
    
CH3H3C - -Cl Cl
                 
                                                                                                                                                                                        
                                                
(a)                                                                  (b)                      
Fig. 1.19 Chemical structure of (a) bis-calix4]arene and (b) methyl viologen 
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1.4.3 Upper rim functionalisation 
As previously stated the upper rim of calixarenes can be functionalised through the removal of the p-
tert-butyl groups which makes the p-positions of the phenolic groups as a target for electrophilic 
substitution reactions122,123. 
AlCl3
Toluene, 60 °C
R
 
                                                             R= CH2NR2, SO3H, NO2, COH, CH2CH=CH2 
 
Scheme 1.4 De-alkylation and upper rim functionalization of p-tert-butylcalix[4]arene 
 
Rebek124 has reported remarkable research on the functionalization of the upper rim of calix[4]arene 
by urea  and found that the functionalised compound tends to form a dimeric capsule facilitated by 
hydrogen bonding through the urea groups (Fig. 1.20). Thus the substituent works as a linker between 
two molecules of calix[4]arene. This work has been expanded and exploited by chemists to produce 
molecular capsules with unique behaviour125 
 
          
Fig. 1.20 Functionalization of the upper rim of calix[4]arene by urea and the formation of  dimeric 
structure when an appropriate guest is present124 
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Sulfonation of calix[4]arene and calix[5]arene (Fig. 1.21) has led to the formation of non-toxic 
molecules which were found soluble in aqueous media. As such these findings gained much attention 
for biological and environmental applications due to their binding properties with different guests 
and their application as molecular capsules in the solid state governed by guest size125,126 
 
                                
SO3H SO3H SO3H SO3H 
 
                                    
  Fig. 1.21 Chemical structure of sulfonated calix[4]arene 
 
Wang et al 126 reported the formation of bis molecular capsules resulting from the complexation of  
p-sulphonatocalix[4] arene (SC4A), p-sulfonatocalix[5]arene (SC5A) and p-
sulfonatothiacalix[4]arene (STC4A) with 5, 6- dihydropyrazion[1, 2, 3, 4- lmn] [1,10] 
phenanthroline-4, 7-diium (DP2+)  in aqueous media at a pH range of 2-3 and they demonstrated that 
the guest molecule is encapsulated between two molecules of the host and thermodynamically stable 
complexes were formed stabilised by π-π interaction between the hosted phenanthroline rings with 
the hydrophobic cavity of calix[n]arene n=4, 5 (Fig. 1.22) 
 
+ +
2+
DP
      
Fig. 1.22 “Bis-Sulfonated” calix[4]arene as a molecular capsule126 
Water soluble p-phosphonic acid calix[4]arene (Fig.1.23) tends to self-assembled in the presence of    
acetonitrile into a bilayer and a nanorafts structure is formed driven by multiple hydrogen bonds  
associated with π stacking and C-H..π bonding127. 
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Fig. 1.23 Chemical structure of p-phosphonic acid calix[4]arene 
Functionalization of both, the lower and the upper rim of calix[4]arene by different functional groups 
led to enhance their ability towards radioactive elements. Lu et al128 have used p-phosphorylated 
calix[4]arene to extract thorium from aqueous media (nitrate as counter-ion) and have shown a good 
selectivity for thorium over other radioactive species (Fig. 1.24) 
                                                               
H5C2 C2H5
C3H7
                                                                          
Fig. 1.24 Lower and upper rim functionalized calix[4]arene. 
Functionalisation of the upper rim by hydrophilic groups such as sodium sulfonate Na+SO3
- and  hexyl 
hydrophobic substituents at the lower rim leads to the formation of amphiphilic macrocycles which 
can be self-assembled to generate spherical nano vesicles in aqueous solution (Fig. 1.25 ). This 
aggregation has gained much attention in the field of nanomedicine due to their application as a 
chaperone in drug delivery129-130. The drug non-covalently loaded inside the nanocup of the 
amphiphilic macrocycle generates supramolecular amphiphiles driving the drug directly to targeting 
the infected cells. The aggregation process is not continuous and the releasing of the drug from the 
vesicle is induced by a specific enzyme.  The usefulness of this approach is to concentrate the drug 
at the disease site in order to maximise the therapeutic activity by increasing the drug uptake by the 
cells and also to minimise the metabolic pathway of the drug in order to minimise the undesired side 
effects which exist by using other technologies. This approach was utilised successfully to drive and 
localise the cationic anticancer drug at the cancerous tissues129. 
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 Fig. 1.25 Chemical structure of amphiphilic calix[4]arene and the aggregation to form vesicle129 
Gutsche et al 131 have reported the interaction of p-tert-butylcalix[4]arene and p-tetra-
allylcalix[4]arene with tert-butyl amine in acetonitrile and they concluded that the complexation 
process is promoted by a proton transfer reaction from the p-tert-butylcalix[4]aren to the amino 
compound. They suggested that the complexation process occurred in two steps, the first step includes 
the proton transfer to form ions and the second step includes the association of these ions to form a 
host- guest complex (eq.1.1) 
eq.1.1
 
HNR3ArO
-ArOH + R3N
K1 K2
Ar R3
-
Gutsche and See132 demonstrated that the double-cavity calix[4]arene (Fig. 1.26) has a weak affinity 
to complex with neutral guests such as phenols, aldehydes, carboxylic acids, pyridines, imidazoles 
and aliphatic amines and they reported stability constants  in the order of 5 to 55.    
                                          
(CH2)4
(CH2)4
                                                                         
Fig. 1.26 The chemical structure of a double cavity p-tert-butylcalix[4]arene 
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Immobilisation of a functionalised calix[4]arene containing di-substituted dithiocarbamate (Fig. 
1.27) on the surface of gold nanoparticles surface led to enhance the colorimetric and quantitative 
responseof the receptor towards the cobalt (II) metal cation over other metal cations. The anchoring 
process has led to produce a rigid macrocycle compared with the non-immobilized calix[4[arene 
moiety that has affinity to interact strongly with cobalt (II). The advantage of this process is to induce 
changes in the physico-chemical properties of the gold nanoparticles which could lead to increase 
this sensitivity. The changes include red shift in the SPR (surface plasmon resonance) absorption 
band as a result of complexation with Co2+ compared with the free form of the receptor133. 
                                       
Au
 
Fig. 1.27 Immobilizing calix[4]arene derivative on the surface of gold nanoparticles  
1.4.4 Applications of calixarenes and derivatives 
The potential industrial applications of calixarenes have been discussed by Perrin and co-workers134 
Applications included i) the recovery of high concentrations of caesium from nuclear waste using a 
calixarene derivative ii) the selective transport of cations using calixarenes, iii) the removal of 
lanthanides, iv) their use as antioxidants for polymers, iv)  separation of organic molecules making 
use of the hydrophobic cavity of these receptors v) Extracting agents mainly for cations,  vi ) 
environmental control and vi) the production of the electronic devices such as calixarene based ion 
selective electrodes. In addition, new materials have been produced in which calixarenes were 
anchored to silica through the upper rim, prior removal of the p-tert butyl groups so the complexing 
properties of the functionalised lower rim for cations are not disturbed as a result of this modification. 
Since then this area of applied research has expanded significantly to an extent that the role of 
calixarenes in Nanosciences has been the subject of a book (Calixarenes in the Nanoworld) 135  
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The complexing ability of calixarenes for actinides has been emphasised in several review articles 
related to the nuclear industry136. A recent review by Kiegel and co-workers137 contains a 
comprehensive account on the efficient use of calix[6]arenes for uranium separation processes and 
their involvement in liquid-liquid extraction, liquid-membrane separation and ion exchange 
processes. Among them, the advantage of the ion exchange process was highlighted in that the use 
of environmentally unfriendly organic solvents is eliminated 
In recent years the use of unsupported calixarenes and derivatives have been considered as an 
efficient approach for the removal of pollutants from wáter due to the lack of solubility of these 
receptors in aqueous médium and the advantages with respect to liquid-liquid extraction processes 
which involve the use of non-aqueous solvents particularly chlorinated ones such as dichloromethane. 
Within this context Toumi and co-workers138 used unsupported p-tert-butyl calix[4] arene and lower 
rim functionalised calix[4] arenes for the removal of polluting cations such as Cu(II), Cd(II) and 
Pb(II) from wáter with satisfactory results The recycling of the material , an important issue for 
commercial applications, was also considered by these authors.This point is addressed here because 
extraction processes investigated in this thesis make use of unsupported calix[4]arene derivatives. 
1.5 Calix[4]pyrrole (CP)  
  The calix[4]pyrrole, a tetrapyrrolic macrocyclic receptor synthesised over a century ago by 
Baeyer139 from the acidic catalysed condensation reaction of pyrrole with acetone (Scheme 1.5), was 
given the name of meso-octamethyl porphyrinogen. In the last three decades, calix[4]pyrrole has been 
used as a receptor by Sessler and co-workers140,141 for hosting anionic and electron rich neutral 
moieties through the formation of four intermolecular hydrogen bonding aided by the current effect 
of the four pyrrole rings. 
       
Methanol, H+
Ambient temperature, 24 hours
 
Scheme 1.5 Synthesis of meso-octamethylcalix[4]pyrrole  
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1.5.1 Calix[4]pyrrole conformations 
  Due to the presence of four pyrrole rings in the structure of calix[4]pyrrole, separated from each 
other by methylene bridges, these  rings are flexible to rotate via the methylene bridges leading  to 
four different conformations ( cone, partial cone, 1,2-alternate and 1,3-alternate) for this receptor. 
The conversion from one conformation into another is very fast. In a cone conformation all pyrrole 
rings are oriented in one direction (up or down) while in a partial cone conformation, three pyrrole 
rings are oriented in the same direction (either up or down) with the remaining one in the opposite 
direction. As far as the 1,2-alternate conformation is concerned, two neighbouring pyrrole rings are 
oriented in the same direction while the remaining two in the opposite direction. The 1,3-alternate 
conformation pyrrole rings are up or down in an alternate fashion as shown in Fig. 1.28. The “cone” 
conformation was found to be the less stable due to the electrostatic repulsion between the pyrrole 
rings142-145.                                               
                      
Fig. 1.28 Four different conformations adopted by calix[4]pyrrole144 
Therefore the free calix[4]pyrrole receptor  adopts in the solid state and in solution the 1,3- alternate 
conformation to minimise the electrostatic repulsion between the pyrrole rings which then re-
organised to a “cone” conformation upon complexation with the anion through hydrogen bond 
formation (Fig. 1.29) 
                
Fig. 1.29 Conformational changes of calix[4]pyrrole to a “cone” conformation upon anion  
complexation (A = F , Cl, Br)141. 
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1.5.2 Functionalisation of calix[4]pyrrole 
Calix[4]pyrrole derivatives can be obtained by introducing different functional groups in three active 
positions in order to enhance their chelating behaviour. These positions are the C-rim or β-position, 
the meso position and the N-rim (Fig. 1.30) 
                                               
Meso  position
β-position
N-rim
                                
 Fig. 1.30 Different active positions for functionalization of calix[4]pyrrole 
1.5.2.1 Functionalisation of the C-rim (β-position) of calix[4]pyrrole 
 In order to study the effect of the substituents at β-position on the chelating behaviour of   
calix[4]pyrrole, Gale and co-workers146 reported that the  functionalised calix[4]pyrrole at the β-rim 
can  alter the chelating behaviour of this macrocycle towards guests. This modification can be 
achieved by applying two subsequent strategies; firstly by condensation of 2, 3-disubstituted pyrrole 
with ketones, and secondly by the introduction of substituents directly into the pre-synthesised 
calix[4]pyrrole.  
By applying the first strategy they reported the synthesis of β-octamethoxy-meso-tetra-spiro-
cyclohexylcalix[4]pyrrole by the condensation reaction of the 3,4-dimethoxypyrrole with 
cyclohexanone catalysed by glacial acetic acid.(Fig. 1.31 (a)). The condensation reaction between 3, 
4-di-flouropyrrole-1H- pyrrole with acetone catalysed by methanesulfonic acid has led to the 
formation of the octamethyl-octaflourocalix[4]pyrrole (Fig. 1.31 (b)) It should be emphasised that 
this macrocycle showed a higher affinity towards fluoride and chloride anions in solution than the 
non-fluorinated calix[4]pyrrole due to the formation of stronger hydrogen bonds. It also led to an 
increasing affinity for neutral guests in the solid state as a result of the higher acidity of N-H groups. 
Following the second strategy described above, Gale and co-workers146 have reported the first 
esterification of meso-octamethylcalix[4]pyrrole at the β-position (Fig. 131 (c)) through the 
electrophilic substitution by ethylbromacetate in the presence of tert-butyl lithium as the base. The 
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product was partially and fully substituted at the β-positon. The de-esterfication of the compound 
facilitated the reaction with the solid support. The resulting material was used as an extracting agent 
for the removal of halides anions from water.  
Anzenbacher et al147 have demonstrated that the direct formylation of the pre-synthesised meso-
octamethylcalix[4] pyrrole by the Vilsmeier reagent led to produce optical sensors for anionic species 
(Fig. 1.31 (d)) which were further modified by Farinha and co-workers148 to produce receptors 
containing the C-N group ( Fig. 1.31 ( e)). These exhibited a strong affinity to complex with fluoride, 
chloride and dihydrogen phosphate anions.  
According to the second strategy, Gale and co-worker146 have reported the fully brominated 
calix[4]pyrrole( Fig. 1.31 (f)) from the reaction of meso-octamethylcalix[4] pyrrole with N-bromo-
succinimide by using methanol as solvent and methansulfonic acid as catalyst. By doing these 
modifications these authors concluded that the functionallisation of the β-position by electron 
withdrawing groups led to increase the strength of the hydrogen bond between the N-H funtionality 
of the pyrrole ring and the targeted guest. 
 
(f)
R=CH2CO2Et
(d) (e)
(a) (b) (c)
CHO
Me
CN CN
Me
Me
Me
Me
Me
MeMe
 
Fig. 1.31 Different products with different substituents at the β-position on the pyrrole rings of 
calix[4]pyrrole. 
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1.5.2.2 Functionalisation of the N-rim of calix[4]pyrrole 
The functionalization of the N-rim of calix[4]pyrroles has been carried out by Furusho et al 149 to 
introduce alkyl groups groups to the N-rim of meso-octaethylcalix[4]pyrrole by using alkyl iodide in 
the presence of n-butyllithium as a base. The author has demonstrated that five possible N-methylated 
and N-monomethylated meso-octaethylporphyrinogens were obtained (Fig. 1.32) 
                                                                               
                                                               R1 = Methyl, R2 = R3, R4 = H 
                                                               R1 = R2 = Methyl, R3 = H, R4 = H 
                                                               R1 = R3 = Methyl, R2= R4 = H 
                                                               R1 = R2 = R3 = Methyl, R4 = H 
                                                               R1 = R2 = R3 = R4 = Methyl   
                                                               R1 = Ethyl, R2 = R3 = R4 = H 
Fig. 1.32 Functionalisation of meso-octaethylcalix[4]pyrrole through the N-rim 
1.5.2.3 Functionalisation of the meso position 
Woods et al 143 reported the synthesis and complexation studies for an extended calix[4]pyrrole (Fig. 
1.33) with halides and hydrogen phosphate anions (as tetrabutylammonium salts) in DMSO and they 
concluded that the receptor exhibited selectivity towards fluoride over other anions 
                                                    COCH3  
Fig. 1.33 Structure of the receptor synthesised containing acetoxy group at the meso position 
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Danil de Namor and Shehab150 have carried out complexation of meso-octamethylcalix[4]pyrrole 
with halides and dihydrogen phosphate in acetonitrile and DMF and they demonstrated that the 
receptor exhibited preferences towards the fluoride over the chloride anion with stoichiometric ratio 
1: 1 and the thermodynamic parameters for the complexation was derived from calorimety.   
Thermodynamic studies by Danil de Namor and Shehab32 revealed that the extended calix[4]pyrrole 
derivative containing a double cavity (Fig. 1.34) has significant effect on the binding properties of 
the receptor towards halide anions and complexation studies were confirmed by 1H NMR and 
conductivity measurements in addition to calorimetric studies to derive the thermodynamic 
parameters of the complexation process. They identified that the ability of the receptor to complex 
with the fluoride anion dramatically increases as compared with other halides and dihydrogen 
phosphate anions            
                                                           
Fig. 1.34 Structure of meso-tetramethyl[N-(phenoxyethyl)-N-phenylurea]calix[4]pyrrole 
 
Danil de Namor and co-workers151 reported thermodynamic studies of the interaction of the meso-
tetramethyl-tetrakis{4-[2-(thio) ethoxy] phenyl}calix[4]pyrrole (Fig. 1.35) as a ditopic receptor with 
fluoride and mercury ions in acetonitrile. The receptor exhibited affinity to complex with Hg2+ and 
Ag+ cations as well as the fluoride anion. The composition of the complexes formed was investigated 
by conductance measurements. Titration calorimetry was used to calculate the thermodynamic 
parameters of complexation. They concluded that the addition of sulphur moieties has played an 
important role in the complexation with the cations whereas the NH interacts with the fluoride anion.  
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Fig. 1.35 Chemical structure of the calix[4]pyrrole functionalised by groups containing sulphur  
 
 Danil de Namor and co-worker152 reported detailed thermodynamic studies for a new ditopic receptor 
by modification of the meso position (Fig. 1.36) and they found that increasing the depth of the 
calix[4]pyrrole cavity led to increasing the binding strength towards halide anions especially towards 
the fluoride anion. Thermodynamic parameters and stoichiometric ratios for the complexation of 
calix[4]pyrrole and derivativs functionallised at the  meso position reported by Danil de Namor and 
co-workers with anions are included in Table 1.5150-152 
                                                                
Figure 1.36 Functionalised meso position of calix[4]pyrrole synthesised by Danil de Namor et al  
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Table 1.5 Thermodynamic parameters and stoichiometric ratios for the complexation of 
calix[4]pyrrole and functionalised calix[4]pyrrole at the meso position with anions synthesised by 
Danil de Namor and co-workers150-152. 
Receptor Anion L: X log Ks ∆cG 
kJ mol-1 
∆cH 
kJ mol-
1 
∆cS 
J mol-1K-
1 
 
F− 1: 1 6.21 -35.4 -43.5 -27 
Cl− 1: 1 4.70 -26.8 -44.7 -60 
Br− 1: 1 3.65 -20.8 -30.7 -33 
I- 1: 1 1.55 -8.8 -4.0  15 
H2PO4
− 1: 1 5.00 -28.5 -48.1 -66 
      
 
F− 1: 1  5.44 -31.1 -32.4 -5 
Cl− 1: 1 3.82 -21.8 -20.5  5 
Br− 1: 1 3.20 -18.2 -15.4  9 
H2PO4
− 1: 1 4.82 -27.5 -32.1 -15 
      
 
 
                          
F− 1: 1 3.08 -17.6 -97.1 -267 
Cl− 1: 1 2.36 -13.5 -55.9 -142 
Br− 1: 1 1.61 -9.2 -58.6 -166 
H2PO4
− 1: 1 4.80 -27.4  20.2   25 
 1:2 4.66 -15.2 -29.9 -50 
      
R
R=CH2CH2NHCONHC6H5
 
F− 
 
1: 1 
1:2 
5.00 
4.72 
-28.5 
-27 
-31.4 
-61.5 
-10 
-116 
Cl−  1: 1 2.43 -13.9 -86.4 -244 
H2PO4
- 
 
1: 1 
1:2 
4.8 
4.66 
-27.4 
-27.4 
-61.5 
-29.9 
-116 
-50 
R
R= -CH2COCH3
 
F− 
 
1: 1 
1:2 
4.3 
2.8 
-24.6 
-15.7 
-21.1 
-6.4 
12 
32 
H2PO4
− 1: 1 4.11 -23.4 -22.74 03 
      
R
R=CH2CH2NHCONHC6H5
 
F− 1: 1 5.00 -28.7 -20.2 29 
Cl− 1: 1 3.3 -18.7 -3.1 52 
Br− 1: 1 2.2 -12.7 -1.8 36 
      
 
F− 1: 2 5.25 -29.9 -31.5 -05 
Cl−  1: 1 4.15 -23.7 -51.7 -95 
Br− 1: 1 3.46 -19.7 -34.6 -49 
 
H2PO4
− 
1: 1 
1:2 
4 
3.7 
-22.7 
-21.2 
-43.7 
-17.8 
-70 
 11 
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Introduction of different functional groups to the parent calix[4]pyrrole at the meso position enabled 
these macrocycles to interact with anionic and cationic guests and have gained considerable attention 
due to their application in biological processes. These receptors can be used as ion transporter through 
biological membranes (Fig. 1.37)153 
 
  Fig. 1.37 Calix[4]pyrrole as ion transporter across the biological membrane153 
 
Sessler et al154-a concluded that the addition of caesium perchlorate to the fluoride complex with 
functionalised calix[4]pyrrole in an acetonitrile: methanol (9: 1) mixture led to fasten the 
complexation with the fluoride anion and the caesium cation nested in the cup-like portion of the 
calix[4]pyrrole whereas the addition  of potassium perchlorate led to complex with the potassium in 
the crown ether part. They demonstrated that this type of complexation led to increase the electrostatic 
interaction between the receptor and the ion-pair and can be act as a ion-pair transporter through the 
cell membrane (Scheme 1.6) 
K+
F-
F-F-
K+ Cs
+
Cs+
 
 Scheme 1.6 Complexation of ions in different sites of calix[4]pyrrole 
Also Sessler et al 154-b reported the synthesis of strapped calix[4]pyrrole with calix[4]arene at the 
meso position as an ion pair receptor which has affinity to interact with anionic and cationic moieties. 
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They demonstrated that the receptor has affinity to complex with Cs+ and F— ions in a mixture of 
methanol and chloroform (MeOD: CDCl3) and found that the addition of an excess of CsF led to the 
formation of a supramolecular polymer (Scheme 1.7) 
                    
 
Fig. 1.38   Schematic representation for the formation of a supramolecular polymer during the 
addition of an excess amount of caesium fluoride.154-b                       
                                                                                           
1.5.3. Applications of calix[4]pyrroles 
Calix[4]pyrrole Ion Selective Electrodes ISEs 
Producing electrical devices used to determine the activity of specific ion in electrolyte solutions in 
the presence of others remains a huge challenge155.  Supramolecular chemistry enabled chemists to 
produce selective and sensitive hosts that can be used as sensors for anions, electron deficient cations 
and neutral molecules even in very diluted solutions156,157. Calix[4]pyrroles possess  relatively large  
cavity  for hosting anions supported by four hydrogen bonds  between the anions and the NH groups 
and electron rich  cavity that can be reorganised when this is essential.  Calix[4]pyrroles are easily to 
synthesise and functionalise to make them useful receptors for different guests especially for electron 
rich guests with appropriate size and the cooperative effect of solvents  . This unique behaviour has 
been explored to construct potentiometric sensors through the formation of supermolecular host-guest 
complexes reflected in the potentiometric signals. ISEs based on polyvinyl chloride (PVC) containing 
calix[4]pyrrole (Fig. 1.27) produced by Kra´l 157 and co-workers showed much higher responses at 
low pH (pH = 3.5-5.5) towards Br ̅, Cl ̅ and H2PO4 ̅
̅̅  than F ̅  .This was attributed to the anionic 
propensity for the macrocycle and to the size fitting effect in the coordination processes. At high pH 
(pH = 9) the membrane displayed non-Hofmeister selectivities (Br ̅ ˂ Cl ̅ ˂ OH ̅ ≈ F ̅ ˂ HPO4  ̿) as a 
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result of the coordination of the receptor with the OH ̅  anion157,158. Steinle et al 159 have studied the 
enhancement of anion selectivity of octaethyl (OEP) and tetraphenyl porphyrines derivatives drugged 
with trivalent gallium, indium and thallium into the polymeric ISEs membrane. These authors have 
concluded that the ISEs based on PVC doped indium (III) has a significant effect on the selectivity 
enhancement of the membrane towards the chloride anion. In the same way the membrane containing 
gallium (III) showed remarkable sensing properties toward the fluoride anion whereas general 
selectivity enhancement was obtained in the sensitivity by the membrane doped with thallium (III) 
towards the chloride over other anions. Park et al 160 have studied the efficiency of calix[4]pyrrole 
based ISEs  and its derivative to respond to monovalent thallium and they found that the receptor was 
more efficient than others as a result of the presence of four cyclohexyl groups which led to increasing 
the rigidity and the geometry of the receptor towards monovalent thallium. 
 Recently Danil de Namor and co-workers161 have demonstrated that the functionalised 
calix[4]pyrrole containing amide groups showed high selectivity towards mercury cation (II). 
Resorcinarenes are receptors involved in this thesis, therefore a brief introduction on the synthesis 
and properties of these ligands with reference to the cyclic tetramer is now given 
1.6 Resorcin[4]arenes 
A new class of molecular capsules synthesised by the acid catalysed condensation reaction of 
aliphatic or aromatic aldehydes with resorcinol in 1940 by Niederl and Vogel162 are currently known 
as resorcin[4]arenes (Scheme 1.8 ) 
Heat, 80 °C
EtOH/ HCl
 
Scheme 1.7 Synthetic pathway of resorcin[4]arene 
The cyclic tetramer structure was confirmed by X-ray crystallography by Erdtman et al 163 in 1968. 
Gutsche and Bӧhmer91 have proposed that the compound was similar to calix[4]arenes and classified 
these cyclic tetramers as  calix[4]resorcinarenes.  Due to the presence of more hydroxyl groups on 
the phenyl rings with respect to calix[4]arenes which enhances hydrogen bond formation, these 
receptors are more rigid than calix[4]arenes and hexameric aggregation164 for these macrocycles in 
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the solid state and in solution have been reported.  The connectivity between the aryl groups via the 
methylene bridges allows the formation of hydrophobic cavities able to encapsulate guests with the 
appropriate size. 
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Fig. 1.39 General structure of resorcin[4]arene showing (a) 2, 8, 14, 20-tetramethyl, the numbering 
of substituent positions  and (b) Hexameric aggregation in solution164 
Hӧgberg165 has reported the condensation of resorcinol with different aldehydes. The   
resorcin[4]arene formed can adopt four different conformations; “crown”, “boat”, “chair”, and 
“saddle” conformation  (Fig.1.40) but he demonstrated that the cyclic tetramer is formed in only two 
isomers namely “chair” and “crown” conformers. Although the “chair” conformation is energetically 
more favoured than the “crown” to reduce the repulsion between the aryl groups, the ratio between 
these isomers depends on the reaction conditions. Atwood et al 166 have synthesised a series of 
resocin[4]arene derivatives containing phenyl groups as pendant arms and they concluded that the 
isolated products was only in a chair conformation. 
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Crown Chair
Boat Saddle
  
 
Fig. 1.40 Possible conformations can adopted by the resorcin[4]arene cyclic tetramer. 
Atwood and co-workers167 in their pioneering work on C-methyl resorcin[4]arene in wetted 
chloroform  proved  that the compound  tends to form an hexameric capsule in the solid state aided 
by eight water molecules. Rebek and Shivanyuk168 reported that the resorcin[4]arene containing 
dodecyl pendant arms in moisturized chloroform tends to form a stable hexameric capsule driven by 
the appropriate guest. Modification of these molecular capsules through the hydroxyl groups prevents 
self-aggregation and leads to enhance their electrostatic attraction towards the guests. Steric factors 
as well as the size of the guests play a crucial rule in the formation of molecular capsules.  Danil de 
Namor and co-workers have synthesised and characterised a resorcine[4]arene derivative containing  
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P, O and S donor atoms (Fig. 1.41)  and found that the receptor exhibited selectivity towards 
mercury169.  
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 Fig. 1.41 Structure of 4, 6, 10, 12, 16, 18, 22, 24-diethyl thiophosphate calix[4]resorcarene 
 
 
Cram and co-workers170,172 have reported the synthesis of new rigid macrocyclic containers created 
by the modification of resorcin[4]arene called “cavitands” (Scheme 1.9). The fully bridging of the 
adjacent aryl rings through the hydroxyl groups leads to the production of these cavitands with a deep 
cavity, rigid enough to encapsulate strongly appropriate guests. Their complexes are known as 
“caviplex”, Cram derived the concept “molecule within molecule” according to his research on these 
molecular containers. These cavitands have gained much attention in host-guest, coordination and 
material chemistry 
 
CH3
CH3
BrCH2Cl, Cs2CO3
DMF, 88 °C
CH3
CH3 CH3CH3
CH3
CH3
Scheme 1.8 Synthetic route for the cavitands 
 
 The bridging of the neighbouring hydroxyl groups can be achieved by different groups which can 
expand the size of the container and also to assist in the production of different bridges with different 
functional and consequently different reactivities (Fig. 1.42). Danil de Namor and co-workers173 have 
demostrated that the selectivity of functionalised resorcine[4]arene towards the silver cation has been 
dominated when the adjacent hydroxyl moieties are bridged by sulphur and phosphorous groups (Fig. 
1.42-c) 
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R=C11H23
  
(a)                                                                (b)                                                 (c)                                         
Fig. 1.42 Showing the bridging of the hydroxyl groups of the resorcin[4]arene by different groups 
The bridging of two cavitands leads to produce more complicated and spherical closed capsules 
named by Cram as “carcerands”. In these receptors the guest is imprisoned permanently in the closed 
structure which means that the guest must be introduced before the encapsulation process takes place 
(Scheme 1.10). The carcerand complexes are known as “carciplex” and there is no possibility for the 
guest to leave the cavity without disruption of the bridges bonds.  
CH2CH2 CH2CH2GUESTCH2ClBr
K2CO3
 
Scheme 1.9 Synthesis of carcerand capsules and encapsulation of the guest to form the “carceplex”  
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The partially bridging of the hydroxyl groups of cavitands has led to produce “hemicarcerands” in 
which the guest can leave the cavity without any disruption to the host bonds (Scheme 1.11)171
 
BrCH2Cl
CH2CH2 CH2GUEST
K2CO3
Scheme 1.10 Synthesis of an hemicarcerand and showing the formation of hemicarceplex and the 
possibility of the guest to leave the cavity. 
Given that in this thesis preliminary studies were carried out with pyrogallol[4]arenes, a brief 
introduction on these macrocycles is now reported  
1.7 Pyrogallol[4]arenes 
 These macrocyclic tetramers were first synthesised in 1990 from the condensation reaction between 
pyrogallol and an aldehyde in acidic conditions (Scheme 1.12)  
Heat, 80 °C
EtOH, H+
 
Scheme 1.11 Synthesis of the pyrogallol[4]arene macrocycle 
1.                                                                                                                                   Introduction 
 
46 
 
A general structure of this macrocycle is shown in Fig. 1.43. Theoretically there is a possibility of 
producing receptors containing an increased number of aryl groups in their structure to form   
pyrogallol[n]arenes but all the work reported in the literature is referred to the cyclic tetramer.                                   
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Fig. 1.43   2, 8, 14, 20-tetra-alkyl-5, 11, 17, 23-tetrahydroxyresorc[4]arene showing the numbering 
of substituent positions 
 Studies carried out by Atwood and co-workers174 in 2002 on p-tert-butyl-calix[4]arene have revealed 
that the macrocycle does not contains pores in its chemical structure but it can be used as a molecular 
container for the solid  guests to form thermodynamically stable supermolecular structure,  the hosted 
solid can be dynamically transported through the host structure as a result of a reversible phase 
transition of the crystal structure to another form with significant change in the size and dimensions 
until the system reaches the stable state.  Crystal phase transfer leads to defect the properties of the 
structure and may lead to enhance its packing capacity175,176. Based on these results. 
pyrogallol[4]arene containing C-pentyl pendant arms was exploited as a container for gas storage and 
the effects of chain length of the pendant arms and the solvent on the storage capacity of these 
receptors have been investigated177. They conclude that the C-pentylpyrrogallol[4]arene is able to 
frusturate CO2 gas at ambient temperature and they emphasised the important contribution for the C-
pentyl pendant arm in the storage efficiency as compared with the pyrrogallol[4]arene containing 
propyl as pendant arm. 
Atwood et al 178 reported the use of pyrogallol[4]arene with different pendant arms (R= methyl, ethyl, 
propyl) as molecular containers for xanthone as solid guest to form co-crystal host-guest complexes 
in different solvents. They demonstrated the role of the solvent and the length of the bendant arm on 
the cavity size which leads to increase the number of guest molecules encapsulated in the cavity, 
which consequently resulted in the production of complexes of different composition. 
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Xanthon Pyrogallo[4]arene, R = methyl, ethyl, propyl
                                         
Fig. 1.44 Chemical structure of xanthon and C-alkyl pyrogallol[4]arene 
 Avram and Cohen179 studies on resorcin[4]arene and pyrogallol[4]arene capsules proved that the 
capsules formed by pyrogallol[4]arene are more stable than those  formed by resorcin[4]arene. Water 
molecules were not included in the complexation processes involving the former capsules. It was 
therefore concluded that no hetero molecular capsules were obtained by mixing pyrogallol[4]arene 
and resocin[4]arene solutions, and these capsules disrupted in both cases by adding a protic polar 
solvent like methanol. Recently Danil de Namor and O. Webb have been carried out the synthesis of 
cavitand, carceplex (Fig. 1.45), carcerands and hemicarcerands arising from resorcin[4]arene and 
pyrogallol[4]arene and were tested as promising capsules to remove  unwanted amines from the fuel 
( petrol or diesel) to enhance the quality of fuel180. 
                                         
       Fig. 1.45 Molecular modelling of carceplex180 
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 1.8 The use of silica based compounds for extraction purposes 
Silica gel was first synthesized by Thomas Graham in 1861 from reacting an aqueous solution of 
hydrochloric acid on sodium silicate181.Nowadays silica gel is produced by the Patrick’s process in a 
similar manner which includes releasing silicic acid by hydrochloric acid from an aqueous solution 
of sodium silicate (eq.1.2). This is prepared by heating sand at a high temperature in the presence of 
sodium hydroxide or sodium carbonate followed by self-polymerisation of the silicic acid with the 
removal of water (Scheme 1.13) 
     Na2SiO3 + H2O + 2HCl              Si (OH)4 + 2 NaCl                  eq.1.2 
 
Scheme 1.12 Polymerisation of Silicic acid 
The polymer continues to grow to form aggregates followed by the conversion to polymeric spheres. 
The simplicity, stability over a wide range of pH and the low cost of silica make this material as one 
of the most important materials for solid phase extraction processes which also shows good extraction 
efficiency as compared with liquid-liquid extraction processes. Although the silica has advantages 
but it is considered to be time and energy consuming due to the time and energy required for 
sonication processes in order to disperse it well and to prevent its aggregation in solution.  In order 
to overcome these problems, the surface of silica can be modified by different functional groups to 
enhance the uptake efficiency towards targeted species. This modification can be achieved by the 
introduction of appropriate organic (Scheme 1.14 a) or inorganic functional groups (Scheme 1.14 b). 
Also the modification of the surface of silica can make the surface more hydrophylic with higher 
energy which can lead to reduce the affinity of silica to interact with   materials which are considered 
hydrophobics in nature. From the health view point silica is considered harmful, the too fine dust of 
silica called respirable crystalline silica (RCS) which is not easily shown in the normal light but its 
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inhalation can cause silicosis, bronchitis or cancer and reduces the capacity of lungs towards 
oxygen182-184. 
NH2 NH2
Me
Me
Me
3-aminopropyltrimethoxy 3-aminopropyl silica
a
b
Scheme 1.13 Modification of silica by (a) organic functional group, (b) inorganic groups 
Danil de Namor and co-workers185 have reported the use of silica as a solid support for the 
functionalised p-tert-butylcalix[4]arene containing amino groups (Fig. 1.46) and they demonstrated 
the ability of this material to remove the acidic herbicides from water. These authors revealed that 
the silica used interacted with water and the heat of interaction was determined calorimetrically. Also, 
the removal of tert-butyl group can reduce the hydrophobicity of the macrocycle which means this 
modification is also useful for the removal of hydrophilic species. 
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Silica
MeMe
                                              
                                    
Fig. 1.46 Chemical structure of 5, 11, 17, 23-tetrakis-[(diethylamine)ethoxy)]calix[4]arene legend 
and its immobilization to silca 
Recently Li and co-workers186 reported the complexation of p-tert-butylcalix[4]arene containing 
crown-5 ether (Fig. 1.47 a) with 1-naphthyl methylcarbamate  (Fig. 1.47 b) which is used as an 
insecticide and they demonstrated that the crown ether pendant arm of the  receptor exhibited 
excellent efficiency to bind the insecticide.  
              
(a)                                                                            (b) 
Fig. 1.47 The chemical structure of (a) the receptor used for the complexation and (b) the 1-naphthyl 
methylcarbamate 
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The propargylated pendant arm was used to link the receptor with a solid support like silica via click 
reaction (Scheme 1.15). The binding selectivity of the crown ether towards the potassium cation was 
exploited to switch off the complexation between the receptor and the insecticide for recycling the 
receptor.  
 
N3
Click reaction
N3N3 N3
 
Scheme 1.14 Using of Silica as solid support for functionalised p-tert-butylcalix[4]arene 
 
1.8.1 Click Chemistry 
The Click chemistry term was introduced by Sharpless et al in 2001187. According to these authors 
for this terminology to be applied, reactions “must be fast, modular, wide in scope, give very high 
yields, generate only inoffensive by-products that can be removed by non-chromatographic methods, 
and be stereospecific (but not necessarily enantioselective”1. The characteristics of the process 
involve simple reaction conditions, starting materials and reagents readily available, the use of 
environmentally friendly solvents such as water or those easily removed and a straight forward 
methodololy of isolation. The azide-alkyne cycloaddition to form five-membered heterocyclic 
compounds is the most prominent click reaction and has gained much attention due to its use in the 
synthesis of a wide variety of compounds with important applications such as drugs, biomarkers, 
nano-carriers polymeric materials and many others. In the absence of heat and catalyst, the reaction 
is slow and when reactants are used in small concentration levels, a mixture of products are formed. 
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Meldal et el in Denmark and Sharpless et al 188,189 in US independently discovered that the reaction 
is kinetically fast and has an increase in specificity for a target compound when Cu (I) is used as 
catalyst (Scheme 1.15) 
 
Uncatalysed
CuSO4, Na ascorbate
ButOH: H2O
1
2
Thermal
1,4- regioisomer 1,5-regioisomer
2
2
2
1
1
1
Scheme 1.15 Uncatalysed and catalysed zide-alkyne cycloaddition reaction   
 
The following mechanism was proposed (Scheme 1.16) 
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Scheme 1.16 Proposed mechanism for catalysed azide-alkyne cycloaddition reaction  
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1.9 BET Theory 
BET is the abbreviation of three names of three scientists; Brunauer, Emmett and Teller (BET), 
BET theory was suggested by the above scientists to describe the ability of porous materials to 
adsorb gases such as nitrogen gas by specific surface area and this ability can be expressed by the 
following BET equation (eq.1.3) 
  1/ (W ((P/P ◦) −1)= 1/WmC +( C −1) /Wm C {P/ P 
◦
)}                                                       eq.1.3 
In this equation, W is the weight of gas adsorbed, P/P◦ is the relative pressure in torr unit applied on 
the solid sample, Wm is the weight of the solid as a monolayer and C is the BET constant.  Plotting 
the relation of 1/ [W (P / P
◦
) -1] against P/P
◦
 gives a straight line for most solids, using nitrogen as 
adsorbent.   The porosity of the material under study can be predicted from the plot190,191 
1.10 Aims of the Thesis 
  This thesis is concerned with the design, synthesis and characterisation of a number of macrocyclic 
receptors (host) with the ability to bind biologically active species (guest). In addition, a 
functionalised silica will be tested for the same purpose. Pharmaceuticals are targeted in this thesis 
due to lack of thermodynamic studies concerning the interaction of macrocyclic receptors with 
pharmaceuticals. Supramolecular hosts are selected due to their selective behaviour for a particular 
guest, provided suitable functionalities are incorporated in their structure. The pharmaceuticals 
selected are diclofenac, sodium diclofenac (NaDF), chlofibric acid, ibuprofen, aspirin and 
carbamazepine (CBZ) due to their common usage (Table 1.6). Diclofenac belongs to the group of 
non-steroidal anti-inflammatory drugs (NSAIDs) used in human medical care to treat painful 
conditions such as arthritis, sprains and strains, gout, migraine, dental and pain after surgical 
operations. It is a pain-killer which also reduces inflammation. Ibuprofen (also belongs to NSAIDs) 
is used as an analgesic and antipyretic. Aspirin (NSAIDs) is used as an analgesic, antipyretic, anti-
inflammatory and anti-coagulant, carbamazepine is an anti-epileptically drug used worldwide.  
Clorofibric acid is used as a lipid regulator in blood to lower the risk of atherosclerosis192,193. 
The design and synthesis of macrocyclic receptors able to interact with the selected drugs requires 
information about the guest such as its solubility in water and common organic solvents as well as 
knowledge of the partition coefficients for these drugs in water-membrane-like solvent systems. 
Receptors to be synthesised and characterised are cyclodextrins (heptakis-(6-chloro-6-deoxy)-β–
cyclodextrin and heptakis-( 2, 3 , 6-tri-O-benzoyl)-ß-cyclodextrin) and synthetic macrocycles such 
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as calix[4]arenes (5, 11, 17, 23- tert-butyl-25, 26, 27, 28-(O-ethylethanoate)calix[4]arene, 5, 11, 17, 
23- tetra-tert-butyl, 25, 27-bis (2-cyanomethoxy)-26, 28-dihydroxycalix[4]arene , 25, 27-dihydroxy-
26-28-(dioxypropargyl)  tert-butylcalix[4]arene , 4-tert-butyl-azidocalix[4]arene,25, 26, 27, 28-
(diethylamino) ethoxycalix[4]arene), calix[4]pyrroles (meso-tetramethyl-tetrakis-(4-hydroxyphenyl 
ethyl) calix[4]pyrrole, meso-tetramethyl-tetrakis-(4-ethylacetatophenoxyethyl) calix[4]pyrrole ), 
resorc[4]arene (C-pentyl-resorcin[4]arene ,C-pentylresorci[4]arene ester) and pyrogallol[4]arene (C-
decyl pyrogallol[4]arene and C-4-aminophenyl pyrogallol[4]arene) Fig. 1.48 and Fig. 49. This is to 
be followed by 1H NMR studies to obtain information whether or not interaction between receptor 
and drug takes place and if so the identification of the active sites of the receptor. From all receptors 
synthesised, the ones selected for further studies involving drugs (aspirin, clofibric acid, diclofenac, 
sodium diclofenac, ibuprofen and carbamazepine) were the calix[4]arene ester, (5, 11, 17, 27- tert-
butyl-25, 26, 27, 28-(ethylacetatoethoxy)calix[4]arene) CAE, the per-benzoylated cyclodextrin 
(BzBCD), the partially functionalised calix[4]arene amine derivative (5, 11, 17, 23 tetra-p-tert-butyl, 
25, 27- bis[aminoethoxy], 26, 28 dihydroxycalix[4]arene) (CA-(NH2)2),  C-decylpyrogallol[4]arene 
(PG11), calix[4]pyrrole derivatives which are meso-tetramethyl-tetrakis-(4-hydroxyphenyl 
ethyl)calix[4]pyrrole (TTHCP) and meso-tetramethyl-tetrakis-(4-ethylacetatophenoxyethyl) 
calix[4]pyrrole (TTECP) . The 3 –aminopropyl functionalised silica gel was used for the removal of 
aspirin from water. When ionic species are present or occur as a result of complexation, conductivity 
measurements will be performed to establish the composition of the complex and obtain qualitative 
information on the strength of host-guest binding and also the stoichiometry of the complexation. UV 
measurements will be explored to further corroborate the composition of the complex. Whenever 
possible the complexation process will be thermodynamically characterised to obtain the stability 
constant (log Ks) and the standard Gibbs energy ΔcG°, enthalpy ΔcH° and entropy ΔcS° associated 
with this process. Aminopropyl silica will be also tested to remove the selected drugs from water.  
Following previous work on calix[4]ester derivatives and their complexation with metal cations in a 
variety of solvents, calix[4]pyrrole esters will be for the first time synthesised and characterised and 
their binding properties will be investigated. The aim of this part of the work is to assess the effect of 
i) the calix structure on the selective complexation of cations and ii) the ester functionality on the 
recognition of anions by calix[4]pyrrole. The strategy of this research is shown in Scheme 1.18 
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Scheme 1.18   Main strategy for this research  
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Table 1.6 The chemical structure of pharmaceuticals with commercial and IUPAC names 
PHARMACEUTICALS 
 
IUPAC NAME 
 
 
 
     Diclofenac [DF] 
 
 
 
 
 
2-[2-(2,6-Dichloroanilino)phenyl]ethanoic acid 
 
 
 Sodium diclofenac    [NaDF] 
 
 
 
 
 
Sodium {2-[(2,6-dichlorophenyl) 
amino]phenyl}ethanoate 
 
 
 
Clofibric acid [CLF] 
 
 
 
 
2-(4-Chlorophenoxy)-2-methylpropanoic acid 
 
 
 
 
 
Aspirin 
 
 
 
 
 
 
 
 
2-(Acetoxy)benzoic acid 
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PHARMACEUTICAL IUPAC NAME 
 
 
 
Ibuprofen [Ibu] 
 
 
 
 
 
(RS)-2-(4-(methylpropyl)phenyl)propanoic 
acid 
 
 
 
Carbamazepine (tegretol) [CBZ] 
 
 
5H-dibenzo[b,f]azapine-5-carboxamide  
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Fig. 1.48 Chemical structures of heptakis-(6-chloro-6-deoxy)-β–cyclodextrin, (ClBCD),  heptakis-( 
2, 3 , 6-tri-O-benzoyl)-ß-cyclodextrin (BzBCD), 5, 11, 17, 27-tert-butyl-25, 26, 27, 28-(ethylacetoxy) 
calix[4]arene(CAE)  , 5, 11, 17, 23 tetra- tert -butyl, 25, 27 bis[2-cyanomethox] methoxy, 26, 28 
dihydroxycalix[4]arene (CA-(CN)2) , 5, 11, 17, 23 tetra-tert-butyl, 25, 27-bis[aminoethoxy]-26, 28 
dihydroxycalix[4]arene [CA-NH2)2], Synthesis 25, 26, 27, 28-tetrahydroxycalix[4]arene (CA), 5-
tert-butyl-3-azidomethyl-2-hydroxybenzaldehyde (AzArOH)  , 25, 27-dihydroxy-26, 28-
(dioxypropargyl)tert-butylcalix[4]arene (Ar-CH)  , tert-butyl-azidocalix[4]arene (AzCA) 
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Fig. 1.49 Chemical structures of  25, 26, 27, 28-(diethylamino) ethoxy calix[4]arene [CA(Et2N)4], 
meso-tetramethyl-tetrakis-(4-hydroxyphenylethyl) calix[4]pyrrole (TTHCP), meso-tetramethyl-
tetrakis-(4-ethylacetato-oxyphenylethyl) calix[4]pyrrole (TTECP), calix[4]pyrrole polymer 
(CPPOL), 2, 8, 14, 20-tetra-pentyl-1-resoc[4]arene (RC6), 4, 6, 10, 12, 16, 18, 22-octahydroxyl, 
(PG6)], [4, 6, 10, 12, 16, 18, 22, 24-octa-oxy-ethylacetato-2, 8, 14, 20-tetrapentylresorcin[4]arene 
(RC6-Es) ,2, 8, 14, 20-tetraphenylpyrogallol[4]arene, 4, 5, 6, 10,11, 12, 16, 17, 18, 22, 23, 24-
dodecahydroxyl-2, 8, 14, 20-tetrapentylcalix[4]arene (PG6),  C-decyl pyrogallol[4]arene (PG11)
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2.1 List of abbreviation 
BCD -Cyclodextrin  
BrCH2Cl Bromochloromethane 
CA Calix[4]arene 
CA-(NH2)2 5,11, 17, 23-tetra-p-tert-butyl, 25, 27-bis[aminoethoxy], 26, 28- 
 
dihydroxycalix[4]arene 
 
CA(CN)2 5, 11, 17, 23-tetra-tert-butyl, 25, 27-bis(2-cyanomethoxy)-26, 28- 
 
dihydroxycalix[4]arene 
 
CD Cyclodextrin 
CD3OD Methanol-d4 
CDCl3 Chloroform-d 
CP Calix[4]pyrrole 
TTHCP meso-tetramethyl-tetrakis-[2-(4-hydroxyphenyl)ethyl]calix[4]pyrrole 
TTECP Meso-tetramethyl-tetrakis-[2(4-ethylacetatophenoxy)ethyl]calix[4]pyrrole 
 Change in chemical shift 
 Chemical shift (ppm) 
DCM Dichloromethane 
DEPT Distorstionless Enhancement by Polarisation  Transfer 
DMF N,N-Dimethylformamide 
DMSO Dimethyl sulfoxide 
EtOAc Ethyl acetate 
H2O2 Hydrogen peroxide 
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HCl Hydrochloric acid 
MHz MegaHertz 
LiAlH4 Lithium aluminum hydride  
MeCN Acetonitrile 
MeOH Methanol 
MgSO4 Magnesium sulphate 
NaOH Sodium hydroxide 
Na2SO4 Sodium sulphate 
NMR Nuclear Magnetic Resonance      
NMP N-methyl-2-pyrolidone      
PG11 C-decyl pyrogallol[4]arene 
P4O10 Phosphorous pentoxide 
ppm Parts per million 
Pyrogallol 1, 2, 3-Trihydroxybenzen 
RC6 C-pentylresorc[4]arene 
Resorcinol 1,3-Benzenediol 
RC6-Es 4, 6, 10, 12, 16, 18, 22, 24-octa-oxy-ethylacetato-2, 8, 14, 20-tetrapentyl- 
 
resorcin[4]arene 
 
Sol. Solid 
TEA Triethylamine 
THF Tetrahydrofuran 
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TLC Thin Layer chromatography 
TMS Tetramethylsilane 
UV-vis Ultraviolet-visible 
Nano-ITC Nano-Isothermal Titration Calorimetry 
FTIR Fourier transform infrared Spectroscopy 
BET Brunauer-Emmett-Teller 
DSC Differential Scanning Calorimetry 
TGA Thermogravimetric analysis 
EDS Energy Dispersive X-ray Spectroscopy 
XRD X-Ray Powder Diffraction 
 
 
 
2.2 Chemicals 
Chemicals used during the course of this research, abbreviations and   sources are given as follows: 
2.2.1 Solvents 
Acetonitrile (MeCN), Fisher Scientific, HPLC grade, 99.99 % 
Acetone (Me)2CO, Sigma-Aldrich, 99 % 
Chloroform (CHCl3), Fisher Scientific, Reagent grade, 99 % 
Dichloromethane (DCM), Sigma-Aldrich, ≥ 99 % (GC) 
Diethylether, (Sigma-Aldrich), 99 % 
Dimethyl sulfoxide (DMSO), Fisher Scientific, 99 %, E/0850/1 
Ethanol (EtOH) Fisher Scientific, Reagent grade, 99.98 % v/v. 
Ethyl acetate (EtAc), Sigma-Aldrich ≥ 99.5 %. 
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Hexanal, Sigma-Aldrich, 98 % 
Hydrochloric acid, Fisher Scientific, 35-38 %, H/1150/PB17 
Hexane (Hex), Fisher Scientific, Laboratory reagent grade, 95 % 
Methanol (MeOH), Sigma-Aldrich, HPLC grade, 99.7 %. 
N, N- Dimethylformamide (DMF), Sigma- Aldrich, anhydrous 99.8 %, 22705-6 
1-Octanol, Acros organics, 99 % 
Pyrogallol, Sigma-Aldrich, ≥ 99 % 
Resorcinol, Sigma-Aldrich, 99 % 
Silica 60 A, Fisher Scientific, 40-63 μm, S/0698/53 
3-Aminopropyl- functionalised silica gel, 40-63 m 
Sulfuric acid, Sigma-Aldrich, 95-98 % 
Tetrahydrofuran, (THF) Scientific, HPLC grade, 99.99  
1-Methyl-2-pyrolidone (NMP), Acros organics, 97 % 
 2.2.2 Deuterated solvents used in 1H NMR experiments 
Deuterated acetonitrile, CD3CN, Cambridge Isotope Laboratories, Inc, (D, 99.8 %). 
Deuterated chloroform, CDCl3, Cambridge Isotope Laboratories, Inc, (D, 99.8 %) + 0.05 % v/v 
TMS. 
Deuterated methanol, CD3OD, Cambridge Isotope Laboratories, Inc, (D, 99.8 %). 
Deuterated dimethyl sulfoxide, (CD3)2SO, Cambridge Isotope Laboratories, Inc (D, 99.9 %) 
2.2.3 Pharmaceuticals  
1. Sodium diclofenac, Sodium {2-[(2,6-dichlorophenyl)amino]phenyl}ethanoate C14H10Cl2NNaO2 
2. Clofibric acid, 2-(4-Chlorophenoxy)-2-methylpropanoic acid C10H11ClO3, 97 %, Aldrich 
3. Carbamazepine, 5H-Dibenz[b, f]azepine-5-carboxamide, C15 H12 N2O, Sigma-Aldrich 
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4. Aspirin (Acetylsalicylic acid), Sigma-Aldrich  
5. Ibuprofen (RS)-2-(4-(2-methyl propyl) phenyl) propanoic acid; C13 H18O2, ≥ 98 %   Sigma-
Aldrich.  
2.2.4 Analytical Reagents 
Reagents used in the synthesis (without further purification). 
β-Cyclodextrin, Sigma-Aldrich, ≥ 97 % 
P-tert-butyl calix[4]arene, C44H56O4  ≥ 97 % HPLC, Sigma- Aldrich 
18-Crown-6, 18-C-6, C12H24O6, Fluka, 99 %. 
Pyrrole reagent grade, Sigma-Aldrich, 98 % 
4-[4-hydroxyphenyl]-2-butanone C10H12O2, Sigma-Aldrich ≥ 98 %) 
Magnesium sulphate anhydrous MgSO4, Fisher Scientific 
Potassium carbonate anhydrous, K2CO3, Fisher Scientific, 99.99 % 
Sodium hydride, NaH, Sigma-Aldrich, 95 % 
Sodium azide, NaN3, Sigma-Aldrich, ≥ 99.99 % 
Lithium aluminium hydride, LiAlH4, Sigma-Aldrich, 95 % 
Acetic acid, CH3COOH, Fisher Scientific, glacial analytical reagent grade 99.7 %. 
Bromoacetonitrile, BrCH2CN, Aldrich, 97 %. 
Phenol, C6H5OH, Sigma-Aldrich,   99 % 
Ethyl bromoacetate, BrCH2COOC2H5, Sigma-Aldrich,   98 % 
4-tert-Butylphenol, (CH3)3CC6H4OH Fluka, ≥ 97 % 
Triethylamine, (C2H5)3N Sigma-Aldrich, ≥ 99.5 % 
Tin (IV) chloride SnCl4, Sigma- Aldrich, 98 % 
(2-Diethylamino) ethylchloride hydrochloride, (C2H5)2N(CH2)2Cl·HCl, Aldrich-Sigma.  
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(+)-Sodium L-ascorbate, C6H7NaO6, Sigma-Aldrich 98 % 
Lead (II) perchlorate trihydrate, Pb (ClO4)2·3H2O, Aldrich –Sigma. 
Lithium perchlorate, LiClO4, Aldrich –Sigma. 
Mercury (II) perchlorate hydrate, Hg (ClO4)2· xH2O, Aldrich –Sigma, 99.99 % 
Methanesulfonyl chloride, CH3CO2Cl, Sigma-Aldrich, 99.7 % 
Potassium chloride, KCl, Fisher Scientific, 99% 
Sodium chloride, NaCl, Fisher Scientific 99 % 
pH buffer tablets from Fisher Scientific 
Magnesium (II) perchlorate hexahydrate, Mg (ClO4)2·6H2O, Aldrich –Sigma. 
Sodium perchlorate monohydrate, NaClO4, Sigma-Aldrich 
Strontium (II) perchlorate, Sr (ClO4)2, Sigma-Aldrich 
Zinc (II) perchlorate hexahydrate, Zn (ClO4)2, 6H2O, Aldrich –Sigma. 
 
   2.2.5 Purification of Solvents [194] 
1. Acetonitrile, MeCN, was refluxed under a nitrogen atmosphere and distilled over calcium hydride. 
The middle fraction of the distilled solvent was collected  
2. Tetrahydrofuran, THF, was stored over a sodium metal wire for 24 hours. Then it was distilled 
under nitrogen, using benzophenone as an indicator  
3. Toluene was treated with anhydrous calcium chloride, filtered and then placed over metallic 
sodium in a round-bottomed flask fitted with a reflux condenser protected by a drying tube containing 
calcium chloride. Then it was refluxed for two hours. The middle fraction of the distilled solvent was 
collected and used. 
4. N, N-Dimethylformamide, DMF, was dried using molecular sieves for 24 hours and then it was 
refluxed under reduced pressure. Only the middle fraction of the purified solvent was collected. 
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2.2.6 Instruments used 
1. 1H-NMR spectra were taken on a Bruker AC-500 NMR spectrometer. 
 2. 1H NMR spectra Bruker AC-300 MHz 
3. UV-visible spectrophotometry measurements were taken on a Cecil CE7200 spectrophotometer. 
4. Conductance measurements were carried out by Wyne Keer LCR Meter 4300 
5. The isothermal Titration Calorimeter ITC type TA Nano-calorimeter                          
6. Differential scanning calorimeter DSC, Instrument DSC Q1000 V9.9 Build 303 
7. Thermogravimetric analysis, Instrument TGA Q 500, V6.7 Build 203 
8. FTIR Spectrometer type Agilent technologies, Cary 600 series  
9. Scanning electron microscope, SEM analysis, Mechanical Engineering Sciences, FEPS 
10. AB 15 pH meter Fisher Scientific (AB 15 pH Meter Fisher Scientific)  
 11. BET analysis by Gemini model V2.00  
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2.3 Solubility measurements 
2.3.1 Solubility of selected pharmaceuticals in different organic solvents at 298.15 K 
 The solubility of a solid is defined as an equilibrium state between the solid and its saturated solution 
at constant pressure and temperature (eq.2.1).  Addition to the temperature and the pressure, the 
solubility correlates with the lattice energy holding the crystals together in the crystal structure and 
the polarity of solvents. The solubility of a substance has significant importance in a number of 
scientific fields like medical applications and pollutants transportations. The determination of the 
solubility of a substance leads to the calculation a number of parameters such as the solution Gibbs 
energy ΔsG, the enthalpy ΔsH and therefore the entropy ΔsS. In general, the equilibrium state between 
a ligand L as solid (sol.) and its saturated solution (s) can be expressed in the following equation 
(eq.2.1)     
                                  eq.2.1L(sol.) L(s)  
                                                                                                                                                                                                                                                                                                                                                                                               
This enabled to calculate the solubility s (mol dm-3) of the solid in different solvents. For a non-
electrolyte, L, the standard Gibbs energy of solution, ΔsG°, can be calculated from the following 
equation (eq.2.2) 
                          ΔsG° = −RT ln [L]s                                     eq.2.2                                            
The more negative the value obtained for ΔsG°, the greater the solubility is. When investigating the 
solubility in a number of different solvents the required standard Gibbs energy of transfer ΔtG° from 
one solvent s1 to another s2 can be calculated from the following process:  
                                  
KtL(s1) L(s2)       eq.2.3                  
  Hence, 
                              ΔtG° = - RT ln Kt = ΔsG° (s2)-ΔsG° (s1)     eq.2.4              
In this equation Kt denotes the thermodynamic transfer constant, R is the gas constant (8.314 J K
-
1mol-1) and T is the absolute temperature in Kelvin. In doing so the contribution of the crystal lattice 
energy is eleminated. Therefore, it is possible to assess the difference in the solvation of the 
pharmaceutical in the two solvents. The pharmaceuticals were first tested in different solvents to 
investigate if these undergo solvation. Solvation experiments were carried out by exposing separately 
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pre-weighed crucibles containing the pharmaceutical to a saturated environment of different solvents 
in desiccators for several days. The crucibles were then weighed to check the uptake of solvent by 
the solid. From solubility data, ΔsG◦ were calculated for the samples when the compound was not 
altered by solvation195-197.The solvents investigated for the possibility to obtain solubility data were 
water, methanol, ethanol, acetonitrile, dichloromethane, chloroform, 1-octanol, dimethylsulphoxide 
and N, N-dimethylformamide.  
The analytical technique used to determine the concentration of the drug in the saturated solution was 
UV spectrophotometry 
2.3.2 Calibration curve for the analysis of pharmaceuticals  
   Stock solutions were made by dissolving a known amount of each pharmaceutical in the appropriate 
solvent, different volumes were taken and diluted in volumetric flasks (10 ml). Samples were 
measured using spectrophotometric measurements in the ultraviolet region. Calibration curves were 
obtained when absobances, A, were plotted against molar concentration (mol dm-3). The linear 
relationship (higher R values) obtained were used to determine the unknown concentration of the 
pharmaceutical in the saturated solution198 
2.3.3 Solubility of selected pharmaceuticals 
Saturated solutions of targeted pharmaceutical (sodium diclofenac, aspirin, and clofibric acid) in 
different solvents were mixed for one minute on a whirlimixer, sealed and left to equilibrate overnight 
in a water bath at 298.15 K. The solutions were filtered through a 0.22 Millipore and a known volume 
of each solution (2 ml) was transferred to an UV cell and diluted volumetrically with the respective 
solvent to obtain absorbance values in the linear range of the calibration curve for each system. All 
the experimental results are an average of at least three independent measurements. From the 
absorbance values, the concentration of the drug in the saturated solution was obtained by the use of 
the Beer’s-Lambert law198,199.  
2.4 Determination of partition coefficients of selected drugs in the water-1-octanol 
solvent system 
 The partition coefficient (KP) is calculated from the ratio of concentration of a solute in two partially 
or completely immiscible phases at equilibrium. This parameter is essential in many applications 
such as distribution of drugs between two immiscible layers and it is used to know the distribution of 
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chemicals in the environment. Usually one of the solvents is water, the other is a non-aqueous solvent 
such as 1-octanol. The partition coefficient Kp can be expressed by the following equation (eq.2.5) 
                                                 Kp= 
[D]org
[D]aq
                                                              eq.2.5 
 In this equation [D]org and [D]aq represents the molar concentration of the drug in the organic and   
aqueous phase respectively. For the determination of KP, both solvents were mutually saturated with 
each other to avoid volume changes when mixed. The pharmaceuticals were dissolved in 1-octanol 
saturated with water. Equal volumes of solvents were mixed and left to equilibrate overnight at 298 
K. The two phases were separated and the concentration of the drug in the aqueous phase was 
determined by UV/Vis   spectrophotometry200. 
 
2.5 Synthesis of the receptors 
2.5.1 Synthesis and characterization of heptakis-(6-chloro-6-deoxy)-β–
cyclodextrin(ClBCD) 201  
The procedure used to synthesise heptakis-(6-chloro-6-deoxy)--cyclodextrin is shown in Scheme 
2.1  
CH3SO2Cl 12
3
4 5
6
6
54
3
12
7
7
DMF, CH3ONa
Scheme 2.1 Synthesis of heptakis-(6-chloro-6-deoxy)-ß–cyclodextrin 
In a three- necked round bottomed flask containing a solution of β-cyclodextrin (10.04 g, 8.81 mmol) 
in DMF, methanesulfonyl chloride (24.8 g, 230 mmol) was added and stirred at 65 °C for 4 days. The 
solvent was evaporated using a rotary evaporator. The residue was dissolved in methanol and 
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neutralized with sodium methoxide (3 M). The product was precipitated in ice water, the white solid 
obtained was filtered out and washed with cold methanol and dried under vacuum at 55 °C. 1H NMR 
(500 MHz, d6-DMSO), δ in ppm, 5.96 (d, 1 H, 2-OH), 5.82 (s, 1 H, 3-OH), 4.94 (d, 1 H, 1-H), 4.13 
– 3.89 (m, 2 H, 5-H, 3-H), 3.84 – 3.75 (m, 2 H, 4-H, 2-H), 3.61 (t, 1 H, 6a-H), 3.35 (s, 2 H, 6b-H)., 
13C NMR (DMSO-d6), δ in ppm, 102.04 (1-C), 83.57 (4-C), 72.43 (3-C), 71.96 (2-C), 71.17 (5-C), 
44.95 (6-C). Appendix (Figs. 1-B & 2-B) 
2.5.2 Synthesis of  heptakis-( 2, 3 , 6-tri-o-benzoyl)-ß-cyclodextrin (BzBCD)201  
The compound was synthesised according to Scheme 2.2 
        
Bz
Bz
Bz
Bz= -CO-Ar
6
6
4 days
5
DMF, 65 °C
5
4
4
3
3
1
1 2
2
7
7
        
Scheme 2.2 Synthesis of heptakis-( 2, 3 , 6-tri-o-benzoyl)-ß-cyclodextrin 
The synthesis of the perbenzoylated cyclodextrin was accomplished as described by Guillo et al 198 . 
To a solution  of β-cyclodextrin (5 g, 4.4 mmol) dissolved in DMF ,  benzoyl chloride (3.2 g, 0.45 
mmol) was added and stirred at 65 °C for 4 days. The solvent was evaporated using a rotary 
evaporator, the residue was dissolved in methanol and neutralized with sodium methoxide (3 M) .The 
product was precipitated from ice water , filtered out and washed with methanol . The product was 
vacuum-dried at 55 °C and was obtained as  a white solid. 1H NMR (d6-DMSO), δ in ppm, 4.42 (H4, 
7 H), 4.9 (H5 and H6, 14 H), 5.13 (H2,7 H), 5.56 (H6, 7 H), 5.75 (H1, 7 H), 5.85 (H3, 7 H), 
(Apendex,Fig. 3-B) Elemental analysis was carried out at the University of Surrey, calculated %,  C;  
67.5, H;  4.79, N;  0.0. Found %,   C; 67.68, H; 4.53, N; 0.0. 
   2.5.3 Synthesis of 5, 11, 17, 27- tert-butyl-25, 26, 27, 28-(oxy-ethylethanoate) 
calix[4]arene (CAE)202   
A new modified procedure has been carried out in the Thermochemistry Laboratory to synthesise the  
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compound according to the following Scheme  
THF/ DMF
NaH / 60 °
C
                                                                                                                              
                                                                                                                                  (CAE) 
Scheme 2.3 Synthesis of 5, 11, 17, 27-tert-butyl-25, 26, 27, 28-(ethylacetoxy) calix[4]arene (CAE) 
In a 500 ml three-neck round bottom flask and under a nitrogen gas atmosphere, p-tert-butyl-
calix[4]arene (5 g, 7.72 mmol) was dissolved in a mixture of freshly distilled THF and dry DMF (60: 
40, v/v),  then sodium hydride (0.36 g, 0.016 mmol) was added carefully to the reaction mixture and 
stirred for 30 minutes. This was followed by the dropwise addition of ethyl bromoacetate (5.14 g, 
3.78 mmol) to the reaction solution. The mixture was heated in an oil bath at 60 C and followed by 
thin layer chromatography using a mixture of DCM: MeOH (7: 3 v/v) as the developing solvent 
mixture. After completion, the reaction was stopped and cooled down to room temperature, the 
resultant solution was filtered and the solvent evaporated using a rotary evaporator. A brown viscous 
product was obtained, dissolved in 100 ml dichloromethane and transferred to a separation fennel, 
washed with distilled water and then with brine. The organic layer was separated and dried over 
anhydrous magnesium sulphate, the mixture was filtered and the solvent evaporated under reduced 
pressure. A viscous colourless liquid was obtained. The crude product was dissolved in methanol and 
sonicated to break the oil. A white powder was obtained and filtered. Further purification was carried 
out by dissolving the product using a MeOH: DCM (15: 1) mixture which was refrigerated. Large 
needle-like crystals were obtained. Yield 5.5 g, 71.6 %, 1H NMR (500 MHz in CDCl3), δ in ppm, 
6.77 (s, 8 H, Ar-H), 4.85 (d, 4 H, C-Haxial), 4.8 (s, 8 H, O-CH2-CO), 4.2 (q, 8 H, O-CH2CH3), 3.19 
(d, 4 H, C-Hequatorial), 1.28 (t, 12 H, CH3), 1.05 (s, 36 H, CH3), (Fig. 4-B- Appendix) 
13C NMR (500 MHz in CDCl3), δ in ppm, 14.22, 31.6, 33.38, 60.30, 71.34, 125.35, 133.46, 145.15, 
152.59, 170.54 
Microanalysis (C60H80O12, M. Wt, 993.27) was carried out at the University of Surrey calculated % 
:, C; 72.58, H; 8.06, N 0.0. Found %: C, 72.35, H; 8.12, N; 0.0 
Melting point: 155 C, TGA and DSC analysis were carried out at the University of Surrey 
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2.5.4 Synthesis of 5, 11, 17, 23- tetra-tert-butyl, 25, 27-bis (2-cyanomethoxy)-26, 
28-dihydroxycalix[4]arene (CA-(CN)2203,204 
The compound was synthesised according to the following Scheme  
       
K2CO3, 18-Crown-6 / BrCH2CN
Acetonitrile / reflux
                                                                                                                                               
Scheme 2.4 Synthesis of 5, 11, 17, 23-tetra- tert -butyl, 25, 27 bis [2-cyanomethox] methoxy, 26, 28 
-dihydroxycalix[4]arene 
In a three-neck round bottom flask (500 ml) containing a magnetic stirrer at room temperature under 
a nitrogen gas atmosphere, p-tert-butyl calix[4]arene (10.293 g, 15.862 mmol), 18-crown-6 (1.004 g, 
3.799 mmol) and potassium carbonate (18.087 g, 130.87 mmol ) was dissolved in dry acetonitrile 
(200 ml). Bromoacetonitrile (7.394 g, 61.643 mmol) dissolved in acetonitrile (20 ml) was added 
dropwise. The reaction mixture was heated in an oil bath at 75 oC and refluxed for 24 hours under 
vigorous stirring. The reaction was monitored by thin layer chromatography using a mixture of 
hexane: ethyl acetate (8: 2) as the developing solvent. After 24 hours, the reaction mixture was 
allowed to cool to room temperature. The solvent was evaporated by a rotary evaporator and a yellow 
solid was obtained. The solid was dissolved in DCM, filtered gravitationally and the solvent was 
removed under reduced pressure, methanol was added to the resulting oil which was sonicated to 
break the oil. Afterwards the solid was filtered and washed with cold methanol. The solid was left in 
a vacuum drier at 90 oC. The product obtained in 70% yield was characterised by 1H NMR 
spectroscopy. 1H NMR (500 MHz, in CDCl3), δ in ppm, 7.11 (s, Ar-H, 4 H), 6.72 (s, Ar-H, 4 H), 
5.540 (s, OH, 2 H), 4.80 (s, O-CH2, 4 H), 4.19 (d, CHaxial, 4 H), 3.42 (d, CHequatorial, 4 H) 1.34 (s, CH3, 
18 H), 0.87 (s, CH3, 18 H). (Fig.5-Appendix) 
2.5.5    Synthesis of 5, 11, 17, 23-tetra-p-tert-butyl, 25, 27-bis[aminoethoxy], 26, 28-
dihydroxycalix[4]arene [ CA-(NH2)2]205 
The compound was synthesised according to the following Scheme   
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Dry THF, LiAlH4
0 °C, 4 hours
 
Scheme 2.5 Synthesis of 5, 11, 17, 23-tetra-tert-butyl, 25, 27-bis [aminoethoxy]-26, 28 
dihydroxycalix[4]arene. 
A solution of CACN (9 g, 21.45 mmol) was dissolved in dry THF (100 ml)  and stirred in an ice bath 
until the temperature reached 0 C,  LiAlH4   (1.896 g , 49.95 mmol) was dissolved  in freshly dried 
THF, then added dropwise to the reaction mixture with continuous stirring for four hours and the 
temperature was kept at 0°C. After completion, the reaction was monitored using TLC and hexane 
and ethyl acetate (8: 2, v/v) as the developing solvent. An aqueous solution of sodium hydroxide (10 
ml, 20 %) was added, followed by distilled water (10 ml). A white precipitate was obtained. The 
undesired white precipitate was filtered gravitationally and the solvent was evaporated by using a 
rotary evaporator to obtain a white solid which was dried in a vacuum drier at 90 oC. The product 
obtained in 60 % yield was characterised by 1H NMR spectroscopy, (500 MHz, in CDCl3), δ in ppm, 
7.03 (s, Ar-H, 4 H), 6.96 (s, Ar-H, 4 H), 5.2 (s, OH, 2 H), 4.34 (d, Ar-CHaxial-Ar, 4 H), 4.06 (t, 
OCH2CH2N, 4 H), 3.37 (d, Ar-CHequatorial-Ar, 4 H), 3.3 (t, -O-CH2-CH2-N, 4 H), 1.2 (s, CH3, 18 H), 
1.09 (s, CH3, 18 H). Fig. 6 Appendix -B 
2.5.6 Synthesis of 25, 26, 27, 28-tetrahydroxycalix[4]arene206  
The synthesis was carried out according to Scheme 2.6 
AlCl3/ Toluene
phenol/ 60 °C,4 h
 
                 Scheme 2.6 Synthesis 25, 26, 27, 28-tetrahydroxycalix[4]arene 
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In a three-neck round bottom flask, a mixture of 4-tert-butylcalix[4]arene (5.13 g,7.7 mmol) and 
phenol ( 4.35 g, 46.2 mmol) were dissolved in dry toluene (100 ml), stirred for 30 minutes at room 
temperature under a nitrogen gas atmosphere.  Aluminium chloride (6.09 g) was added and the 
reaction mixture was stirred at 60° C for 6 h. The reaction was monitored by TLC using a hexane: 
ethyl acetate (8: 2) mixture as the developing solvent mixture. After completion of the reaction the 
mixture was cooled to room temperature, hydrochloric acid (100 ml, 0.2 M) was added dropwise and 
stirred for 30 minutes until the white precipitate disappeared. The reaction mixture was then 
transferred to a separating funnel. The upper organic layer was collected and the solvent was rotary 
evaporated. Then methanol (50 ml) was added to the concentrated mixture to obtain a white 
precipitate which was then recrystallized from methanol and dried over a vacuum oven. (3.02 g, 90 
%). The compound was characterised by 1H NMR spectroscopy in CDCl3, δ in ppm, 10.18 (s, OH, 4 
H), 7.05 (d, Ar-H, 8 H), 6.7 (t, Ar-H, 4 H), 4.25 (d, CHaxial, 4 H), 3.46 (d, CHequatorial, 4 H) (Fig. 7 
Appendix B) 
 
2.5.7 Synthesis and characterization of 5-tert-butyl-3-azidomethyl-2-
hydroxybenzaldehyde (AzAr) 
The preparation of this receptor was carried out in three steps according to the following Scheme  
  
Ambient temperature, 48 hours
SnCl4 / Paraformaldehyde
Toluen, 100 °C, 8 hours
Formaldehyde, HCl
NaN3
24 hours
                                                                                                                                                       
Scheme 2.7 Synthesis and characterization of 5-tert-butyl-3-azidomethyl-2-hydroxybenzaldehyde 
 
2.5.8 Synthesis and Characterization of 5-tert-butyl-2-hydroxybenzaldehyde207 
 The SnCl4 (1.07 g, 4.1 mmol) was added to a magnetically stirred solution containing p-tert-butyl-
phenol (6.01 g, 40 mmol) in dry toluene. Tri-n-butylamine was added dropwise to the reaction 
mixture with continuous stirring for 20 minutes. To the reaction mixture, paraformaldehyde (2.43g, 
81 mmol) was added and the mixture was refluxed for 8 hours. After cooling the reaction mixture to 
room temperature, the solution was transferred into a separating funnel and then extracted with 
2.                                                                                                                         Experimental Part 
 
76 
 
diethyl ether (2 × 50 ml). The combined organic layer was washed with saturated brine and then dried 
over anhydrous sodium sulphate. The product formed was purified by a silica gel column 
chromatography using a hexane: chloroform (1: 1) mixture as eluent. Yield (4.5 g, 63 %), a yellow 
liquid was obtained upon evaporation of the solvents, 1H NMR (500 MHz in CDCl3), δ in ppm, 1.27 
(s, 9 H), 6.76 (s, 1 H), 7.57 (d, 1 H), 7.50 (dd, 1 H), 9.89 (s, 1 H, aldehyde), 10.80 (s, 1 H, OH). Fig. 
8-B Appendix 
2.5.9 Synthesis and characterization of 5-tert-butyl-3-chloromethyl-2-
hydroxybenzaldehyde 208 
 A concentrated hydrochloric acid (12 M, 125 ml) was added to a mixture of 5-tert-butyl-2-
hydroxybenzaldehyde (5.0 g, 28 mmol) and formaldehyde (25 ml, 35 %) in methanol and the solution 
was stirred for 2 days at room temperature. Water was added to the mixture, the product was extracted 
into dichloromethane (3 × 40 ml), and the organic layer was dried over anhydrous sodium sulphate. 
The dichloromethane was then evaporated under reduced pressure to afford the pure product as a 
yellow liquid. Yield (5.2 g, 82 %). 1H NMR (500 MHz in CDCl3),  in ppm, 1.34 (s, 9 H), 4.70 (s, 2 
H), 7.52 (d, 1 H), 7.67 (d, 2 H), 9.90 (s, 1 H), 11.28 (s, 1 H). Fig. 9B-Appendix 
 
2.5.10 Synthesis of 5-tert-butyl-3-azidomethyl-2-hydroxybenzaldehyde 208 
 
The 5-tert-butyl-3-chloromethyl-2-hydroxybenzaldehyde (2.65 g, 11.89 mmol) was added to a 
solution of sodium azide (1.519 g, 23.37 mmol) in dimethylformamide (30 ml) under stirring for 12 
hours. A mixture of water and ethyl acetate (100 ml, 50 %, v/ v) was added to the reaction mixture. 
The organic layer was separated and washed with water and brine. A yellow liquid was obtained upon 
evaporation of the organic solvent. Yield 89 %.  
1H NMR (500 MHz, CDCl3),  in ppm, 11.28 (broad s, 1 H), 9.9 (s, 1 H), 7.57 (dd, 1 H), 7.52 (s, 1 
H), 4.45 (s, 2 H), 1.28 (s, 9 H). Fig. 10-B Appendix 
2.5.11 Synthesis and characterization of 25, 27-dihydroxy-26-28-(dioxypropargyl) 
tert-butylcalix[4]arene (ArCH)208 
The synthesis of the compound was carried out according to the following Scheme 
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Acetone, K2CO3, reflux
 
 
                                                                                                   
 Scheme 2.8 Preparation of 25, 27-dihydroxy-26, 28-(dioxypropargyl)-tert-butylcalix[4]arene 
 
In a three-neck round bottom flask and under inert conditions, anhydrous potassium carbonate (5.1 
g, 36.72 mmol) and p-tert-butylcalix[4]arene (10 g, 15.43 mmol) were dissolved in dry acetone (200 
ml) and stirred at room temperature for 1 hour. A solution of propargyl bromide (6.49 g, 30.8 mmol) 
in acetone (50 ml) was added dropwise over a period of 30 minutes. The reaction mixture was 
refluxed for 24 hours and then cooled down to room temperature. The reaction mixture was filtered 
and then concentrated. Hydrochloric acid (100 ml, 2 M) was added and the product was extracted by 
dichloromethane (3 x 100 ml). The organic layer was separated, washed with water and then with 
brine, collected and dried over anhydrous sodium sulphate, filtered and the solvent evaporated by a 
rotary evaporator. The crude product was recrystallized from a dichloromethane: methanol (4: 1) 
mixture to afford a white solid (9.10 g, 82 % yield). 1H NMR (500 MHz, in CDCl3),  in ppm, 7.07 
(s, 4 H), 6.72 (s, 4 H), 6.46 (s, 2 H), 4.74 (d, 4 H), 4.73 (d, 4 H), 3.32 (d, 4 H), 2.54 (t, 2 H, alkyne), 
1.30 (s, 18 H), 0.89 (s, 18 H). Fig. 11-B Appendix 
Microanalysis was carried out at the University of Surrey, calculated   %: C; 82.7, H; 8.27. Found %: 
C; 82.76, H; 8.36   
 
2.5.12 Synthesis and characterization of 4-tert-butyl-azidocalix[4]arene208 
 
The compound was synthesised according to the following Scheme 
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Sodium ascorbate
DCM/H 2O   12 h
 
Scheme 2.9 Preparation of 4-tert-butyl-azidocalix[4]arene 
 
 Compound CAD (3.0 g, 4.14 mmol) was added to a solution of propargylated p-tert-
butylcalix[4]arene (2.12 g, 9.53 mmol) in a mixture of dichloromethane and water (100 ml, 50: 50 v/ 
v), then copper (II) sulphate pentahydrate, CuSO4·5H2O (0.124 g, 0.50 mmol) and sodium ascorbate 
(328.0 mg, 1.70 mmol)  were added to the above reaction mixture and stirred for 12 hours at room 
temperature. After completion, the reaction mixture was transferred to a separation funnel and the 
organic layer was separated. The aqueous layer was extracted with dichloromethane (2 × 50 mL). 
The combined organic layer was washed with water and then with brine (2× 100 mL) and dried over 
anhydrous sodium sulphate Na2SO4, filtered and the solvent was evaporated by a rotary evaporator. 
The resulting product was purified by triturating with hexane and then the precipitate was filtered. 
Yield: 89.91%. 1H NMR (CDCl3, 500 MHz), δ in ppm, 11.25 (s, 2 H), 9.83 (s, 2 H), 8.05 (s, 2 H), 
7.63 (s, 2 H) 7.49 (d, 2 H), 7.21 (s, 2 H), 6.98 (s, 4 H), 6.73 (s, 4 H), 5.46 (s, 2 H), 5.2 (s, 2 H), 4.16 
(d, 4 H), 3.16 (d, 4 H), 1.27 (s, 18 H), 1.26 (s, 18 H), 0.96 (s, 18 H). Fig. 12-B Appendix.  
Microanalysis was carried out at the University of Surrey, calculated %: C; 74.6, H; 7.5, N; 7.05. 
Found %: C; 73.97, H; 7.84, N; 6.73 
                                                                                                                                                                                                                                                                                                                                                                                                
2.5.13 Preparation of 2-azidoacetamide209  
The compound was prepared according to Scheme 2.10 
60 °C
NaN3 / H2O
Scheme. 2.10 Preparation of 2-azidoacetamide. 
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In a three-neck round bottom flask, an aqueous solution of sodium azide (4 g, 61.5 mmol) was added 
slowly to 2-chloroacetamide (5 g, 126.5 mmol) in 100 ml of water. The reaction mixture was refluxed 
in an oil bath for 17 h at 60°C. The reaction mixture was allowed to cool. It was then concentrated 
and extracted by ethylacetate. The solvent was evaporated and the white solid product was 
recrystallized from diethyl ether to afford white crystals of 2-azidoacetamide. The yield was 87 %, 
mp: 57-58 °C, 1H NMR (500 MHz, in CDCl3), 3.9 (CH2), 5.5-6.3 (d, NH2). Fig. 13-B Appendix 
 IR max (cm-1) 3371 and 3183 (N-H) Str., 2980-2910 (C-H) str., 2105 (N3) str., 1622 and 1411 (C=O) 
str.     
 
2.5.14 Synthesis of 25, 26, 27, 28-(diethylamino) ethoxycalix[4]arene CA-(NH2)4210 
 
The synthesis of 25, 26, 27, 28-(diethylamino)ethoxy calix[4]arene was carried out according to the 
following Scheme  
HCl
MeCN / NaH,  refluxe  6 hours
  
                                                                                                                                     
                                                                                          
Scheme 2.11 Synthesis of 25, 26, 27, 28-(diethylamino)ethoxy calix[4]arene 
 
A solution of 25, 26, 27, 28-tetrahydroxycalix[4]arene (2.52 g, 5.52 mmol) and sodium hydride (2.12 
g, 88.36 mmol) was prepared in a THF: DMF (80: 20) solvent mixture (150 ml) under a nitrogen 
atmosphere. The mixture was stirred at 25 C for 30 minutes.Then 2-diethylamino ethylchloride 
hydrochloride (6.09 g, 35.4 mmol) was added over a period of 30 minutes .The mixture was stirred 
for 6 hours at 80 C.  The progress of the reaction was monitored by TLC using a DCM: MeOH (9: 
1) mixture. Following the completion of the reaction, the mixture was allowed to cool down to room 
temperature and the solvent was evaporated in a rotary evaporator. The resulting crude mixture was 
extracted into DCM (100 ml) and washed with water (100 ml). The organic phase was separated and 
dried over magnesium sulphate and then filtrated. The filtrate was evaporated by a rotary evaporator 
to a brown solid residue. The solid product was sonicated and then was recrystallised from methanol. 
White crystals were obtained (1.01 g, 40 % yield). 
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1H NMR (500 MHz in CDCl3), δ in ppm, 6.5 (m, Ar-H, 12 H), 4.4 (d, 4 Haxial, Ar-CH2-Ar, 4 H), 4.0 
(t, 8 H, Ar-O-CH2CH2N, 8 H), 3.1 (d, Ar-CH2-Ar, 4 Hequatorial), 2.9 (t, CH2-N (CH2CH3)2, 8 H), 2.5 
(q, N-CH2CH3, 8 H), 1.04 (t, N-(CH2CH3)2, 24 H). Fig. 14-B Appendix 
 
2.5.15 Synthesis of meso-tetramethyl-tetrakis-(4-hydroxyphenyl ethyl) 
calix[4]pyrrole ( TTHCP) 
This novel compound was synthesised at the Thermochemistry Laboratory by applying the modified 
procedure by Danil de Namor and co-workers32 to the procedure reported earlier211 according to 
Scheme 2.12 
/
Ambient temperature
1
2
3
4
5
6
7
8
9
10
CH3SO3H MeOH
                                                                                                                                                                                                                               
Scheme 2.12 Synthesis of meso-tetramethyl-tetrakis-(4-hydroxyphenylethyl)calix[4]pyrrole 
 
 In a three-neck round bottom flask (500 ml) containing a magnetic stirrer at ambient temperature, 4-
[4-hydroxyphenyl]-2-butanone (12.24 g, 74.52 mmol), was dissolved in methanol (100 ml). 
Methanesulfonic acid (1 ml) was added to the solution and stirred for 30 minutes. Pyrrole (5 g, 74.53 
mmol) was added dropwise to the reaction solution and the reaction was left overnight. The mixture 
was poured into a beaker containing distilled water (200 ml) and a brown solid precipitated. The 
compound was filtered, dried by air then collected and dissolved in diethyl ether. Then it was filtrated 
to remove the black tar from the solid. The solvent was evaporated using a rotary evaporator and the 
solid obtained was recrystallized from acetic acid and left to cool. Further purification by using 
acetone-acetonitrile mixture was applied to get a pure white powder which was dried in a vaccum. 
1H NMR (500 MHz, in d6-DMSO), δ in ppm, 9.32 (s, NH, 4 H), 9.08 (s, OH, 4 H), 6.83 (d, Ar -H, 8 
H), 6.56 (d, Ar-H, 8 H), 5.78 (d, β-H pyrrole ring, 8 H), 2.25 (t, Cmeso- CH2-CH2-Ar, 8 H), 2.05 (t, 
Cmeso-CH2-CH2-Ar, 8 H), 1.56 (s, 12 H, CH3). Fig. 15-B Appendix 
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13C NMR (500 MHz, in d6-DMSO),  in ppm, 155.7 (C10), 137.8 (C9), 132.9 (C8), 129.4 (C7), 
115.5(C1), 103.39 (C2), 44.03 (C6), 39.8 (C5), 30.5 (C4), 25.41 (C3). Fig. 16 B Appendix 
 
2.5.16 Synthesis of meso-tetramethyl-tetrakis-(4-ethylacetatophenoxyethyl) 
calix[4]pyrrole (TTECP)202 
This super extended compound was synthesised for the first time in the Thermochemistry Laboratory 
by applying a new modified procedure according to Scheme 2.13 
THF/ DMF, 
60 °C
 
Scheme 2.13 Synthesis of meso-tetramethyl-tetrakis-(4-ethylacetato-oxyphenylethyl) calix[4]pyrrole 
 
In a three-neck round bottom flask (250 ml) containing a magnetic stirrer at ambient temperature and 
under a N2 atmosphere, meso-tetramethyl-tetakis-(4-hydroxyphenylethyl)calix[4]pyrrole ( 2 g, 1.67 
mmol ), was dissolved and stirred in a mixture of freshly distilled THF and dry DMF (THF: DMF 
60: 40, v/ v). Then sodium hydride (0.056 g, 2.24 mmol), was added carefully followed by dropwise 
addition of ethylbromo acetate (0.28 g, 1.67 mmol). The reaction mixture was heated in an oil bath 
at 60 °C under vigorous stirring. The reaction was monitored by thin layer chromatography using a 
DCM: MeOH (9: 1) mixture as the developing solvent. After the reaction was completed, the mixture 
was allowed to cool down to ambient temperature. The solvent was evaporated by a rotary evaporator 
and a colourless viscous liquid product was obtained, dissolved and extracted by DCM. It was then 
washed with distilled water and then with brine. The organic layer was collected and dried over 
anhydrous magnesium sulphate, filtered and the solvent evaporated using a rotary evaporator. A 
white powder was obtained, collected and recrystallised from methanol. The white powder obtained 
was filtered and dried, 1H NMR (500 MHz, in CDCl3), δ in ppm, 7.03 (s, NH, 4 H), 6.91 (d, Ar-Hmeta, 
8 H), 6.69 (d, Ar-Hortho, 8 H), 5.95 (d, C-H, 8 H pyrrole rings), 4.54 (s, O-CH2-CO, 8 H), 4.25 (q, O-
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CH2–CH3, 8 H), 2.30 (t, Cmeso-CH2-CH2-Ar, 8 H), 2.10 (t, Cmeso-CH2, 8 H), 1.53 (s, CH3, 12 H) 1.28 
(t, CH3). Fig. 17 B Appendix 
Elemental analysis was carried out at the University of Surrey. Calculated %; C; 72.7, H; 7.07, N; 
4.68. Found % C; 72.19,   H; 7.02, N; 3.95  
2.5.17 Polymerisation of meso-tetramethyl-tetrakis-(4-hydroxyphenyl ethyl) 
calix[4]pyrrole (CPPOL)212 
The polymerisation reaction was carried out according to Scheme 2.14  
NMP, H2SO4
90 °C, 2 hours
 
Scheme 2.14 Synthesis of calix[4]pyrole oligomer 
In a three- neck round bottom flask (250 ml), the calix[4]pyrrole derivative (2 g, 1.73 mmol) was 
dissolved in N-methyl pyrrolidone (25 ml), then sulphuric acid (2 ml) was added to the mechanically 
stirred solution, followed by the addition of formaldehyde (10 ml, 37 %) with vigorous stirring and 
heating to 90 °C. After 2 h, the solution became viscous and then it was converted into a dark brown 
solid which was washed with water then with ethanol. The solid product was collected and dried. 
Microanalysis was carried out at University of Surrey, found %: C; 67.35, H; 5.88, N; 5.72  
FTIR, ν (cm-1), 3335 (N-H), 3280-3192 (O-H), 3008 (C-H) str. Also, TGA, SEM, XRD and XPS 
have been also carried out at the University of Surrey.  
2.5.18   Synthesis of 2, 8, 14, 20-tetrapentyl-1-resorc[4]arene ( 4, 6, 10, 12, 16, 18, 
22-octahydroxy, 2, 8, 14, 20-tetrapentylresorcin[4]arene213,214(RC6) 
 
The synthesis of the compound was carried out according to the Scheme 2.15 
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R=C5H11
reflux, 80 °C 
Resorcinol
EtOH, HCl
Hexanal
 
Scheme 2.15 Synthesis of C-pentyl-resorcin[4]arene 
In a three-neck round bottom flask fitted to a reflux condenser, a solution of resorcinol (11 g, 99.8 
mmol) in ethanol (100 ml), was stirred and cooled to 0 °C in an ice bath, hydrochloric acid (12 M, 2 
ml) was added to the stirring solution which was followed by the careful addition of hexanal (12.1 
ml, 99.9 mmol) maintaining the temperature at 0 °C. The reaction vessel was then removed from the 
ice bath under continuous stirring (one hour) and transferred to an oil bath heated to 80 °C for 16 
hours. The reaction mixture was removed, allowed to cool down to ambient temperature and then 
refrigerated. The product was filtered and washed by an ice cold mixture of ethanol and water (1:1, 
v/v) to yield a yellow orange solid which was dried in vaccuo at 80 °C. 1H NMR (500 MHz, in 
CD3CN), δ in ppm, 7.59 (s, Ar-OH, 4 H), 7.27 (s, Ar-H, 4 H), 6.21 (Ar-H, 8 H), 4.16 (t, CHbridge, 4 
H), 2.26-2.22 (m, CHCH2CH2, 8 H), 1.34-1.22 (m, CH2CH2CH2, 24 H), 0.890 (t, CH3, 12 H). Fig. 
18-B Appendix 
2.5.19 Synthesis of 4, 6, 10, 12, 16, 18, 22, 24-octa-oxy-ethylacetato-2, 8, 14, 20-
tetrapentylresorcin[4]arene RC6-Es 
The synthesis of the compound was carried out according to the Scheme 2.16 
  
NaH, 60 °C
THF/ DMF,
4
4
      
Scheme 2.16 Synthesis of C-pentylresorcin[4]arene ester  
2.                                                                                                                         Experimental Part 
 
84 
 
In a 500 ml three-neck round bottom flask and under a nitrogen gas atmosphere, C-
pentylresorcin[4]arene (5 g, 6.5 mmol) was dissolved in a mixture of freshly distilled THF and dry 
DMF (60: 40, v/ v),  then sodium hydride (0.16 g, 6.6 mmol) was added carefully to the reaction 
mixture and stirred for 30 minutes. This was followed by the dropwise addition of ethyl bromoacetate 
(1.09 g, 6.5 mmol) to the reaction solution. The mixture was heated in an oil bath at 60 °C.  The 
reaction was followed by TLC using a DCM: MeOH (7: 3) mixture as the developing solvent system. 
After completion, the reaction was stopped and cooled down to ambient temperature. The resulting 
solution was filtered and the solvent evaporated using a rotary evaporator. A brown viscous product 
was obtained, dissolved in 100 ml dichloromethane and transferred to a separation funnel. Then it 
was washed with distilled water and brine, the organic layer was separated and dried over anhydrous 
magnesium sulphate. The mixture was filtered and the solvent was evaporated   under reduced 
pressure. A viscous colourless liquid was obtained. The crude product was dissolved in methanol and 
sonicated to break the oil. Light yellow crystals were obtained, filtered, collected and then dried. 
Yield 3 g, 60 %,1H NMR (500 MHz, in CDCl3), δ in ppm, 6.64 (s, Ar-H, 4 H), 6.23 (s, Ar-H, 4 H), 
4.61 (t, C-Hbridge, 4 H) ,4.3 (s (O-CH2CO,8 H), 1.86 (8 H, q (CHCH2CH2), 1.6-1.3 (m, 
CHCH2CH2CH2CH3, 24 H), 0.87 (s, CH3, 12 H). Fig. 19 B Appendix 
13C NMR (500 MHz, CDCl3, δ in ppm), 14.14 (CH3), 22.66 (CH2), 27.67 (CH2), 32.09 (CH2), 34.47 
(CH2), 35.79 (CH3), 51.92 (Cbridge), 60.97 (CO-OCH2CH3), 66.8 (OCH2CO, 100.17 (Ph-C), 117.88, 
128.54 (Ph-CH), 126.55 (Ph-CH), 154.9 (C-OH), 170.14 (C=O) 
 C80H112O24     
Microanalysis was carried out at the University of Surrey. Calculated %: C; 65.9, H; 7.69, N; 0.0 
Found %:  C; 64.12, H; 7.34, N; 0.0 
 
2.5.20 Synthesis of   2, 8, 14, 20-tetradecyl-5, 11, 17, 23-
tetrahydroxyresorc[4]arene ( 4, 5, 6, 10, 11, 12, 16, 17, 18, 22, 23, 24-
dodecahydroxyl-2, 8, 14, 20-tetrapentylresorcin[4]arene215  (PG6) 
The compound was synthesised following the same procedure used by Gerkensmeier and co-workers 
215 according to the following Scheme  
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C-pentyl pyrogallol[4]arene
4
Pyrogallol
HCl , 80  0C
Hexanal
 
                                                                                                                                                                     
Scheme 2.17 Synthesis of C-pentylpyrogallol[4]arene 
 
 A pre-dried three-neck round bottom flask (500 ml) containing a magnetic stirrer and fitted to a 
condenser and dropping funnel was placed in an ice bath under an inert atmosphere. Pyrogallol (7.84 
g, 62.2 mmol), was dissolved in ethanol (100 ml). Hydrochloric acid (12 M, 2 ml) solution in ethanol 
(20 ml) was added dropwise to the stirring solution maintaining the temperature at 0 °C. This was 
followed by the dropwise addition of hexanal (9.6 ml, 62.2 mmol) mixed with ethanol (25 ml). The 
reaction mixture was removed from the ice bath and heated in an oil bath at 80 °C under vigorous 
stirring for 16 hours.  After the reaction was completed, the mixture was allowed to cool to ambient 
temperature. The mixture was poured into ice-water to obtain light purple solid which was filtered 
and washed by ice cold ethanol. The purple solid collected and dried en vacuum at 80 °C. Pure white 
compound was obtained. 
1H NMR (500 MHz, in CDCl3), δ in ppm, 8.77 (s, Ar-OHmeta, 4 H), 7.46 (s, Ar-OHpara, 4 H), 6.88 (s, 
Ar-OHmeta, 4 H), 6.84 (s, Ar-H, 4 H), 4.38 (t, CHbridge, 4 H), 2.25-2.18 (m, CH-CH2-CH2, 8 H), 1.42-
1.34 (m, CH2-CH2-CH2-CH2-CH3, 24 H), 0.9 (t, CH3,12 H), Fig. 20-B Appendix 
13C NMR (500 MHz, in CDCl3), δ in ppm, 138.49 (ArC-OHmeta, 4 C), 137.34 (ArC-OHmeta, 4 C), 
131.37 (ArC-OHpara, 4 C), 125.39 (ArCortho, 4 C), 124.07 (ArCortho, 4 C), 113.76 (ArC, 4 C), 34.1 
(CH, 4 C), 33.17 (CH-CH2-CH2, 4 C), 31.96 (CH-CH2-CH2 ,4 C), 29.96 (CH-CH2-CH2, 4 C), 27.988 
(CH2-CH2-CH3, 4 C), 22.72 (CH2-CH2-CH3, 4 C), 14.11 (CH3, 4 C) 
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2.5.21 Synthesis of 2, 8, 14, 20-tetradecyl-5, 11, 17, 23-tetrahydroxyresorc[4] 
arene215 [C-decylpyrogallol[4]arene] (PG11) 
The synthesis of the compound was carried out following same procedure used in the synthesis of C-
pentylpyrogallol[4]arene ( Scheme 2.18) 
4
HCl , 80  0C
Scheme 2.18 Synthesis of C-decylpyrogallol[4]arene PG11 
A pre-dried three-neck round bottom flask (500 ml) containing a magnetic stirrer and fitted to a reflux 
condenser was placed in an ice bath under an inert atmosphere. Pyrogallol (5 g, 39.9 mmol), was 
dissolved in ethanol (75 ml), and a hydrochloric acid (12 M, 2 ml) solution in ethanol (25 ml) was   
added dropwise to the stirring solution maintaining the temperature at 0 °C. This was followed by 
the dropwise addition of a solution of undecanal (6.75 g, 39.9 mmol) dissolved in ethanol (25 ml) to 
the reaction mixture.  The reaction mixture was removed from the ice bath and heated in an oil bath 
at 80 °C under vigorous stirring for 16 hours.  After the reaction was completed, the mixture was 
allowed to cool to room temperature, the mixture was poured into an ice-water to obtain a brown 
solid which was filtrated and washed with ice cold ethanol. The solid was collected and dried en 
vacuo at 80 °C. 
1H NMR (500 MHz, in CDCl3), δ in ppm, 8.77 (s, Ar-OHmeta, 4 H), 7.46 (s, Ar-OHpara, 4 H), 6.87 (s, 
Ar-OHmeta, 4 H), 6.83 (s, Ar-H, 4 H), 4.38 (t, CHbridge, 4 H), 2.23-2.17 (m, CHbridge-CH2-CH2, 8 H), 
1.54-1.2 (m, CH2-CH2-CH2-CH3, 24 H), 0.9 (t, CH3, 12 H), Fig. 21-B Appendix 
2.5.22 Synthesis of C-4-aminophenyl pyrogallol[4]arene 
 This compound was synthesised according to following scheme 
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Ethanol/ HCl
80 °C, 24 hours
 
Scheme 2.19 Synthesis of C-4-aminophenyl pyrogallol arene 
In a 500 ml three neck round bottom flask containing a magnetic stirrer fitted with a reflux condenser, 
pyrogallol (4.66 g, 36.95 mmol) was dissolved in ethanol (50 ml), hydrochloric acid (2 ml, 12 M) 
mixed with ethanol (10 ml) were added dropwise under continuous stirring. Then p- amino-
acetophenone (5 g, 36.99 mmol) was dissolved in ethanol (50 ml) and was added to the reaction 
mixture dropwise. Then the reaction mixture was heated in an oil bath at 60 °C. After 20 minutes the 
colour of the solution was changed to deep purple colour. The mixture was left overnight, then 
removed from the oil bath, cooled down to ambient temperature and then it was neutralised by an 
aqueous solution of sodium bicarbonate solution (10 %) and refrigerated, the obtained precipitate 
was collected by filtration and dried under vacuum. Microanalysis were carried out at the University 
of Surrey. Calculated %: C; 69.00, H; 5.30, N; 5.76. Found %: C; 68.35, H; 5.79, N; 6.97 
2.6 Solubility measurements of receptors 
Saturated solutions of each receptor were prepared in different solvents and kept in a water bath at 
298.15 K for 24 hours to attain equilibrium between the solid and its saturated solution which were 
filtered by using Millipore filters 0.22 µm and a known volume of the solution was placed into a pre-
weighed porcelain crucible, dried and the weight of the residual solid was gravimetrically determined. 
Solvation experiments were carried out by exposing separately pre-weighed crucibles containing the 
solid in a saturated environment of the appropriate solvent in a desiccator for several days. The 
crucibles were then weighed to check the uptake of solvent by the solid. From solubility data, ΔsG° 
were calculated for the samples that were not altered by solvation. 
2.7 1H NMR measurements 
1H NMR measurements were carried out at 298 K using a Bruker AC-500 MHz.  The investigations 
were carried out by dissolving each compound (30 mg) in the appropriate deuterated solvents (0.5 
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ml) in 5 mm NMR tubes using TMS as the internal reference. 1H NMR titrations were carried out to 
determine the complexation between the receptor and the targeted guest by adding increasing 
amounts of known concentrations of guest solutions to the NMR tube containing a known 
concentration of the receptor. Chemical shift changes of the receptor after each addition were 
recorded. Subtracting the chemical shift for the free receptor r from the chemical shifts of the 
complex, c, the chemical shift changes, ∆, was calculated from the following equation (eq.2.6) 
 
 
                                             ∆  c  r                                                         eq. 2.6 
 
2.8 Conductometric measurements 
 
Conductance measurements are very supportive tool to monitor the complexation process between 
the receptor and the targeted species by testing the variation of the electrical behaviour of the guest 
solution in the conductivity cell caused by the gradual addition of the host solution and to identify 
the stoichiometry of the interaction at 298.15 K. A brief introduction on conductance measurements 
is given. Conductance measurements follows Ohm’s law in which the current I (amperes) in a 
conductor is directly proportional to the applied   electric force E (volts) and inversely proportional 
to the resistance R (ohm’s) of the conductor (eq.2.7)216 
 
                            I = E / R                                                                                    eq.2.7 
 
The resistance of an homogenous sample material, Ɩ, and cross sectional area, A, is given by eq.2.8  
 
                                     R = ρ Ɩ /A                                                                        eq.2.8 
 
In this equation, ρ; is a characteristic property of the material and is known as resistivity and it is 
measured in Ω cm. 
 
                                          ρ = R A / Ɩ                                                                                  eq.2.9 
 
The reciprocal of the resistivity is the conductivity, κ, is given as S.cm-1 where S is the notation used 
for the reciprocal of the resistivity   ρ (Seimens or Ω-1). Therefore eq.2.9 can be written in terms of    
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                                     = I Ɩ / R A                                                                                  eq.2.10 
 
The conductivity of the solution under study was obtained by using the pre-determined value of the 
cell constant (θ = Ɩ /A) and the measured value of the resistance R of the same sample as shown in 
eq.2.11       
                 
                                    = I θ / R                                                                            eq.2.11 
In this equation, the cell constant units are cm-1. The molar conductance, m, of an electrolyte is 
given by eq.2.12 
 
                                   m =1000  / c                                                                     eq.2.12 
 
 In eq.2.12 c, is the concentration of the solution in mol dm-3 and the units of m   are   given in S.cm2 
mol-1.     
 
2.8.1  Determination of the conductivity cell constant 
 
The conductivity cell constant,  , was determined according to the method described by Jones and 
Bradshaw217 by adding stepwise additions of a solution of potassium chloride in deionised water (0.1 
mol dm-3) to the conductivity cell containing deionised water (25 ml) at 298.15 K. Conductivity 
values were recorded after each addition.  The molar conductance, m (S cm
2
 mol
-1
) was calculated 
from the equation derived by Lind, Zwolenik and Fuoss218 
 
                             m = 149.93 – 96.65 c
1/2
 + 58.74 c log c + 198.4 c                     eq.2.13 
 
In eq.2.13, c, denotes to molar concentration (mol dm-3) of potassium chloride solution. The cell 
constant, θ (cm-1) was calculated from the following equation 
 
                    θ  = m c / κ ×1000                                                                   eq.2.14 
 
2.8.2 Conductometric titrations at 298.15 K 
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Conductometric titrations involved the gradual addition of the receptor solution in acetonitrile to the 
conductivity cell containing the targeted guest in the same solvent at 298.15K. To achieve these 
measurements, the conductometric cell connected to a thermostated water bath was loaded with the 
guest solution in the appropriate solvent (25 ml). Then the electrodes were immersed into the solution 
cell under continuous stirring during the course of the titration. Accurate aliquots of the receptor were 
gradually added to the guest solution in the same solvent, the resistance was recorded after each 
addition once equilibrium was attained. Molar conductance Λm (S cm2 mol -1) were plotted against 
the [receptor/ guest] concentration ratio. The stoichiometry of the complexation was identified by the 
graphical tangent method (intercept between the two lines prior and after the end point of the 
reaction).  
 
2.9 Nano Isothermal Titration Calorimeter Nano-ITC 
 
Isothermal titration calorimetry is a highly sensitive technique designed to determine rapidly and 
accurately the thermodynamic parameters associated with the complexation process between the host 
and the guest in solution (stability constant and enthalpy of a reaction). From these parameters, the 
Gibbs energy and the entropy of complexation can be calculated by applying the following equations 
 
                          ΔcG° = ─ RT ln Ks                                                                       2.15 
 
                                      ΔcG° = ΔcH°─TΔcS°                                                                  2.16 
 
In eqs. 2.15 and 2.16, ∆cG °, R, T, Ks, ∆cH° and ∆cS° denote the standard Gibbs energy, the gas 
constant, the temperature (Kelvin), the stability constant, the standard enthalpy and entropy of 
complexation respectively 
The Nano Isothermal Titration Calorimeter consists of the main features: 
1. A burette stirring system. 
2.  A syringe (100 µl)  
3.  A reference cell (1 cm
3 
each) 
4. Thermoelectric devices. 
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The Nano ITC is connected to a personal computer that included the software delivered from the 
manufacturer with the information needed for the operation of the instrument and to analyse the data 
obtained to display the thermodynamic parameters for every single reaction taking place219, 220. 
 
  
2.9.1 Calorimetric measurements 
 
The Nano- ITC measurements were carried out in degassed acetonitrile at 298.15 K. The host solution 
(1×10-3 mol dm-3) was used in a 950 l cell volume. Solutions of each guest (2×10-2 mol dm-3) were 
added by an injection syringe programmed to inject 5 or 10 µl successively into the host solution in 
the same solvent with a 3 to 5 minutes’ interval between each injection. The instrument was delivered 
with a program from the manufacturer to control the operation. The heat of dilution was determined 
from the titration curve after the receptor concentration was totally consumed.  The obtained values 
were modelled using an independent nonlinear regression analysis. The fitting was done using a 
software 
 
2.9.2 Calibration of the Nanocalorimeter 
 
Calibration experiments were carried out to check the accuracy of the ITC. The complexation reaction 
between barium chloride with 18-crown-6 in aqueous medium at 298.15 K suggested by Briggner 
and Wadsӧ221,222 as a standard reaction was performed to calibrate the calorimeter. The calibration 
experiment was carried out by setting the instrument to inject automatically 5 µl   from the injection 
syringe containing the aqueous solution of barium chloride (1.5 × 10
-2 mol dm-3) every five minutes 
to the reference cell which was loaded with 18-crown-6 solution (1 × 10-3 mol dm-3) in deionised 
water.  After completion of the reaction, the data were analysed by the software delivered with the 
instrument from the Manufacturer.  From the titration information, the stability constant Ks and the 
enthalpy change ΔH were obtained. From these parameters, the Gibbs energy and entropy were 
calculated by applying equations 2.15 and 2.16 respectively 
 
2.10 Determination of the stability constant and the composition of host-guest 
complexes by UV-Vis, 1H NMR and calorimetric titrations 
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UV-Vis, 1H NMR and calorimetry are the most commonly used analytical techniques for the 
determination of the stoichiometry and the stability constant of the host-guest complex for complexes 
of moderate or low stability. Titration measurements are performed by the addition of increasing 
concentration of one of the component (host or guest) to a fixed concentration of the other67. The 
reversible complexation process between the host and the guest in a solvent (s) is described according 
to the following equation (eq.2.17) 
𝐻 (𝑠) + 𝐺(𝑠) ⇌ 𝐻. 𝐺( 𝑠)                                                                                                                     eq. 2.17 
Where 𝐻, 𝐺 and 𝐻. 𝐺, are the notations used to indicate the host, the guest and the complex 
respectively. Therefore, the stability constant , 𝐾𝑠, can be expressed as follows 
𝐾𝑠 =
𝑎𝐻.𝐺
𝑎𝐻𝑎𝐺
                                                                                                                                               eq. 2.18 
In eq.2.18, 𝑎𝐻.𝐺 , 𝑎𝐻       and 𝑎𝐺  denote the activity of the complex, host and guest respectively. On 
the assumption that the activity coefficients of reactants and product are equal to 1 (at low 
concentrations), the stability constant can be expressed by eq.2.19 in terms of molar concentrations, 
𝐾𝑠 =
[𝐻. 𝐺]
[𝐻] [𝐺]
                                                                                                                                         eq. 2.19 
The concentration of the host and the guest at equilibrium can be calculated from eq.2.20 and eq.2.21 
[𝐻] = [𝐻]° −  [𝐻. 𝐺]                                                                                                                          eq. 2.20 
[𝐺] =  [𝐺]° − [𝐻. 𝐺]                                                                                                                           eq. 2.21 
In eqs.2.20 and 2.21,  [𝐻]° , [𝐻], [𝐺], [𝐺], [𝐻. 𝐺]°, are the initial and final molar concentration of the 
host, the guest and the complex respectively. By replacing eqs. 2.20 and 2.21 in eq.2.19, it follows 
that   
𝐾𝑠 =
[𝐻. 𝐺]
[𝐻]°[𝐺]° − [𝐻. 𝐺][𝐺]° − [𝐻. 𝐺][𝐻]° + [𝐻. 𝐺]2
                                                                       eq. 2.22 
Rearrangement of eq.2.22 leads to eq.2.23 
𝐾𝑠([𝐻]°[𝐺]° − [𝐻. 𝐺][𝐺]° − [𝐻. 𝐺][𝐻]° + [𝐻. 𝐺]
2) = [𝐻. 𝐺]                                                         eq. 2.23 
 
𝐾𝑠[𝐻. 𝐺]
2 − (𝐾𝑠[𝐺]° − 𝐾𝑠[𝐻]° + 1)[𝐻. 𝐺] + 𝐾𝑠[𝐻]°[𝐺]° = 0                                                        eq. 2.24 
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Eq.2.24 can be solved as follows 
[𝐻. 𝐺] =
1
2
([𝐺]° + [𝐻]° +
1
𝐾𝑠
) − √([𝐺]° + [𝐻]° +
1
𝐾𝑠
)2 + 4[𝐻]°[𝐺]°                                        eq. 2.25 
Or  
[𝐻. 𝐺] =
[𝐻]°𝐾𝑠[𝐺]
1 + 𝐾𝑠[𝐺]
                                                                                                                                 eq. 2.26 
In eq.2.26, the concentration of the complex [[H.G] is expressed as a function of 𝐾𝑠 , which is the 
only unknown and can be determined by UV-Vis, 1H NMR and calorimetric titrations. 
 In the UV-Vis spectrum, the complex has a particular absorption band, 
𝐴 = 𝜀𝐻.𝐺[𝐻. 𝐺]                                                                                                                                          eq. 2.27   
Taking into account eq.2.25, it follows that 
 
𝐴 = 𝑓(𝜀𝐻.𝐺 , 𝐾𝑠)                                                                                                                                         eq. 2.28  
In the UV-Vis the change in the absorption band, ∆𝐴𝑜𝑏𝑠,  during the titration is given by  
∆𝐴𝑜𝑏𝑠 = 𝜀∆[𝐻.𝐺]([𝐻. 𝐺])                                                                                                                           eq. 2.29  
In 1H NMR, the chemical shift changes,  ∆𝛿, during the titration is 
∆𝛿 = 𝛿∆𝐻𝐺  
[𝐻. 𝐺]
[𝐻]°
                                                                                                                                   eq. 2.30 
In the calorimetric titration, the change in the heat of complexation, 𝑄, is given by               eq.2.31  
𝑄 = ∆𝐻𝐻.𝐺𝑉([𝐻. 𝐺])                                                                                                                              eq. 2.31 
In eq. 2.31, ∆𝐻𝐻.𝐺, is the change in enthalpy of the reaction and  𝑉 , is the volume of the guest added 
after each addition to the cell containing the host 
Determination of stability constant based on absorbance, 𝑨 
𝐴 = 𝐴𝐻.𝐺 + 𝐴𝐻 + 𝐴𝐺                                                                                                                                eq. 2.32  
Assuming  [𝐺]° ≫ [𝐻]° , thus, 𝐴
𝐺 > 𝐴𝐻, it follows that  
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𝐴 = 𝐴𝐻𝐺 + 𝐴𝐺                                                                                                                                           eq. 2.33 
∆𝐴 = 𝐴 − 𝐴°                                                                                                                                              eq. 2.34 
∆𝐴 = 𝜀𝐻.𝐺[𝐻. 𝐺]𝑏 + 𝜀𝐺[𝐺]𝑏 + 𝜀𝐺°[𝐺]°𝑏                                                                                             eq. 2.35 
 
∆𝐴 = ∆𝜀[𝐻. 𝐺]𝑏     with   ∆𝜀 = 𝜀𝐻.𝐺 − 𝜀𝐺                                                                                             eq. 2.36 
∆𝐴 = 𝑏∆ℰ
[𝐻]°𝐾𝑠[𝐺]°
1 + 𝐾𝑠[𝐺]°
                                                                                                                             eq. 2.37 
And finally 
1
∆𝐴
=
1
𝑏∆𝜀[𝐺]°[𝐻]°𝐾𝑠
+
1
𝑏∆𝜀[𝐻]°
                                                                                                          eq. 2.38 
 
2.11  General procedure for the determination of optimum amount of the receptor 
for the uptake of targeted guest from aqueous solution at 298.15 K 
Extraction experiments were carried out in an attempt to assess the efficiency of calix[4]arene 
derivatives and 3-aminopropyl functoinalised silica (Sil-NH2) to remove pharmaceuticals from 
water.The optimal conditions were determined by taking into account the effect of the amount of 
receptor and the pH of the solutions, The capacity of the receptor ( or silica) defined as the maximum 
amount of the drug (mmol) per gram of material was determined  
2.11.1  Effect of the amount of material on the extraction of pharmaceticals 
In order to calculate the optimal amount of the receptor to be used in the extraction experiment,  
different amounts of the receptor (0.01, 0.02, ...,0.1 g) were added to a fixed concentration of the 
targeted guest in water, the mixtures were mixed well by whirlimixer and left overnight in a water 
bath at 298 K. Eeach solution was filtered and analysed by UV-Vis measurements. The percentage 
of extraction was calculated according to eq.2.39 
                                             % 𝐸 =
Ci−Ce
Ci
× 100                                                                         eq.2.39 
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In this equation, % 𝐸, is the extraction percentage of the targeted guest, ci and ce is the initial and 
final concentration of the guest (pollutants) before and after extraction respectively in mol dm-3. 
The capacity q of Sil─NH2 was calculated from the eq.2.40 
                                           q =
(𝐶𝑖−𝐶𝑒)𝑉
𝑚
                                                                                    eq.2.40          
where ci and ce are the initial and final concentration of aspirin before and after extraction respectively 
in mol dm-3,  𝑚 is the mass of the material used for the removal of the pollutants, 𝑉 is the volume of 
the solution in dm3and q is the capacity of the material used to remove the pollutants. 
2.11.2 Effect of pH on the extraction 
The effect of pH values on extraction of aspirin by 3-aminopropyl functionalised silica was tested 
by the addition of 0.08 g of Sil-NH2 in the aspirin solutions (10 ml) containing 5.59 × 10
-3 mol dm-3 
of aspirin with different pH values. The mixtures were mixed on whirlimixer and left for six hours 
in a water bath at 298 K. The mixtures then flitered and analysed by UV-Vis spectroscopy. The 
percentage of extraction, % E, and the capacity, q, were calculated using eq.2.39 and 2.40 
2.11.3 Kinetics of removal of pharmaceuticals by macrocycles and Si-NH2 
In order to assess the effect of the time required on the removal processes, a series of solutions with 
the same concentration prepared, fixed mass of receptor were added, mixed and filtrated after 
different contact times from 10 minutes to 18 h at 298 K by filter (Millipore 0.22), the UV-Vis 
measurements were used to determine the final concentration for each solution 
2.12 Thermal Properties measurements TGA, DSC 
These measurements include the thermogravimetric analysis, TGA and the Diffrential Scanning 
Calorimetry DSC. TGA and DSC are powerful and accurte thermoanalytical techniques used 
successfully in the investigation of the host-guest complexes by following the variation in the 
physicochemical properties of the materials in the solid state as a result of fixed rate increase of 
heating and cooling under an inert or potent atmosphere at constant pressure. The investigation of the 
complexation process can be determined by the comparisim of the TGA and DSC thermograms for 
the host, guest and the complex. Getting different TGA thermograms indicating that the complexation 
of the host with guest has significant effect on their thermal stabilities while the obtaining of different 
thermodynamic parameters from the DSC thermograms such as shifting the value of melting 
enthalpies of the complex compared with its components to another temperature or vanishing during 
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the temperature scale of the sample cracking indicate that the complexation process was achieved 
successfully which means that the complexation process has led to an effect on their physicochemical 
properties223-225. TGA measurements were carried out to obtain information required in the next DSC 
measurements. In the TGA measurements, the solid sample was weighed accurately then placed in a 
platinum pan, the pan was inserted into the furnace, and the furnace was sealed. The sample was then 
heated from ambient temperature to a maximum temperature of 600 or 800 °C processed to 20 °C/ 
min temperature rise.  Between each analyses, the furnace was cooled by nitrogen gas to make sure 
that the instrument had reached ambient temperature. The sample mass was taken by using a 
microbalance. The onset temperature of weight loss and first derivative plot were obtained through 
the TA Universal Analysis, a software program delivered by the manufacturer of the instrument.  
Differential Dcanning Calorimetric DSC tecqniqu is a thermal analysis used to study the change in 
the physical properties of the materials as a result of an increase or decrease of temperature at a 
constant rate with time in a fixed presure. In the DSC runs, the solid sample was weighed, placed into 
an aluminium pan and an empty pan was used as a reference.   To start the measurements, the 
instrument was cooled to – 25 °C using liquid nitrogen and then the empty reference pan was heated 
electrically at a rate of 10 °C/ min and the heat transferred to the sample pan was recorded. The 
conditions used for these measurements are shown in Table 2.2.  Melting points were calculated. 
 
 
 
 
 
 
 
 
 
Table 2.1 Different conditions used during TGA analysis. 
 
Sample name 
 
Weight 
used mg 
Temperature 
range 
Ramped 
Temperatur 
N2 Gas flow 
Sodium diclofenac NaDF 
 
  2.397   RT-800 °C     20 °C/ min 60 cm3/ min 
Carbamazepine     CBZ 
 
  4.314   RT-600 °C     20 °C/ min 60 cm3/min 
 CAE   2.832   RT-800 °C     20 °C/ min 60 cm3/ min 
2.                                                                                                                         Experimental Part 
 
97 
 
 
C10-pyrogallol[4] arene PG11 
 
  2.352   RT-800 °C     20 °C/ min 60 cm3/ min 
PG11+ CBZ 
 
  2.878   RT-600 °C     20 °C/ min 60 cm3/ min 
PG11+ aspirin 
 
  2.592   RT-600 °C     20 °C/ min 60 cm3/ min 
PG 11+ Diclofenac 
 
  3.909   RT-600 °C     20 °C/ min 60 cm3/ min 
PG11+ clofibric acid 
 
  3.157   RT-800 °C     20 °C/ min 60 cm3/ min 
Calixamine 
 
  2.704   RT-800 °C     20 °C/ min 60 cm3/ min 
Calixamin+aspirin  
 
  4.446   RT-800 °C     20 °C/ min 60 cm3/ min 
Calix-(NH2)2+diclofenac  
 
  3.7910   RT-800 °C     20 °C/ min 60 cm3/ min 
Aspirin 
 
  5.802   RT-800 °C     20 °C/ min 60 cm3/ min 
Diclofenac  
 
  2.337   RT-800 °C     20°C/ min 60 cm3/ min 
Clofibric acid  
 
  4.525   RT-800 °C     20 °C/ min 60 cm3/ min 
 
 
 
 
 
 
 
 
 
 
 
Table 2.2 The conditions applied for DSC analysis 
 
Sample name 
 
Weight  
used 
mg 
Temperature range       
°C 
Ramped 
Temperature 
N2 Gas flow 
Sodium diclofenac      3.7     25-250 °C   10 °C/ min 50 cm3/ min 
Carbamazepine     CBZ     4.7     25-200 °C   10 °C/ min 50 cm3/ min 
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Calix[4]arene tetraester CAE              3.8     25-260 °C   10 °C/ min 50 cm3/ min 
C10-pyrogallol[4] arene PG11     2.8     25-250 °C   10 °C/ min 50 cm3/ min 
PG11+CBZ     3.5     25-190 °C   10 °C/ min 50 cm3/ min 
PG11+ aspirin     3.6     25-120 °C   10 °C/ min 50 cm3/ min 
PG 11+ Diclofenac     3.1     25-160 °C   10 °C/ min 50 cm3/ min 
PG11+clofibric acid     4.2     25-120 °C   10 °C/ min 50 cm3/ min 
Calixamine     2.2     25-220 °C   10 °C/ min 50 cm3/ min 
Calixamin+aspirin      3.9     25-100 °C   10 °C/ min 50 cm3/ min 
Calix-(NH2)2+diclofenac      5.1     25-120 °C   10 °C/ min 50 cm3/ min 
Aspirin     5.6     25-120 °C   10 °C/ min 50 cm3/ min 
Diclofenac      2.2     25-150 °C   10 °C/ min 50 cm3/ min 
Clofibric acid      4.7     25-120 °C   10 °C/ min 50 cm3/ min 
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3.1 Solubility of drugs in different solvents 
Under the IUPAC-NIST Solubility Data Seies, Acree226 proceeded with a critical evaluation on the 
solubility of non-steroidal anti-inflammatory drugs in pure organic solvents as well as in organic 
solvent mixtures. Drugs included within the context of this work were diclofenac, ibuprofen, sodium 
diclofenac and salicylic acid. In order to familiarise with the experimental work related to solubility 
measurements of drugs in different solvents, two drugs were selected, sodium diclofenac and 
carbamazepine and the results are now discussed  
3.1.1 Solubility of sodium diclofenac in different solvents 
Solvation and solubility measurements were carried out as described in Section 2.1 and results in   
water, methanol (MeOH), ethanol (EtOH), acetonitrile (MeCN), tetrahydrofurane (THF), 1-octanol 
(1-Oct), dimethyl sulfoxide (DMSO), N, N-dimethylformamide (DMF), ethyl acetate (EtAc), 1-
butanol (BuOH) and hexane (Hex) are displayed in Table 3.1. For comparison purposes also included 
are the literature recommended values reported by Acree226. The derivation of standard solution 
Gibbs energy, ΔGs◦ requires that the composition of the solid in equilibrium with the saturated 
solution should be the same. Therefore, solvation was tested in the various solvents. Sodium 
diclofenac NaDF, is expected to be fully dissociated in water as shown in eq.3.1 
 
.                                           NaDF (sol.)  Na+ (H2O) + DF- (H2O)                                  eq. 3.1 
 
 Therefore, the thermodynamic solubility product, Ksp can be represented as shown in eq. 3.2 
 
                                             Ksp= [Na
+] [DF-] γ±2                                                                  eq. 3.2 
 
In eq.3.2 values between brackets denote molar concentrations and γ± is the mean molar activity 
coefficient which can be calculated according to the limited Debye-Hückel equation (eq.3.3) 
                                             log ± =  0.509 z  z  √𝐼                                                                                          eq.3.3      
In equation 3.3, z , z , are the net charge for the cationic and anionic moieties respectively and I is 
the ionic strength which is defined in eq.3.4      
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                                               I = 
1
2
  cz2                                                                                eq. 3.4 
In eq.3.4, c, is the concentration of the solution in mol dm-3 units    
The calculated ionic strength for sodium diclofenac solution in distilled water in this work is  
                                              I = 0.069 mol dm-3 
This value is not in agreement with the value reported earlier227 (I = 0.16 mol dm-3) Therefore, the 
mean molar activity   
 
                                                                       ±  0.735     Ksp = 2.57 × 10-3  
The data are referred to the standared state (1 mol dm-3) for ions and therefore the units are cancelled 
Thus the ΔGs◦ is given by eq.3.5 
                                                ΔGs◦ =  RT ln Ksp                                                                eq. 3.5 
In eq. 3.5, R is the gas constant and T is the absolute temperature in Kelvin. The data are referred to 
the standard state of 1 mol dm-3 for the solid and for the saturated solution. 
In solvents of moderate dielectric constant such as MeOH, EtOH, BuOH, MeCN ions and ion-pairs 
will be present in the saturated solution. In order to calculate the ΔGs◦ for the dissociated salt it is 
necessary to have knowledge of the ion-pair association constant, Ks. These values are not available 
in the literature for this particular drug. Therefore, the ΔGs◦ is not reported in Table 3.1. In solvents 
of low dielectric constant such as 1-Oct, THF and Hex, ion pairs will be predominantly in the 
saturated solution. Therefore, the ΔGs◦ is referred to the process in eq.3.6 
 
                                               NaDF (sol.) → NaDF (s)                                                        eq.3.6 
 
In this case, the ΔGs◦ can be obtaind directly from eq.2.2. Therefore, the Gibbs energies of transfer, 
ΔtG ° from   water to low permittivity solvents reported in Table 3.1 are referred to the following 
process  
 
                                             
                                              Na+ (H2O) + DF
- (H2O) → NaDF (s)                                      eq.3.7 
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Table 3.1 Solubility and standard Gibbs energies of solution of sodium diclofenac in different 
solvents at 298.15 K.  
Solvent       Ksp ΔGs◦/ kJ mol-1 ΔGt◦ (H2O→S2)   kJ mol-1  
 
H2O 
 
(6.69  0.04) ×10 -2 
  
   14.78 ± 0.2 
 
             0.00 
 
MeOH 
 
(5 ± 0.01) ×10 -1 
 
   ------------ 
 
          ---------- 
 
EtOH 
 
(3 ± 0.02) ×10-2 
  
   ------------                 
 
          ---------- 
 
MeCN 
 
(1.52 ± 0.01) ×10-3 
 
   ------------ 
 
          ---------- 
 
THF 
 
(7.53 ± 0.01) ×10-3  
 
   20.56 ± 0.1 
 
             5.78 
  
DMF 
 
(2.25 ± 0.01) ×10-2 
 
9.41 ± 0.1 
 
            -5.37 
 
DMSO 
 
(2.91 ± 0.05) ×10-2 
 
   8.76  0.3 
 
             -6.02 
 
EtAc 
 
(5.1 ± 0.03) ×10-3 
 
   8.14  0.2 
 
             -6.64 
 
1-BuOH 
 
(4.3 ± 0.04) ×10- 4 
 
  ----------- 
    
            --------- 
 
It is clear from Table 3.1 that in protic solvents (able to enter hydrogen bond formation) the solubility 
of NaDF follows the sequence 
                            MeOH > H2O > EtOH > 1-Oct 
 For other solvents, the following pattern was found 
                        DMSO > DMF > MeCN > THF > BuOH194.  
Water will be used as the main solvent for sodium diclofenac   as it is the primary focus of this study 
to remove this pharmaceutical from water. Unlike sodium diclofenac, carbamazepine CBZ is a non-
electrolyte and therefore the standard solution Gibbs energy can be directly calculated from the 
solubility of the drug in the appropriate solvent provided the solvation phenomenon is not observed 
when the solid is exposed to a saturated atmosphere of the solvent. The results obtained are now 
presented and discussed  
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3.1.2 Solubility of carbamazepine (CBZ) in different solvents 
Solubility data for the CBZ drug in different solvents at 298.15 K are shown in Table 3.2. From the 
solubility value, both the Gibbs energy of solution and then the transfer Gibbs energy tG of the 
drug from one solvent to another using water as reference solvent were calculated 
Table 3.2 Solubility of carbamazepine CBZ in different solvents at 298.15 K and derived standard 
Gibbs energies of solution and transfer from water   
 
Solvent 
 
Solubility/ mol dm-3 
 
  ΔsG°/   kJ mol-1 
 
ΔtG° (kJ mol-1) H2Os2(H2O) 
 
   Water 
 
 
(7.66 ± 0.04) ×10-4 
 
   17.78 ± 0.2 
 
                  0.00 
 
   MeCN 
 
(4.25 ± 0.04) ×10-3  
 
 
13.39 ± 0.2 
 
          - 4.48 
 
   DCM 
 
 
(1.8 ± 0.03) ×10-2 
 
9.96 ± 0.2 
 
                - 3.37 
 
   DMSO 
 
(1.66 ± 0.03) ×10-2 
 
 
10.13 ± 0.2 
 
                - 7.65 
 
   Hex 
 
(5.0 ± 0.06) ×10-1 
 
 
1.71 ± 0.3 
 
                - 15.96 
 
   MeOH 
 
(4.4 ± 0.04) ×10-1 
 
2.03 ± 0.2 
 
                - 15.64 
 
 
   EtOH 
 
(1.6 ± 0.05) ×10-1 
 
 
4.54 ± 0.3 
 
                - 13.13 
 
   DMF 
 
(3.7 ± 0.02) ×10-2 
 
 
8.17 ± 0.1 
 
                - 9.61 
 
From the above data it can be seen that CBZ is least soluble in water and is most soluble in hexane 
than in any other solvent. The structure of CBZ itself has a hydrophobic region due to the aromatic 
groups but the amide moiety confers to it a certain degree of hydrophilic character and therefore even 
though its hydrophobic presence seems to be reflected in the low solubility observed in water and the 
highest solubility found in hexane. It seems that protophilic dipolar aprotic solvents such as DMF 
and DMSO containing basic oxygen atoms are able to interact through hydrogen bond formation with 
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the amide fuctional groups of the drug given that the solubility of the drug in these solvents is higher 
than that in water. 
Again the carbonyl oxygen of the amide functional group in CBZ can interact with the alcohols 
through hydrogen bond formation. It is important to emphasise that water is the most strongly 
‘structured’ solvent (tri-dimentional nature of molecules associated) while this is not the case for 
protic solvents such as the alcohols (chains). Therefore, the latter are more likely to interact with the 
drug than water and the results shown in Table 3.2 corroborate this statement. As a result of the low 
solubility of CBZ in water, this drug is more favourably transferred to non-aqueous media as reflected 
in the negative transfer Gibbs energies. In an attempt to obtain experience on the determination of 
partition coefficients of drugs and its relationship with solubility as described below, four drugs were 
selected and these are diclofenac, clofibric acid carbamazepine, aspirin nd sodium diclofenac228-231.  
3.2 Determination of partition coefficients for diclofenac, clofibric acid, 
carbamazepine, aspirin and NaDF in the water-1-octanol solvent system 
The relationship between solubility of a drug and its partition coefficient, Kp, is described as follows; 
the solubility of a non-electrolyte, D, as described by eq.3.8 is an equilibrium between the solid and 
its saturated solution in a given solvent, s1 
 
                                             D (sol.) → D (s1)                                                                       eq.3.9 
 
The equilibrium constant, K (s1) = [D] (s1)   given that the activity of the solid is by convention =1  
For solvent s2, the process is described as follows, 
 
                                             D (sol.) → D (s 2)                                                                     eq.3.10 
 
Therefore, K (s2) = [D] (s2). The ratio between these equilibrium constants is the transfer equilibrium 
constant, Kt as defined by eq.3.9 
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                                            Kt = K (s2)/ K (s1)                                                                      eq.3.11 
 Kt differs from the partition coefficient, Kp (eq.3.12) in that in the former, pure solvents are involved 
while in the latter, the mutually saturated (satd) solvents are involved. 
 
                                            Kp = [D] (satd s2) / [D] (satd s1)                                                eq.3.12 
In solvents of low mutual solubility, Kt is approximately equal to Kp but differs considerably for 
solvents for which their mutual solubility is high. This issue has been addressed by Danil de Namor 
and co-workers232.                                        
High values of partition coefficients are important and imply that the drug is able to penetrate through 
the biological cell membrane which is a low permittivity medium to target the receptor site, this 
means these drugs have low solubility in water and when excreted as a metabolite or as a parent 
compound to the environment it will take long time to decompose and will be distributed through a 
wide range of aquatic area. The determination of the partition for these pharmaceuticals have been 
reported by many researchers199 but the values obtained are not in accord with each other and this 
may be due to different factors such as the conditions applied or companies using different procedures 
to synthesise the chemicals and therefore different crystal structures are obtained. These differences 
in the crystal structure can have an effect on the solubility and as a result different values are obtained 
for the parameters related to the solubility. Usually 1-octanol and chloroform are used as solvents 
representative of the biological membrane due to their low permittivity (dielectric constant) 
Values obtained in this work for the partition coefficients of these drugs in the water-1-octanol 
solvent system obtained (expressed as log Kp) are considered acceptable when compared with the 
values reported in the literature shown Table 3.3. The dissociation constants of the drugs expressed 
as pKa   values at 298 K are also included in this Table  
Table 3.3 Partition coefficients of drugs in the water-1-octanol solvent system at 298.15.K 
Pharmaceutical log Kp pKa 
Diclofenac 2.2a, 1.9b, 4.51b 4.16b 
Clofibric acid 3.3a, 2.88b 3.2b 
Carbamazepine 2.32a, 1.5b, 2.25b 14b 
Aspirin 2.02a 3.49 
a This work, b ref. 199 
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It can be seen that within the experimental error not much differences are found in the partition of 
these drugs from water saturated with 1-octanol to 1-octanol saturated with water. 
Having gained experience on solubility measurements and derived thermodynamic parameters as 
well in the determination of partition coefficients, among all the macrocycles synthesised and 
characterised, only few were selected for complexation with drugs. These are the functionalised 
cyclodextrin, Bz-β-CD and the calix[4]arene ester, CAE for sodim diclofenac. For drugs containing 
carboxylic acids in their structures, such as clofibric acid, diclofenac, aspirin and ibuprofene, the 
calix[4]arene amine derivative CA-(NH2)2 was the receptor selected for further studies. Preliminary 
studies in the solid state were carried out with a pyrogallol derivative, PG11 and carbamazepine. The 
reason for this selection of receptors is explained through the text 
 
3.3 Complex formation of sodium diclofenac NaDF with the per-benzoylated-β-
cyclodextrin receptor (BzBCD)  
There are a number of possible interactions between NaDF and the functionalised cyclodextrin. It is 
clear from the chemical structure of the perbenzoylated-β-cyclodextrin. The later contains ester 
groups which are known to interact with the sodium cation through ion-dipole interactions113,114. On 
the other hand, the NH functionality of the drug can interact with the oxygen atom of the receptor via 
hydrogen bond formation. Another possibility is that the hydrophobic region of the receptor can 
interact with the hydrophobic region of the drug. Different techniques were used to investigate 
whether or not sodium diclofenac interacts with the per-benzoylatec-β-cyclodextrin and if so, to 
identify possible sites of interaction.  
 
3.3.1 1H NMR complexation studies 
The 1H NMR spectrum of the sodium diclofenac with the perbenzoylated cyclodextrin in DMSO-d6 
at 298 K (Fig. 3.1) shows significant changes in the chemical shifts for the sodium diclofenac protons 
especially for the N-H proton and a downfield shift (∆ = 0.5 ppm) was observed (Table 3.4) which 
may indicate that there is interaction between this proton and the oxygen atom of the receptor. In 
addition to strong - interaction between the aromatic systems of the sodium diclofenac and the 
benzoyl groups of the receptor which could be attributed to the formation of host-guest complex 
through the inclusion of the sodium diclofenac in the receptor cavity233,234 
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Table 3.4 Chemical shift changes for the NH proton of sodium diclofenac resulting from 
complexation with per-benzoylated--cyclodextrine in DMSO-d6 at 298 K 
Compound Related proton chemical shift  
𝜹/ ppm 
        / ppm          / ppm 
Sodium diclofenac N-H 10.06            10.56         0.5 
 
Fig. 3.1 1H NMR spectrum for the complex resulted from the complexation of sodium diclofenac and 
per-benzoylated-β- cyclodextrin in DMSO-d6 at 298 K 
3.3.2 Photophysical properties of the host-guest complex 
 UV-Vis spectroscopy was also used to investigate the complexation process.  The study of the 
complexation of per-benzoylated –ß-cyclodextrin and sodium diclofenac were carried out in 1-
octanol at 298 K. The selection of 1-octanol was based on the fact that this non-aqueous solvent is 
representative of the cell membrane due to its low permeability. The titration experiment was carried 
out by the addition of increasing concentrations of the receptor in 1-octanol to the UV cell containing 
the solution of sodium diclofenac (5.029 × 10-5 M) in same solvent. The increase of the concentration 
of the receptor in the cell solution containing sodium diclofenac caused an increase of the absorption 
band intensity and changed the shape of the absorption band (Fig. 3.2). It can be seen from the plot 
of absorbance against the wavelength λ (nm) that the absorption band (n  π) of the carbonyl group 
at λmax 292 nm was shifted to a shorter wavelength due to the solvent-drug interaction through the 
formation of hydrogen bonding between n electrons and the solvent which can lead to decrease the 
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energy of the n state without any effect on π orbitals. This means that the energy required for the 
transition increased and the wavelength will moved shorter while the intensity of the peaks increased 
(hyperchromic effect) in spite of the decrease in the absorbance of the pharmaceutical which may 
attributed to the effect of the receptor to lowering the aggregation and promote the dissociation of 
NaDF to form the complex with the receptor235-237. The red shifting of π transition is attributed 
to the conjucation process for  systyms of the aromatic rings. These are indications that there is 
possible interaction between the receptor and sodium diclofenac. Given that glucose is one of the 
components of the β-cyclodextrin derivative, this compound was added to the drug solution. The 
intensity of the peaks was not affected by this addition. 
                                 
  
Fig. 3.2 UV-Vis spectrum for the titration of sodium diclofenac solution in 1-octanol (bottom scan 
,5.029×10-5 mol dm-3) as a result from the addition of different concentrations (3.08×10-5, 4.6×10-5, 
6.17×10-5, 7.7×10-5, 9.2×10-5 and 1.08×10-4 mol dm-3) of perbenzoylated β-cyclodextrin receptor,  
  
Assuming that the complexation reaction between sodium diclofenac NaDF and the receptor L 
occurred in 1: 1 stoichiometric ratio, thus the complexation can be expressed by equation eq.3.13  
                NaDF (1-oct) + BzBCD (1-oct) ⇌ NaDFBzBCD (1-oct)                   eq.3.13 
In equation 3.13 [NaDF], [BzBCD] and [NaDFBzBCD] denote the molar concentration of sodium 
diclofenac, the per-benzoylated-β- cyclodextrin receptor and the complex respectively. Therefore, 
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the stability constant, 𝐾𝑠  (expressed in terms of concentrations) for the complexation process is 
defined in eq.3.14 on the assumption that one molecule of the receptor takes up one unit of the drug 
𝐾𝑠 =
[𝑁𝑎𝐷𝐹𝐵𝑧𝐵𝐶𝐷]
[𝑁𝑎𝐷𝐹][𝐵𝑧𝐵𝐶𝐷]
                                                                              eq. 3.14 
The difference between the solutions having the maximum absorbance in the presence of the receptor, 
𝐴, and its absence, 𝐴° is denoted as ∆𝐴𝑚𝑎𝑥. The change in absorbance with the concentration of the 
receptor can be represented in eq.3.15 
𝐴 = 𝐴° +
∆𝐴𝑚𝑎𝑥𝐾𝑠[𝐵𝑧𝐵𝐶𝐷]
1 + 𝐾𝑠[𝐵𝑧𝐵𝐶𝐷]
                                                                 eq. 315 
In eq. 3.15, 𝐴, 𝐴°are the measured absorbance at a given wavelength for the drug solution with and 
without receptor and ∆𝐴𝑚𝑎𝑥, represents the change in the absorbance between the complex and the 
free drug. The stability constant, 𝐾𝑠 of the reaction can be calculated from equation 3.16. Plotting   
[BzBCD] [NaDF]/ [𝐴 − 𝐴°] against the concentration of the receptor (Fig. 3.3) the stability constant 
was calculated from the slope (slope =1/𝐾𝑠, 𝑙𝑜𝑔 𝐾𝑠= 4.01)
238. It is clear from Fig. 3.3 that the linearity 
of the equation deviates at the highest concentration of the receptor, which means that as the 
concentration of the receptor increases the receptor may undergo aggregation instead of complexation 
with sodium diclofenac. 
 
Fig. 3.3 Plot of [BzBCD] [NaDF]/ [A-Aº] against the concentration of the receptor in mol dm-3 
In an attempt to corroborate the data obtained by UV-Vis spectrophotometry and to verify the 
composition of the complex, conductmetric measurements are now discussed. However due to the 
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difficulties encountered in the use of 1-octanol in the conductometry cell, 1-butanol was the solvent 
used for conductometric measurements 
3.4 Conductometric measurements 
3.4.1 Determination of the conductivity cell constant 
The cell constant was determined using the method described in the Experimental Section. The 
numerical values of molar conductance and the cell constant of an aqueous solution of KCl (0.1 
mol dm-3) at 298.15 K are shown in Table 3.5  
Table 3.5 Molar conductance of an aqueous solution of KCl at 298.15 K for the calculation of the 
cell constant, (θ) 
Λm (S.cm2.mol-1) θ(cm-1) 
147.07 1.03 
 
 
 
 
146.12 1.08 
145.42 1.09 
144.84 1.07 
144.34 1.09 
143.91 1.07 
143.15 1.07 
142.82 1.07 
142.52 1.07 
 
The average value for the cell constant obtained at 298.15 K, θ (cm-1) was 1.07 ± 0.01 cm-1  
 
3.4.2 Conductometric measurements of sodium diclofenac with heptakis-( 2, 3 , 6-
tri-o-benzoyl)-ß-cyclodextrin in 1-butanol at 298.15 K 
  The solution of the non-steroidal inflammatory sodium diclofenac in 1-butanol has low conductivity 
due to the association (ion-pair formation) of this salt in butanol as a result from the low dielectric 
constant of the solvent. Addition of the receptor solution into the sodium diclofenac solution led to 
an increase of the conductivity values as shown in Fig. 3.4. The conductivity increase is due to the 
fact that more ions are present in solution. Indeed, the complex consists of a cation larger than the 
free sodium cation. As a reresult, the new salt NaBzBCDDF is expected to be more dissociated than 
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NaDF. After the ligand/ drug concentration ratio reaches a value of 0.5, an excess of the receptor 
shifts the equilibrium to the right leading to a further increase in conductance. In conclusion, a 2: 1 
complex is the most probably formed between NaDF and heptakis-( 2, 3 , 6-tri-o-benzoyl)-ß-
cyclodextrin in this solvent. 
 
Fig. 3.4 A plot of molar conductance of sodium diclofenac in 1-butanol against the [ligand]/ [drug] 
concentration at 298.15 K, [NaDF] = 1.25×10-4 mol dm-3 (the experiment was carried out once). 
 
3.5 Complexation studies of sodium diclofenac with heptakis-( 2, 3 , 6-tri-O-
benzoyl)-ß-cyclodextrin in 1-octanol using Nano-Isothermal titration calorimetry 
(Nano-ITC) 
Before proceeding with the determination of thermodynamic data of complexation, the ITC 
calorimeter was calibrated and therefore in the following section, the calibration of the instrument is 
discussed 
3.5.1 Calibration of the Nano-Isothermal Titration calorimetrt (Nano-ITC) 
A standard titration experiment between 18-Crown-6 and barium chloride in de-ionised water at 
298.15 K was carried out   to determine the reliability of the instrument.  An aqueous solution of 18-
crown-6 ether (1×10-3 mol dm-3) was loaded in the reference cell and a solution of barium chloride in 
de-ionised water (1.5 × 10-2 mol dm-3) injected automatically to the sample cell. A typical baseline 
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and fitting curve were obtained (Fig.3.5) indicating that the experiment was carried out carefully and 
the instrument was highly accurate  
Ba2+
[Ba-18-C-6]2+
2+
298.15 K
18-Crown-6, 18-C-6
Aquious medium
 
Scheme 3.1 The standard reaction between barium chloride and 18-crown-6 ether in aqueous mdium 
at 298.15 K 
 
From the data obtained from this titration, thermodynamic parameters for the complexation process 
such as stability constant (log Ks) and the change in enthalpy, ∆cH were calculated from the software 
provided with the instrument. The standerd Gibbs energy, ΔcG° and entropy ∆cS°, were calculated 
according to the following equations 
 
 
                                      ΔcG° =  RT ln KS                                                 eq.3.16 
 
 
In eq.3.16 Ks represents the stability constant, ΔcG° is the standard Gibbs energy change of 
complexation, R is the gas constant (8.314 J mol-1K-1) and T is the temperature in Kelvin. The 
standard entropy change, ΔcS° for the complexation was calculated according to the following 
equation  
 
                                      ΔcG° = ΔcH°TΔc S°                                               eq.3.17 
 
A typical calibration curve was obtained (Fig. 3.5) indicating that the stoichiometry of the reaction 
is 1: 1 [18-Crown-6]/ [Ba]2+ and the thermodynamic parameters obtained for the complexation of 
18-crown-6 with BaCl2 in water at 298.15 K are shown in Table 3.6. It was found that the obtained 
values were in good agreement with the values reported earlier in the literature. 
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Table 3.6 Thermodynamic parameters of complexation of barium with 18-crown-6 measured by 
ITC in aqueous medium at 298.15 K. 
 
Log Ks 
 
∆cG◦/ kJ mol-1 ∆cH◦/ kJ mol-1 ∆cS◦/ J K mol-1  Reference 
 
    3.60 ± 0.06 
 
   
     - 20.8 ± 0.3  
  
     - 29 ± 2 
    
        - 27  
 
   This work 
 
  3.45 – 3.87 
 
 
   - 21.9 
    
     - 29  33 
   
        - 33 
 
   Ref. 219 
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Fig. 3.5 Isothermal titration calorimetry for the complexation of 18-crown-6 (1× 10-3 mol dm-3) 
with BaCl2 (1.5 × 10
-2 mol dm-3). The curve shows the change in enthalpy after each injection as a 
result of complexation. 
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3.6 Determination of the thermodynamic parameters of complexation of sodium 
diclofenac with heptakis-( 2, 3 , 6-tri-o-benzoyl)-ß-cyclodextrin in 1-octanol at  
298.15 K 
The experimental work to determine the complexation of BzBCD and NaDF in 1-octanol by titration 
calorimetry at 298.15 K was carried out by the addition of NaDF in 1-Oct into the ITC cell loaded 
with the receptor solution in the same solvent. The baseline of the titration curve shown in Fig.3.6 
indicated that the complexation process was achieved successfully. The heat evolved is very small 
implying that the process was driven by weak forces and therefore the stability of the complex is 
entropy controlled as shown in Table 3.7. The data fits into a 1: 1 (drug: receptor) stoichiometric ratio 
as found by UV-Vis spectroscopy. Good agreement is found between the two sets of data. The 
advantage of nanocalometry relative to UV-Vis spectrophotometry is that the former gives the 
contribution of enthalpy to the stability of the complex and by the use of eq. 3.17 the entropy could 
be calculated 
 
Table 3.7 Thermodynamic parameters of complexation of the cyclodextrin derivative with sodium 
diclofenac at 298.15 K.15 in 1-octanol 
 
 
Titration type 
 
 log Ks     
 
 ΔcG°/ kJ mol -1 
 
ΔcH°/ kJ mol -1 
 
 ΔcS°/ J K-1 mol-1 
 
By ITC measurements 
 
 
4.04 ± 0.01 
 
 
 
 23.07 ± 0.06 
 
 
 
 0.45 ± 0.02 
 
 
 
        79 
 
UV/ Vis measurements 
 
 
4.01 ± 0.001 
 
 
 22.90 ± 0.01 
  
 
 
 
Unfortunately, the use of the per-benzoylated as a solid phase to remove sodium diclofenac from 
water could not be investigated due to the aggregation of the receptor in the aqueous medium To 
overcome this limitation, a calix[4] arene ester derivative, CAE was explored as discussed below 
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Fig. 3.6 Isothermal titration calorimetry for the complexation of sodium diclofenac [Guest] and     
perbenzoylated-- cyclodextrin in 1-octanol at 298.15 K. Top: the heat evolved after each addition   
of sodium diclofenac to the receptor sloution and bottom plotted against the molar ratio.                   
[NaDF] = 1×10-3 mol dm-3 
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3.7 Complexation studies of sodium diclofenac and 5, 11, 17, 27- tert-butyl-25, 26, 
27, 28-(oxy-ethylethanoate)calix[4]arene (CAE) 
3.7.1 1H NMR complexation studies 
The esterification of p-tert-butyl calix[4]arene has been carried out in one step and the compound  
was obtained in a high degree of purity which is very important for complexation studies.  The 
modified procedure used here differs from those previously reported. In the procedures used earlier 
the authors239 introduced ethyl bromoacetate in several portions in order to give time for the activation 
of the phenolic hydroxyl group. Other workers did not give a detailed account of the procedure114 
and used a base like sodium bicarbonate which appears to be time consuming (5 days)212. It was 
concluded in the literature that there is a probability that the ester group could be reduced to alcohol 
in the presence of a base, but the anhydrous solvent used prevents the reduction to alcohol which 
means that the use of the hydrated solvent can facilitate the reduction to alcohol due to the protonation 
of the carbonyl groups which can deviate the reaction towards the alcohol product. Also controlling 
the pH of the reaction (pH = 7) was a suitable way to direct the reaction to produce the targeted 
receptor. The 1H NMR spectrum confirmed the structure of the compound in addition to the 
microanalysis (see Experimental Part).  The obtained receptor adopts a distorted cone conformation 
as it is clear from the difference in the chemical shift value ∆ =1.47 ppm between the axial and 
equatorial protons117. Initially, the complexation studies were carried out using 1H NMR studies in 
deuterated acetonitrile. The spectrum for the complex (Fig.3.7) showed that the receptor complexed 
with the drug and significant changes in the chemical shift for the axial and equatorial protons of the 
methylene bridge protons of the receptor were observed (Table 3.8). The low solubility of the sodium 
diclofenac in acetonitrile retarded the progress with the titration experiment as to determine the 
thermodynamic parameters associated with this process by isothermal titration calorimetry. Another 
complexation study has been carried out to investigate the complexation process using DMSO-d6 as 
a dipolar aprotic solvent but the spectrum obtained shows that the receptor interacted strongly with 
this solvent and this interaction prevent the 1H NMR titration experiment. However, the binding 
affinity of the receptor to complex with the sodium cation (picrate or perchlorate counter ion) have 
been reported with details by McKervey et al 113and Danil de Namor et al 240and have demonstrated 
that the cation was nested perfectly in the lower rim polar semi-cavity with the cooperation of the 
acetonitrile solvent occupying the hydrophobic cavity of the receptor.  Here the affinity of   the solid 
receptor to complex with the sodium cation was exploited for the removal of the sodium diclofenac 
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from water after proceeding with the fundamental studies to determine the composition of the 
complex. In doing so conductance measurements were carried out prior to these measurements. 
Table 3.8 Chemical shift changes for the receptor protons as a result from the addition of sodium 
diclofenac in CD3CN at 298 K 
Proton  Ar-H C-HAxial OCH2CO O-CH2CH3 HEquatorial O-CH2-CH3 C-CH3 
 
        
 
6.77 
 
4.85 
 
 4.8 
 
4.2 
 
3.38 
 
3.28 
 
1.05 
 
      
 
0.0 
 
Vanished 
 
-0.05 
 
 0.1 
 
 0.04 
 
    0 
 
   0 
 
 
 
Fig. 3.7 1H NMR spectra for the complexation of p-tert-butylcalix[4]arene tetraeseter (3×10-2 mol 
dm-3)  with sodium diclofenac in CD3CN at 298 K. The lower spectrum for the free receptor and the 
upper for the complex with sodium diclofenac (1×10-3 mol dm-3) 
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3.7.2 Conductometric measurements of sodium diclofenac with 5, 11, 17, 27- tert-
butyl-25, 26, 27, 28-(oxy-ethylacetate)calix[4]arene (CAE)  in acetonitrile at 
298.15 K 
  The solution of sodium diclofenac in acetonitrile has low conductivity due to the association   (ion-
pair formation) of this salt in acetonitrile. Addition of the calix[4]arene tetraester solution into the 
sodium diclofenac solution (4.8 ×10-4 mol dm-3) led to an increase in the conductivity values as shown 
in Fig. 3.8 The conductivity increase is due to the fact that more ions are present in solution. Indeed, 
the complex consists of a cation larger than the free sodium cation. As a result, the new salt 
[NaCAE]DF is expected to be more dissociated than NaDF. After the ligand/ drug concentration ratio 
reaches a value of 1, an excess of the receptor shifts the equilibrium to the right leading to a further 
increase in conductance. In conclusion a 1: 1 complex is formed between NaDF and the calix[4]arene 
ester in acetonitrile 
 
Fig. 3.8 A plot of molar conductance against the receptor/ drug concentration ratio for the system 
involving p-tert-butylcalix[4]aren tetraester and sodium diclofenac NaDF in acetonitrile (4.8×10-4 
mol dm-3)  at 298.15 K.  
To investigate further the complexation of NaDF with the calix[4]arene ester, thermogravimetric 
analysis were carried out. 
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3.7.3 Investigation of the complexation between sodium diclofenac and 5, 11, 17, 
27- tert-butyl-25, 26, 27, 28-(oxy-ethylacetato)calix[4]arene by thermogravimetric 
analysis TGA and DSC 
 The thermogravimetric analysis was carried out as described in the Experimental Part. The TGA 
thermograms for sodium diclofenac, the receptor (CAE) and the complex are shown in Figs 3.9-3.12. 
The TG analysis was carried out under a nitrogen gas atmosphere in the rate flow of 50 cm3/ min and 
the temperature was raised from 0 °C to 800 °C. The complexation process between the calix[4]arene 
tetraester receptor with sodium  diclofenac was confirmed by comparing the thermogravimetrical 
behaviour of the pure compounds with that of  the complex formed. TGA thermograms for 
calix[4]arene tetraester CAE, NaDF and the complex formed (Fig. 3.9) provided significant evidence  
that the complexation process between CAE and NaDF was implemented successfully. It is known 
that there is a direct correlation between the rigidity of a solid and its thermal stability. Comparison 
between   these thermograms indicated that the thermal stability of the complex is lower than the 
thermal stability of the free receptor as a result of the increasing flexibility of the complex to achieve 
the conformational changes required for complex formation. The required reorganization processes 
to achieve the complexation process obliged the receptor to be sufficiently flexible to compensate the 
energy loses during the conformational changes and to stabilise the complex formed241.This means 
that the rigidity decreases and, as a consequence, reduction of the thermal stability occurred. In 
addition to the results obtained from TG analysis, the DSC thermograms for the pure compounds and 
the complex indicated that the complexation between the NaDF and the receptor is achieved. The 
DSC curve for sodium diclofenac is not in accord with the DSC thermogram reported earlier in the 
literature and this may be due to the oxidation of the pharmaceutical (Scheme 3.1)242. This can be 
attributed to the quantity of nitrogen gas delivered to the sample which was not enough to prevent 
the oxidation reaction or to the increase in the heat rate to 20 °C/ min which may have accelerated 
the oxidation reaction. Therefore, the curve reported in the literature is considered to give the 
interpretation related to the DSC curve of sodium diclofenac. The DSC thermogram reported in the 
literature241 indicated that the melting point of sodium diclofenac is 280 °C. The DSC thermogram 
of the free receptor (Fig. 3.14) have shown a sharp endothermic peak at 155.04 ºC with a heat of 
fusion; ΔH = +14.878 kJ mol-1 representing the melting point of the pure receptor.  The results 
obtained clearly have indicated that the melting point of the complex shifted to a lower temperature 
than that for the free receptor as a result of the complexation process (Fig. 3.15). It should be 
emphasised that this is the first DSC analysis reported in the literature for the calix[4]arene tetraester 
and its complexation involving  any pharmaceutical. 
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Thermal reaction
Δ
Na+
OH
.
Sodium diclofenac                                                     1-(2, 6-dichlorophenyl) indolin-2-one                                                                     
Scheme 3.2 The cyclisation of the sodium diclofenac due to thermal reaction242 
 
 
Fig. 3.9 TGA Thermogram for pure sodium diclofenac 
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Fig. 3.10 TGA thermogram analysis curve as it was obtained for p-tert-butylcalix[4]arene tetraester 
 
 
Fig. 3.11 TGA thrmogram for the complex formed between sodium diclofenac NaDF and the CAE 
receptor 
Temperature °C 
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Fig. 3.12 TGA curves for the sodium diclofenac NaDF, calix[4]arene tetraester (CAE) and the 
complex formed. 
 
      
Fig. 3.13 DSC thermogram of the sodium diclofenac 
0
1
2
3
0 280 560
W
e
ig
h
t 
%
T °C
Complex
NaDF
3.                                                                                                                          Results & Discussion 
 
124 
 
 
Fig. 3.14 DSC thermogram for the CAE receptor 
Fig. 3.15 DSC analysis for the complex formed between sodium diclofenac and calix[4]arene 
tetraester. 
Having obtained some information regarding the complexation process in solution (conductance 
measurements) and in the solid state (thermal analysis) the ability of calix[4]arene tetraester to 
remove the drug from water was investigated. 
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3.8 Removal of sodium diclofenac from water by using calix[4]arene tetraester 
from water.  
Extraction experiments were carried out under several experimental conditions as shown below  
3.8.1 Determination of the optimum amount of calix[4]arene tetraester for the 
uptake of sodium diclofenac from aqueous solution at 298 K 
In order to determine the optimum mass of the calix[4]arene tetraester for the removal of sodium 
diclofenac from water , batch experiments were carried out . Different weights of the calix[4]arene 
tetraester was added to a fixed concentration of aqueous solution of sodium diclofenac (2×10-4 mol 
dm-3, 10 ml). The mixtures were mixed for 10 minutes on a whirlimixer, sealed and left in a water 
bath at 298 K. The mixtures were filtered and the concentration of the drug at equilibrium was 
determined using a UV-Vis spectrophotometer at λmax = 272 nm. Table 3.9 indicates that the 
percentage of NaDF removed from aqueous solution by the receptor increases with increasing the 
mass of the material, and then the material reaches saturation as shown in Fig. 3.16. 
This is expected as the weight of the receptor increases, the amount of sites available for interaction 
with the sodium cation increases 
Table 3.9 Effect of the amount of calix[4]arene tetraester on the extraction of sodium diclofenac from 
aqueous solution (10 ml) at 298 K 
[conc.]initial 
mol dm-3 (10 ml) 
Receptor added 
(solid in mole) 
[Conc]equilibrium 
mol dm-3 
[Conc.]removed 
mol dm-3 
       % E 
2⨯10 -4    
 
1.01⨯10 -5                      7.93⨯10 -5                     1.21⨯10 -4                        60.35 
2⨯10 -4    
 
2.01⨯10 -5                      7.63⨯10 -5                    1.24⨯10 -4                       61.85 
2⨯10 -4    
 
3.02⨯10 -5                      7.03⨯10 -5                    1.30⨯10 -4                       64.85 
2⨯10 -4    
 
4.03⨯10 -5                      7.03⨯10 -5                    1.30⨯10 -4                       64.85 
2⨯10 -4    
 
5.03⨯10 -5                      7.1⨯10 -5                      1.29⨯10 -4                       64.50 
2⨯10 -4    
 
6.04⨯10 -5                      7.1⨯10 -5                      1.29⨯10 -4                       64.50 
 
The % E was calculated using the eq.2.39 and the concentration of the NaDF at equilibrium was 
calculated using UV-vis measurements (see Fig. 1-A Appendix)  
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Fig. 3.16 The effect of mass on the uptake of NaDF from aqueous solution by calix[4]arene tetraester 
at 298.15 K 
 
The data obtained shows that the optimum mass of the material to remove NaDF from aqueous 
solution was found to be 0.03 g for a volume of aqueous solution of 10 ml. 
3.8.2 Determination of the capacity of calix[4]arene tetraester to uptake NaDF 
from aqueous solution at 298.15 K 
The capacity (quantity of NaDF extracted from the solution per unit quantity of material) was 
determined by equilibrating a fixed mass of calix[4]amine tetraester (0.03 g) with a volume of 10 ml 
of the aqueous solution containing different concentrations of NaDF (Table 3.10 ).Thus Fig. 3.17 
shows the amount of NaDF (mmol) extracted per gram of dry calix[4]arene tetraester. It is observed 
that the degree of extraction of calix[4]arene tetraester is dependent on the concentration of the NaDF 
present but the percentage of extraction is not attained when the concentration of the drug is about 
8.9  10-5 mol dm-3 decreased when the concentration is about 1.03 × 10-4 mol dm-3 and this may 
refer to the increasing  of the interferences at  high concentrations . 
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Table 3. 10 Illustrate the initial equilibrium and removed concentration of NaDF by 
calix[4]tetraester. 
[NaDF]initial [NaDF]equilibrium [NaDF]removed Capacity (mmol g 
-1)         %  E 
 
3.45⨯10-5 
 
1.70⨯10-5 
 
1.75⨯ 10-5 
 
0.005 
 
50.70 
 
4.60⨯10-5 
 
1.90⨯10-5 
 
2.70⨯ 10-5 
 
0.009 
 
58.60 
 
5.75⨯10-5 
 
2.30⨯10-5 
 
3.45⨯ 10-5 
 
0.011 
 
60.00 
 
6.90⨯10-5 
 
2.50⨯10-5 
 
4.40⨯10- 5 
 
0.014 
 
63.70 
 
8.05⨯10-5 
 
2.80⨯10-5 
 
5.25⨯10-5 
 
0.017 
 
65.20 
 
9.20⨯10-5 
 
3.10⨯10-5 
 
6.10⨯10-5 
 
0.020 
 
66.30 
 
1.03⨯10-4 
 
4.00⨯10-5 
 
6.30⨯10-5 
 
0.021 
 
61.16 
 
 
 
 
Fig. 3.17 Uptake isotherm for sodium diclofenac from aqueous solution by CAE at 298.15 K. 
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3.8.3 Determination of the pH effect on the uptake of NaDF from aqueous solution 
by the calix[4]arene tetraester CAE at 298 K 
The influence of pH value on the removal of sodium diclofenac by CAE was assessed in order to 
achieve the best removal condition, the assesment process was tested by the addition of solid receptor 
CAE (0.03 g) to a fixed concentration of aqueous solution of NaDF (6.9 × 10-5 mol dm-3, 10 ml) at 
different pH at 298 K. The mixtures were mixed for 10 minutes on a whirlimixer, sealed and left in a 
water bath at 298. The mixtures were filtered and the concentration of the drug at equilibrium 
determined using a UV-Vis spectrophotometer at 272 nm. The obtained results are displayed in Table 
3.11 and ploted. Fig. 3.18 shows that the efficiency of the receptor to uptake NaDF from water in low 
and high level of pH is dramatically decreased which means that the extraction percentage of NaDF 
moved down due to the sensitivity of ester group to acids and bases. 
Table 3.11 Effect of pH on the extraction of sodium diclofenac by CAE receptor (3.02×10-5 mole) at 
298 K 
          pH solution [NaDF]initial  mol dm
-3 [NaDF]eq   mol dm
-3    E % 
          1 6.9 × 10-5 6.72 × 10-5 2.61 
          3 6.9 × 10-5 3.73 × 10-5 46.0 
          4 6.9 × 10-5 2.49 × 10-5 63.8 
          5 6.9 × 10-5 2.84 × 10-5 58.9 
          6 6.9 × 10-5 3.52 × 10-5 49.0 
          7 6.9 × 10-5 3.82 × 10-5 44.6 
          8 6.9 × 10-5 4.89 × 10-5 29.0 
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Fig. 3.18 The effect of pH on the on the sodium diclofenac uptake (6.9×10-5 mol dm-3, 10 ml) by 5, 
11, 17, 27- tert-butyl-25, 26, 27, 28-(oxy-ethylacetato)calix[4]arene (CAE, 3.02×10-5 mole) 
The results obtained for the removal of NaDF from water by the calix[4]aren ester were encouraging. 
It was thought that it was of interest to explore the complxing ability of a calix[4]arene amine based 
receptor containing amino functional groups for currently used  
 
3.9 Complexation studies of CA-(NH2)2 and pharmaceuticals 
3.9.1 1H NMR complexation studies of diclofenac, clofibric acid, aspirin and 
ibuprofen with the 5, 11, 17, 23-tetra-tert-butyl, 25, 27-bis[aminoethoxy]26, 28 -
dihydroxycalix[4]arene [(CA(NH2)2] receptor in CD3CN at 298 K 
The chemical structure for the receptor and the pharmaceuticals are shown in the Fig.3.19 
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Fig. 3.19 Chemical structures of (1) receptor (CA-(NH2)2, (2) diclofenac, (3) clofibric acid (4) aspirin 
and (5) ibuprofen 
 
As described in the Experimental Section, 1H NMR  titration experiments were  carried out to 
investigate the active sites of complexation of the receptor with the pharmaceuticals and to obtain 
information regarding  the stoichiometry of the complexation. As far as the 1H NMR measurements 
are concerned, the results in CD3CN at 298 K are  listed in Table 3.12 which shows the chemical 
shifts of the free receptor, δ, and the chemical shift changes, Δδ,  for the receptor  upon the addition 
of the pharmaceutical. These were calculated from eq.3.17 
 
                                             Δδ(ppm)= δ (complex) – δ (free)                                           eq.3.17         
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 In eq.3.17, Δδ is the chemical shift observed, δ (complex) is the chemical shift for the complex 
resulting from the addition of the targeted drug,  δ (free) is  the chemical shift for the free receptor. 
As far as the free receptor is concerned quite clearly the calix[4]arene amino derivative  adopts a 
quasi  perfect ‘cone’ conformation in solution as reflected in the difference observed in the chemical 
shifts of the axial and equatorial protons (Δδax-eq = 1.03 ppm)110,117. This conformation is due to the 
presence of hydrogen bond formation between the phenolic hydrogens and the ethereal oxygens of 
the pendant arms of the receptor. This was previously demonstrated by Danil de Namor and co-
workers185 for an homologous receptor, namely 5,11,17,23-tetrakis-
[(diethylamine)ethoxy)]calix[4]arene [CA(Et2)2] in the solid state (X-ray diffraction studies) and in 
solution. In fact the   Δδax-eq = 1.02 ppm in CD3CN for this homologous receptor is practically the 
same as that  for CA(NH2)2.  Furthermore acetonitrile was found in the hydrophobic cavity of the 
receptor. Also the X-ray structure of 5,11,17,23-tetrakis-[(diethylamine)ethoxy)]calix[4]arene  
showed acetonitrile in the hydrophobic cavity of the receptor. Previous studies by Danil de 
Namor185,240  in this solvent demonstrated that this process is also observed in solution. In fact this is 
also the case for the receptor involved in this work as assessed from the chemical shift changes 
observed for the aromatic protons of this receptor in moving from CDCl3  to CD3CN where downfield 
chemical shifts of 0.21 and 0.19 ppm are observed. Further conformational changes are also observed 
in the bridging methylene protons during the complexation or protonation process The equatorial 
protons become less shielded relative to the free receptor particularly for clofibric acid and dicofenac 
( -0.21 ppm)  while for aspirin this effect is less pronounced (-0.11 ppm) while the equatorial protons 
are slightly deshielded relative to the uncomplexed receptor. Hardly any changes for the equatorial 
and axial protons are found for ibuprofen and this may attributed to the presence of the isobutyl group 
in the chemical structure of this drug  which may  reduce the possibility  of ibuprofen to interact with 
the receptor in  addition to the ion-pair formation  for the drug in acetonitrile. A direct consequence 
of that,  is a decrease in the  shift difference between each pair of doublets of the ArCH2Ar system, 
from the free to the complex ligands   ( from 1.03 to 0.76 ppm for aspirin and to 0.66 ppm for clofibric 
acid and diclofenac) , Significant downfield  chemical shift changes are observed for H-7, H-8 and 
the NH proton  as a result of an interaction between the amino  group of the receptor and the proton 
of the carboxylic functional group of the drug.The most significant chemical shift changes are found 
for the NH proton. In an attempt to explain the differences observed in the Δδ values for the NH 
proton for these pharmaceuticals (Table 3.13-Appendix) the pKa values in water are considered
199 
(pKa, values are 3.0, 3.5, 4.16, 4.38 for clofibric acid, aspirin, diclofenac and ibuprofen respectively)  
due to the unavailability of these data in acetonitrile. Although the absolute pKa values of these  in 
the latter solvent are expected to differ significantly from those in water due to the medium effect, 
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the sequence would be the same . It is therefore concluded that the downfield shift of the NH proton 
of CA-(NH2)2 is strongly dependent of the degree of dissociation of the acid. This is further 
corroborated by  1H NMR titrations carried out in CD3CN. Rrepresentative examples for the titration 
of the receptor with diclofenac (Table 3.1-Appendix, Fig. 3.20) and  clofibric acid  (Table 3.2-
Appendix, Fig. 3.21) in acetonitrile at 298 K  are   given where  Δδ values obtained by the addition 
of these drugs  to CA-(NH2)2 are plotted against the drug/receptor  molar ratio where the most 
pronounced chemical shift changes are observed for the NH protons and to a lesser extent for H-7 
and H-8. Regarding aspirin , overlapping between the spectra of receptor and aspirin prevent the 
calculation of the  chemical shift changes after each adition of this drug. 
From Figs.  3.20 and 3.21 it is found from the chemical shift changes of the NH proton  that at [Drug]/ 
[receptor]= 0.5 there is a break which indicates that the stoichiometry of complexation between 
calix[4]arene amine with diclofenac and clofibric acid appears to be 2: 1 [Drug]/ [receptor]. To 
corroborate it further and to determine the composition of the receptor: drug complex conductance 
measurements were carried out. 
Table 3.12 1H NMR complexation study to check the affinity of the receptor to complex with the 
pharmaceuticals in CD3CN at 298 K. 
[Drug] / [receptor]          H1 H2 H3 H4 H5 H6ax H7 H8 N-H 
ppm Free receptor    1.20 1.16 7.24 7.17 3.39    4.32   4.01  3.22  2.17 
 
 (Diclofenac/ L)    ----- 0.01 0.01 ----- -----  -0.21   0.14  0.17  0.21 
 
 (Clofibric/L)    ----- ----- ----- ----- 0.06  -0.21  -0.09  0.15  0.32 
 
 (Ibuprofen+L)    ----- ----- ----- ----- 0.01   0.05   0.02  0.03  0.05 
 
 (Aspirin+L)    ----- ----- ----- ----- 0.08  -0.11 0.25  0.24  0.29 
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Fig. 3.20 The chemical shift changes for the 5,11,17,23 tetra-tert-butyl, 25, 27-bis[aminoethoxy], 26, 
28 dihydroxycalix[4]arene upon addition of diclofenac against the [Drug]/ [receptor] ratios in CD3CN 
at 298 K.  [CA-(NH2)2] = 2  10-3 mol dm-3, [DCF]  4  10-3 mol dm-3 (see Table 3.1-Appendix) 
 The chemical shift changes for the CA-(NH2)2 protons as a result from the addition of increasing 
concentration from clofibric acid are presented in Table 3.2-Appendix. As shown in Fig. 3.21 that 
the addition of clofibric acid to the receptor solution led to significant changes in chemical shift 
changes  
 
Fig. 3. 21 Chemical shift changes for the 5,11,17,23 tetra-tert-butyl, 25, 27-bis[aminoethoxy], 26, 28 
dihydroxycalix[4]arene upon addition of clofibric acid against the [drug]/ [receptor] ratios at 298 
K.[CA-(NH2)2] = 2 ×10
-3 mol dm-3, [CLF] = 4 ×10-3 mol dm-3, 0.04 ml for each addition 
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Conductometric measurements were carried out with the aim of assessing the stoichiometry of the 
drug-receptor interaction 
3.9.2 Investigation of the complexation of the pharmaceuticals with CA-(NH2) in 
acetonitrile by conductance measurements 
3.9.2.1 Conductometric measurments  for the pure receptor CA-(NH2)2 in 
acetonitrle at 298.15 K  
Following the calibration of the instrument to establish the cell constant ( ≈ 1.07 cm-1, Table 3.4) 
the conductance of calix[4]arene amine was established in dry acetonitrile at 298.15K. (Fig. 3.22) 
shows the conductometric titration plot of the molar conductance m versus the increasing analyte 
concentration for calix[4]arene amine. Conductivity values obtained revealed that no significant 
change is caused by the addition of the receptor solution to the conductivity cell containing freshly 
dried acetonitrile. This  indicates that the receptor does not undergo ionization or protonation process 
by acetonitrile as the solvent. It should be noted that although in the plot appears that m increases, 
the values are extremely low 
 
Fig. 3.22 Conductivity curve of the free receptor in acetonitrile (5.29×10-4 mol dm-3) titrated into 
the cell containing 25 ml of pure acetonitrile at 298.15 K  
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Investigation of drug-receptor interactions by conductometric studies will be in the next section  
The selected drugs in this study are weak acids which are able to dissociate in solution according to 
eq.3.18 
                                                                                eq.3.18 
Therefore, monitoring the binding of drugs with the receptor by testing the variation of the electrical 
conductivity of their solution is a suitable strategy to follow the achievement of complexation. 
Conductometric titrations of diclofenac, clofibric acid and aspirin with calix[4]arene amine were 
carried out in acetonitrile as described previously in the Experimental Part at 298.15 K. 
3.9.2.2 Conductometric titration studies of diclofenac DF and CA(NH2)2 in 
acetonitrile at 298.15 K 
The conductivity values of the titration experiments are listed in Tables 3.3-Appendix. It can be 
observed from a plot of molar conductance, Λm (S.cm2.mol-1) versus [receptor]/ [Drug] concentration 
ratio (Fig. 3.23) that upon the addition of increasing concentrations of the receptor solution to 
diclofenac, the molar conductance increases  and this indicates that the interaction process occurred 
through a proton transfer reaction to form host-guest complex salts and the stoichimetric ratio for the 
interaction is 1: 2 [receptor]/[diclofenac] . 
Fig. 3.23 shows that the molar conductance, m, before the addition of the CA-(NH2)2 receptor is 
very low. This is an indication that the diclofenac is fully associated (ion pair formation) in 
acetonitrile. However, upon the addition of the receptor an increase in molar conductance is observed 
from A to B due to the transfer of two protons from the drug to the two amino functional groups of 
the receptor. The reaction is represented as follows  
[CA-(NH2)2] (CH3CN)  2 RCOOH (CH3CN) ⇌ [CA-(NH3)2]2+ (CH3CN) + 2 RCOO (CH3CN)     
                                                                                                                                                    eq.3.19 
Further addition of the receptor leads to the formation of two units of [CA-(NH2) (NH3)]
+. As the 
concentration of the receptor increases (B to C), a proton from the double protonated calix[4]arene 
amine derivative appears to be transferred to the free receptor resulting in the formation of two 
monoprotonated receptors as shown in the followin equation 
[CA-(NH3)2]
2+ (CH3CN) + CA-(NH2) (CH3CN) ⇌ 2 CA-[(NH2) (N+H3)]                              eq.3.20 
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From C to D the increase in conductance occurs due to the excess of receptor which displaces the 
equilibrium to the right 
 
Fig. 3.23 Change in molar conductance resulting from the addition of receptor against the [receptor]/ 
[drug] concentration ratio   in acetonitrile at 298.15 K, [Diclofenac] = 1.6×10-3 mol dm-3, see Table 
3.3-Appendix 
 
3.9.2.3 Conductometric titration studies of clofibric acid with CA-(NH2)2 in 
acetonitrile at 298.15 K 
 Conductance values for clofibric acid with CA-(NH2)2 in acetonitrile at 298.15 K are listed in Table 
3.4-Appendix. It can be observed from the plot of molar conductance, Λm (S.cm2.mol-1) versus 
[receptor]/ [clofibric acid] concentration ratio (Fig. 3.24) that upon the addition of increasing 
concentrations of the receptor solution to the clofibric acid solution, the  conductance values increase 
(A to B) indicating the transfer of two protons from the drug to the receptor given that the [receptor]/ 
[clofibric acid] ratio is 0.5, therefore the composition of the adduct formed is 1: 2. The pattern 
followed from B to C  and from C to D is similar to that observed for diclofenac and this receptor in 
this solvent 
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Fig. 3.24 Change in molar conductance resulting from addition of the receptor against the [receptor]/ 
[clofibric acid] concentration ratio in acetonitrile at 298.15 K. The concentration of clofibric acid 
solution in MeCN is 1.96×10 -3 mol dm-3, see Table 3.4-Appendix 
 
  3.9.2.4 Conductometric titration of aspirin with CA-(NH2)2 in acetonitrile at 
298.15 K 
The conductance values of the titration experiments are listed in Table 3.5-Appendix. It can be 
observed from plots of molar conductance, Λm (S.cm2.mol-1) versus [receptor]/ [aspirin] 
concentration ratio (Fig. 3.25) that upon the addition of increasing concentrations of the receptor 
solution to the aspirin  solution  the  conductance increases (A to B)  and this indicates that the 
interaction process occurred through the transfer of one proton from the drug to the receptor to form 
host-guest complex salts of genaral formula (CA-NH2-N
+H3).(R-CO2
-
 ) and the stoichimetric ratio 
for the interaction is found to be 1: 1 [receptor]/ [aspirine]  
 
0
4
8
12
16
0 0.5 1 1.5 2

m
S
 c
m
2
 m
o
l-
1
[CA-(NH2)2]/ [clofibric acid]
A
B
C
D
3.                                                                                                                          Results & Discussion 
 
138 
 
 
Fig. 3.25 Conductance changes of aspirin solution in dry acetonitrile resulting from the gradual 
addition of calix[4]arene amine against the [receptor]/ [drug] concentration ratio at 298.15 K. The 
concentration of aspirin is 1.79 ×10-4 mol dm-3, see Table 3.5-Appendix 
In order to get further information regarding the complexation of CA-(NH2)2 with the drugs, UV 
titrations were carried out 
3.10 Photophysical properties of the drug bindings 
3.10.1 UV titration of diclofenac with calix[4]arene amine in acetonitrile at 
298.15 K 
 The titrations were carried out in same manner with those above discussed in conductance 
measurements. The receptor solution in dry acetonitrile was added to the UV cell containing the 
diclofenac in the same solvent. The absorption spectrum obtained from a plot of absorbances against 
the wavelengths is shown in Fig. 3.26. The rapid change in the spectrum observed after each addition 
of the receptor solution to the drug solutions indicates that an interaction occurs between the receptor 
and the drug. Also, the absorption bands of the complexed diclofenac are red shifted as compared 
with the absorbances of the free drug (n→π∗ at 𝜆max = 277 nm) which confirms the formation of the 
complex. The red shifting of the n→π∗ transitions are attributed to the polarity of acetonitrile which 
has the ability to stabilise the excited state through the reduction the energy of the π∗ orbitals which 
means that the total energy of the n→π∗ transition required are reduced and this make the wavelength 
longer236,237. By plotting absorbances values against the [receptor]/ [Drug] concentration ratios (Table 
3.6-Appendix) the stoichiometry of the complexation can be identified (Fig. 3.27)  The stoichiometric 
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ratio obtained is not in accord with the stoichiometry obtained from the conductance measurements 
and this may attributed to the presence of N-H group in the chemical structure of diclofenac and can 
act as a proton donor –acceptor at the same time and can compete with the acidic proton to interact 
with the receptor and therefore the spectrum is disturbed. Therefore, ITC measurements were carried 
out to confirm the stoichiometry of the reaction which was obtained by 1H NMR.  From titration 
experiments we can conclude the the red shift for the maximum absorbance band occurred because 
of the polarity of the solvent which can stabilise the transition state of the complex. 
 
Fig. 3.26 UV-Vis titration spectrum of diclofenac in acetonitrile (1.12 × 10-4 mol dm-3, bottom scan) 
showing the increase in the absorbance bands intensity resulting from the addition of p-tert-butyl 
calix[4]arene amine [CA-(NH2)2], see Table 3.6-Appendix 
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Fig. 3.27 Plot of the absorbance of the diclofenac against the [receptor]/ [diclofenac] concentration 
ratio in acetonitrile at 298.15 K, see Table 3.6-Appendix 
 
3.10.2 UV titration of clofibric acid with calix[4]arene amine in acetonitrile 
UV-Vis spectra were recorded on the range 200-400 nm using 1 cm quartz cell. Successive additions 
of the   receptor solution in dry acetonitrile were added to the UV cell containing the clofibric acid in 
the same solvent. The absorption spectrum obtained from the plot of the absorbances against the 
wavelength is shown in Fig. 3.28. It is observed that the receptor exhibits high affinity to bind with 
the clofibric acid as reflected in the rapid change observed after each addition of the receptor solution 
to the drug solution. The absorption bands of the complexed clofibric acid red shifted relative to those 
for the free drug (n→π∗ at 𝜆max = 280 nm) which confirms the formation of the complex. As 
concluded above the shifting of the n→π∗ transition attributed to the lowring of the energy for π∗ 
orbitals resulting from the using of polar solvent. The energy of π∗ orbitals are reduced which 
means that the total energy required for the n→π∗ transitions are reduced and this made the 
wavelength longer236,237. A plot of the absorbance values against the [receptor]/ [drug] concentration 
ratios (Table 3.6-Appendix), Fig. 3.29 gives the stoichiometry of the complexation.  It’s clear that in 
the case of clofibric acid, two protons are taking up per unit of receptor in agreement with the results 
obtained from conductance measurements.  
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Fig.  3.28 UV-Vis titration spectrum of clofibric acid in acetonitrile (3.35×104 mol dm-3) showing 
the increase in the absorbance bands resulting from the gradual addition of increasing concentration 
of CA-(NH2)2 solution in acetonitrile at 298 K, see Table 3.7-Appendix 
 
 
Fig. 3.29 Plot of the absorbance of clofibric acid in acetonitrile against [receptor]/ [drug] 
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3.10.3 UV-Vis titration of aspirin with CA-(NH2)2 receptor at 298 K 
The UV-Vis spectrum was recorded on the 200-400 nm range using a 1 cm quartz cell. The titrations 
were carried out to make sure that the complexation process is achieved.  Addition of CA-(NH2)2 
solution in acetonitrile to the aspirin siolution has led to cosiderable changes in the spectral picture 
of aspirine (Fig. 3.30). It can be concluded from the absorption spectrum obtained from the plot of 
the absorbances against wavelength (Fig. 3.30) that the receptor exhibits high affinity to bind with 
the aspirin and a rapid change in the spectrum is observed after each addition of the receptor solution 
to the drug. The absorption bands of the complex formed red shifted relative to the absorbance of the 
free drug (n→π∗ at 𝜆max = 276 nm) caused by the using of polar aprotic solvent. The polarity of the 
solvent can lower the energy of the π∗ orbitals which can reduce the total energy required for the 
n→π∗ transitions with longer wavelength which confirms the formation of the complex. From 
Fig.3.31 and Table 3.8-Appendix, the stoichiometry of complexation can be identified. It is clear that 
a 1: 1 [aspirin]/ [receptor] complexes   is obtained236,237  
 
Fig. 3.30 UV-Vis spectrum of aspirin solution in acetonitrile resulting from gradual addition of CA-
(NH2)2 solution in acetonitrile at 298 K. The concentration of the diclofenac is 2.99×10
-4, see Table 
3.8-Appendix 
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Fig. 3.31 Variation in absorbance values of aspirin resulting from addition of increasing     
concentrations of the receptor at 298 K, see Table 3.8-Appendix 
 
3.11 Thermodynamic paremeters of complexation of pharmaceuticals with CA-
(NH2)2 in acetonitrile at 298.15 K 
The Nano isothermal titration calorimeter (ITC) was used to investigate the thermodynamic 
parameters for the interaction of p-tert-butyl calix[4]arene amine with aspirin, clofibric acid, 
diclofenac and ibuprofen. It is a powerful and highly accurate tool for evaluating the thermodynamic 
parameters associated to the complexation process which can give quantitative   information about 
the degree of the interaction between the receptor and the targeted drugs. 
The thermograms obtained are shown in Figs. 3.32, 3.33, and 3.34. The stability constants (expressed 
as log Ks), the standard enthalpy, ΔcH° and entropy, ΔcS° for the interaction of aspirin, clofibric acid 
and diclofenac with the calix[4]arene amine derivative in acetonitrile at 298.15 K are listed in Table 
3.13. The standard deviations of the data are also included. The data for aspirin fits into a 1: 1 (host: 
guest) complex while those for clofibric acid and diclofenac into 1: 2 complexes as shown previously 
from conductance data. As previously stated thermodynamics does not provide structural 
information. However, it is indisputable that any model proposed must fit the experimental data. 
Therefore, the thermodynamic data are referred to the following processes, 
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For 1:1 complexes of aspirin, clofibric acid and diclofenac, eq.3.21 is representative of the process 
taking place in solution, in doing so the results obtained from conductance data that these 
pharmaceuticals are predominantly as ion pairs in acetonitrile 
 
R COOH (MeCN) + CA-(NH2) 2 (MeCN) → RCOO- (MeCN) + CA-NH2-NH3+ (MeCN)……eq.3.21                 
 
For 1: 2 complexes of clofibric acid and diclofenac, 
 
RCOOH (MeCN) + CA-NH2-N
+H3 (MeCN) → RCOO- (MeCN) + [CA(NH3)2]2+ (MeCN)…..eq.3.22             
 
 For aspirin the process is enthalpy controlled. The same applies for the 1: 1 complexes of clofibric 
acid and diclofenac. However, the formation of 2: 1 complexes is enthalpically unfavoured and 
entropically controlled. These results are striking and suggest that a great disorder in the structure of 
the receptor occurs to allow the entrance of the second proton. X-ray crystallographic studies of an 
analogous receptor CA-[N(Et2)2], with perchloric acid has shown the double protonation of the 
receptor as well as the loss of the solvent upon protonation while the hydrogen bond between the 
ethereal oxygen and the phenolic oxygen still remains. The conformational change that CA-(NH2)2 
undergoes in moving from the free to the protonated ligand as shown by 1 H NMR studies in CD3 CN 
indicates a flattened ‘cone’ conformation for the latter relative to the quasi ‘cone’ conformation of 
the former and as a result the hydrophobic cavity is able to lose the solvent. This process will lead to 
an increase in entropy. Given that energy would be required to remove the solvent from the cavity, 
the process would be enthalpically unfavoured. This interpretation is corroborated by the data 
reported in Table 3.13. Comparison of the protonation contants of CA-(NH2)2 with clofibric acid and 
diclofenac in acetonitrile at 298.15 K relative to those for CA-[N(C2H5)2] and HClO4 in the same 
solvent and temperature (log Ks1 = 15.68, log Ks2 = 14.36) demonstrates the effect of the strength of 
the acid on the protonation process as well as the basic nature of the amine moieties in the pendant 
arms given that the basicity of the tertiary amine in CA-[N(Et2)2] is higher than that of CA-(NH2)2 
(primary amine). The thermodynamic data reveal that CA-(NH2)2 is selective for these drugs in the 
following sequence  
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Clofibric acid  diclofenac  aspirin     in acetonitrile 
In order to get further insight regarding the different hosting capacity of CA-(NH2)2 for aspirin 
relative to clofibric acid and diclofenac, molecular simulation calculations were carried out. The 
outcome is shown in Figs. 3.35-3.37 where the presence of a carbonyl oxygen in ortho position with 
respect to the carboxylic group in aspirin leads to two contact points involving the amine 
functionalities in each of the pendant arms of the receptor. Thus a proton transfer reaction occurs 
where one of the amino functionality is protonated (as shown from conductance measurements) while 
the remaining one enters hydrogen bond formation with the carbonyl oxygen of the ester group of 
aspirin. It seems that the presence of acetonitrile in the hydrophobic cavity of the ligand pre-organise 
the receptor to interact with the drug. The molecular modelling shows the interaction of two units of 
drug per unit of receptor in the case of diclofenac and clofibric acid (Figs. 3.35-3.37).  
In the following section thermal analysis for the receptor , drug and complex in the solid state are 
discussed. 
Table 3.13 Thermodynamic parameters of the binding between the drugs and calix[4]arene amine 
receptor in acetonitrile at 298.15 K 
Drug interaction 
[L]/[D] 
                                    
log Ks 
 
∆cGº / kJ mol -1 
 
∆cHº/ kJ mol-1 
 
∆cSº J mol-1K-1 
 
Aspirin 1:1  
 
log Ks = 3.92 ± 0.1 
 
∆cG =  22.4 ± 0.6 
 
∆cH1 =  23.0 ± 0.3 
 
∆cS =  2 
 
Clofibric acid 
1:2 
log Ks1 = 7.3 ± 0.05 
log Ks2 = 6.14 ±0.12 
∆cGº1 =  41.4 ± 0.3 
∆cGº2 =  35.7 ± 0.7 
∆cH1 =  48.1 ± 0.7 
∆cH2 = + 14 ± 3 
∆cS1=  23 
∆cS2 = 1.68×102 
 
Diclofenac 1:2 
log Ks1 = 5.83 ± 0.7 
log Ks2 = 5.1 ± 0.6 
 ∆cGº 1 =  33 ± 4 
∆cGº 2 =  29 ± 3 
∆cH1= 34.5 ± 0.12 
∆cH2 = + 17 ± 3 
 ∆cS1 =  4 
∆cS2 = 1.5×102 
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Fig. 3.32 Top is the baseline editor, bottom is the titration curve resulting from the injection of 
aspirin in acetonitrile (2×10-2 mol dm-3) into the receptor solution (1×10-3 mol dm-3)    at 298.15 K 
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                                                          [Ca-(NH2)2] / [Clofibric acid]      mol dm
-3 
Fig. 3.33 Top is the baseline indicated to the heat evolved after each addition of clofibric acid 
solution in acetonitrile (3×10-2 mol dm-3) to the receptor solution (1×10-3 mol dm-3) and bottom is 
a plot of the heat against the molar ratio at 298.15 in acetonitrile  
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[clofibric acid]/ [CA-(NH2)2] 
 
 
                                          [Diclofenac]/ [CA-(NH2)2] 
Fig. 3.34 Top is the baseline indicating the heat evolved per second resulting from addition 
of the diclofenac solution in acetonitrile (5×10-2 mol dm-3) to the macrocyclic receptor 
solution (1×10-3 mol dm-3). Bottom Figure is the titration curve for the interaction of 
diclofenac with calix[4]amine in acetonitrile at 298.15 K. 
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Fig. 3. 35 Molecular modelling of the interaction of diclofenac with calix[4]aren amine  
 
 
Fig. 3.36 Molecular modelling of the interaction of clofibric acid and calix[4]arene amine 
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Fig. 3.37 Molecular modelling of the interaction of aspirin and calix[4]arene (CA-NH2)2 
 
3.12 Investigation of the interaction between diclofenac, clofibric acid and aspirin 
with CA-(NH2)2 by using thermogravimetric analysis TGA and differential 
scanning calorimetry DSC 
Further investigations on the interaction process between CA-(NH2)2 and the pharmaceuticals have 
been carried out by following the changes in the thermal behaviour of the free drugs, the receptor and 
the complexes. The TG thermograms obtained for diclofenac, receptor and the complex formed (Fig. 
3.38) have displayed that the TG thermogram for the complex differs from those for the pure 
compounds which means that the thermal properties of the complex shifted to a lower temperature 
as compared with that for the free receptor as a result from the complexation process indicating that 
the complexation process was achieved successfully. Similar results were obtained for the 
complexation of the receptor with clofibric acid (Fig. 3.39) and the complexation of the receptor with 
aspirin (Fig. 3.40) which means that the thermal properties of the the complex formed in both cases 
differ from the TG thermogram of the pure compounds. These results confirm that the pharmaceticals 
and the receptor incorporated in the complexation led to differ in their chemical structures. 
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Fig. 3.38 TGA thermograms for diclofenac (DF), CA-(NH2)2 and the complex  
 
 
 
Fig. 3.39 TGA thermogram for the complexation process between CA-(NH2)2 and the receptor 
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Fig. 3.40 TGA thermogram for the complexation of aspirin with CA-(NH2)2 
 
Having carried out fundamental studies on interactions exploring CA-(NH2)2 and pharmaceuticals in 
the next section, the extracting properties of this calix[4]arene receptor for the removal of drugs from 
water are discussed 
3. 13 Extraction of clofibric acid and diclofenac from water by CA-(NH2)2 
The affinity of the CA-(NH2)2 receptor to remove clofibric acid and diclofenac from water was 
investigated as a representative example given that two units of the drug were taken up per unit of 
receptor. In doing so, a number of parameters were considered in order to find the optimal conditions 
for the removal process. Among them, the effect of the mass/ solution ratio, the pH of the aqueous 
solution. The removal capacity of the material for these drugs was also determined. These are now 
discussed. 
3.13.1 The effect of mass on the extraction of clofibric acid from water. 
The effect of the receptor dose on the extraction process was determined by the addition of different 
weights of the receptor to a fixed concentration of the drug solutions in water (4.09 × 10-4 mol dm-3, 
10 ml). The mixtures were mixed for 10 minutes on a whirlimixer, sealed and left in a water bath at 
298 K. The mixtures were filtered and the concentration of the drug at equilibrium was determined 
using a UV-Vis spectrophotometer at λmax = 278.5 nm. The percentage of extraction was calculated 
by using equation 2.39. Table 3.14 lists the initial concentration of the drug prior to the addition of 
the receptor, Ci, the equilibrium concentration, Ceq., both in the aqueous solution in the molar scale, 
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the mass of the receptor and the percentage of extraction, % E at 298 K. It can be seen from the table 
that when the mass of the receptor reaches 0.01 g, no further changes in the % E takes place (Fig. 
3.41), given that no material is available for interaction 
Table 3.14 The clofibric acid concentration before and after the extraction, adsorbent used and 
extraction percentages (total volume of the drug solution is 10 ml) 
[Ci] mol dm
-3 
     10 ml 
[Ceq] mol dm
-3  quantity of  CA-(NH2)2  
in mole (solid)   
 Mole ratio 
Solid L/ drug 
                     % E 
 
4.09 ⨯ 10-4  8.63 ⨯ 10-5 
 
1.63⨯ 10-5 
 
3.98 
78.90 
 
4.09 ⨯ 10-4  6.74 ⨯ 10-5 
 
 2.72 ⨯ 10-5     
 
6.65 
 
83.55 
 
4.09 ⨯ 10-4 6.95 ⨯ 10-5 
 
5.70 ⨯ 10-5 
 
13.93 
 
83.10 
 
4.09 ⨯ 10-4 
 
6.85 ⨯ 10-5 
 
6.94 ⨯ 10-5 
 
16.97 
 
83.20 
 
4.09 ⨯ 10-4 6.50 ⨯ 10-5 
 
8.18⨯ 10-5  
 
20.00 
 
84.10 
 
4.09 ⨯ 10-4 6.95 ⨯ 10-5 
 
1.02 ⨯ 10-4 
 
24.93 
 
83.04 
 
4.09 ⨯ 10-4 
 
8.42 ⨯ 10-5 
 
1.25 ⨯ 10-4 
 
30.56 
 
79.40 
 
In Table 3.22 [Ci], [Ceq] and % E denote initial, equilibrium concentration and percentage of 
extraction respectively 
 
Fig. 3.41 The effect of receptor dose on the uptake of clofibric acid from aqueous solution at  
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298.15 K. 
3.13.2 The effect of pH of the aqueous solution on the extraction of clofibric acid 
from water by CA-(NH2)2 at 298 K 
The controlling pH of solutions were carried by using buffer tablets from Fisher Scientific.The effect 
of pH on the extraction of clofibric acid from water by (CA-NH2)2 is shown in Fig. 3.42. The results 
show that at low pH , the % E of the drug by the receptor is very low due to the protonation of the 
receptor, as the pH increases the % E increases consistently once the amino functional group of the 
receptor is fully free to interact with the proton of the carboxilic group of the drug. Therefore the pH 
in the alkaline range will increase the activity of the lone pair of electrons on the nitrogen to interact 
with acidic proton of the pharmaceutical 
 
Fig. 3.42 The effect of pH on the extraction of clofibric acid (4.09×10-4 mol dm-3, 10 ml) by using 
CA-(NH2)2 
 
 3.13.3 Calculation of the capacity of the  CA-(NH2)2 receptor to extract clofibric  
acid 
The experiment was carried out by adding 0.01 g of the receptor to different concentrations(9×10-5, 
1.39×10-4, 1.95×10-4, 2.45 × 10-4, 3.6×10-4, 4.4×10-4 mol dm-3, 10 ml) of the clofibric acid in aquious 
medium. The capacity of the receptor was calculated according to eq.2.40 and the obtained values 
were plotted against the concentration at equilibrium state (Fig. 3.43) 
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Fig. 3.43 The capacity of the calix[4]arene amine towadrs clofibric acid 
 
3.14 Extraction of aspirin from water by CA-(NH2)2  
The extraction of aspirin from water was carried in the same way as for clofibric acid. Table 3.15 and 
Fig. 3.44 shows that the receptor has low efficiency to remove aspirin from water (% E) and the 
increase of aspirin concentration in aqueous solution led to decrease the efficiency of the receptor to 
complex with aspirin which means that the water can compete with the receptor to form hydrogen 
bonding with aspirin molecules which leads to the formation of aspirin-aspirin homodimer through 
the protons of carboxylic groups and also interamolecular hydrogen bond between the acidic proton 
of carboxylic acid with the adjacent acetoxy group is expected to be formed244.  
Table 3.15 Initial and equilibrium concentration of aspirin before and after the extraction and the 
percentages of extraction from water by CA-(NH2)2 
Ci / mol dm-3
 Ceq/ mol dm-3
 % E 
1.96  10-4 1.23 × 10-4 37.2 
3.93  10-4 2.86 × 10-4 27.2 
5.90  10-4 4.6 × 10-4 22.0 
7.80  10-4 7.3 × 10-4 6.90 
9.80  10-4 9.35 × 10-4 4.50 
1.18  10-3 1.13 × 10-3 4.23 
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Fig. 3.44 Extraction of aspirin from water by CA-(NH2)2 at 298 K 
 
From the above results it is concluded that CA-(NH2)2 is a suitable extracting agent for clofibric acid 
and diclofenac but the extraction ability of this receptor for aspirin was very poor. This is in accord 
with the results obtained from fundamental studies which demonstrated that CA-(NH2)2 is able to 
take two protons from the drug in the case of clofibric acid and diclofenac but only one from aspirin 
Given the results obtained by calix[4]arene amine derivative in its interaction  with pharmaceuticals 
in which it was demonstrated  that the amine functionality is the active site of the interaction, 
experimental work was  carried out to remove aspirin from water by 3-aminopropyl functionalised 
silica (Sil-NH2). This drug was selected due to the low degree of extraction found with the 
calix[4]arene amine derivative 
3.15 Aspirin removal by aminopropyl silica  
The removal of aspirin from water by aminopropyl silica was investigated under different 
experimental conditions such as the effect of the amount of receptor and the pH of the aqueous 
solution on the extraction process. The capacity of aminopropyl silica to remove aspirin was also 
investigated. 
3.15.1 Dose effect 
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In order to find the optimum amount of aminopropyl functionalised silica (Sil-NH2), different 
amounts of this material were added to aqueous solutions containing a fix concentration of aspirin 
(5.59 × 10-3 mol dm-3, 10 ml). The mixture was left to equilibrate in a water bath overnight at 298.15 
K. Solutions were filtered and the pH meter (AB 15 pH meter Fisher Scientific) was standardised 
with buffer solutions (pH = 4 and 9.2) and the solution pH was measured. Blank experiments showed 
that no aspirin was extracted in the absence of silica. The percentage of aspirin extracted was 
calculated by eq. 2.39. The results are shown in Table 3.16 and graphically represented in Fig. 3.45 
Table 3.16 Percentage of extraction of aspirin as a function of the dose of Sil-NH2 at 298 K 
[C]i      mol dm
-3 [C]e      mol dm
-3 Mass of Sil-NH2 g % E 
5.59 × 10-3 2.59 × 10-3       0.02 53.5 
5.59 × 10-3 1.83 × 10-3       0.03 67.2 
5.59 × 10-3 1.31 × 10-3       0.04 76.5 
5.59 × 10-3 1.31 × 10-4       0.05 87.2 
5.59 × 10-3 7.10 × 10-4       0.06 90.5 
5.59 × 10-3 5.29 × 10-4        0.07 95.5 
5.59 × 10-3 2.30 × 10-4       0.08 99.1 
5.59 × 10-3 5.20 × 10-4       0.09 99.6 
5.59 × 10-3 3.24 × 10-5       0.10 99.9 
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Fig. 3.45 The effect of the mass of Sil─NH2 on the uptake of aspirin from aqueous solution  
(5.59×10-3 mol dm-3, 10 ml) at 298 K. 
The results show that as the amount of silica increases the % E extraction increases as the sites of 
interaction (amino active sites) in the material increase until saturation occurs. It is concluded that 
between 0.08 to 0.10 g are the optimum mass to be used for almost complete removal of aspirin from 
water 
3.15.2 Effect of pH of the aqueous solution on the removal of aspirin by Sil-NH2 
at 298 K 
Fig. 3.46 (plot of % E vs the pH of the aqueous solution of aspirin) shows that no extraction of aspirin 
occurs at low pH given that the amino group is protonated therefore unable to remove the drug from 
water. As the pH increases the % E increases substantially and at pH ≈ 4 almost 100% of aspirin is 
removed from water due to the change of the acidic pharmaceutical to the ionic form which can be 
interacted with the amino group. In other words the acidic materials with low pKa value will leads to 
rise the number of ions in solution and as a result the percentage of extraction will increased.  
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Fig. 3.46 Effect of pH of the aqueous solution on the extraction of aspirin from water (5.59 × 10-5  
mol dm-3, 10 ml) by Sil-NH2 at 298 K 
3.15.3 Kinetics of removal  
Using a solution of aspirin (5.59 × 10-3 mol dm-3) and 0.05 g of silica, it was found that after 5 minutes 
about 90 % of aspirin was removed, an indication the kinetics of the removal process is very fast 
 
3.15.4 Determination of the capacity of Sil-NH2 for the removal of aspirin from 
water at 298 K 
The capacity of aminopropyl silica (maximum amount of aspirin per gram of silica) was determined 
by using a batch procedure. Eq. 2.40 was used to calculate the capacity, q, where ci and ce are the 
initial and equilibrium concentration of aspirin respectively in the molar scale, 𝑉 the volume of 
solution (10 cm-3) and m denotes the mass of silica (0.05 g)  
Details are given in Table 3.17 and shown graphically in Fig. 3.47 
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Table 3.17 Initial, equilibrium concentration and the capacity of silica to remove aspirin from water  
     [Ci]  mol dm
-3
    [Ceq] mol dm
-3
  q / mmol g
-1 
   1.12× 10-3                              8.59 × 10-7                          0.23 
   2.24× 10 -3                             3.17×10-6                         0.43 
   3.36×10 -3                              1.39×10-4                         0.64 
   4.48× 10-3                              3.98×10-4                                       0.81 
   5.59× 10-3     7.08×10-4                                     0.97 
   6.70× 10 -3                               9.66×10-4                                       1.14 
   7.80×10 -3                               1.32×10-3                         1.29 
   8.95×10-3                              2.58×10-3                                               1.27 
   1.00×10 -2                             3.66×10-3                         1.27 
 
 
Fig. 3.47 Capacity of Sil-NH2 to uptake aspirine from aqueous solution at 298 K 
From Table 3.25, it can be concluded that the capacity, q, of 3-aminopropyl-functionalised silica gel 
to remove aspirin from aqueous solution is 1.27 mmol g-1. The results are striking and indicate that 
the aminopropyl silica is an efficient material for the removal of aspirin from water to an extent that 
its capacity to remove this drug from water is much higher than the capacity of CA-(NH2)2 to remove 
clofibric acid from water. Experimental work on the use of aminopropyl silica to remove clofibric 
acid, diclofenac is now undergoing in the Thermochemistry Laboratory. Despite that the 3-
aminopropyl functionalised silica is effective to remove aspirin and might be effective to remove 
some of acidic pharmaceuticals but the removal process is relying only on the acid-base reactions 
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which can make the removal process not efficient in real water samples due to the presence of many 
of acidic and basic pollutants. Also, most of the manufactured drugs are hydrophobic in order to 
interact with the cell membrane which can diminish the use of silica as receptor for these pollutants 
due to the hydrophilicity of silica. On the other side, the CA-(NH2)2 has its own special features such 
as the high hydrophobicity, can be modified, recycled easier than silica and also can be applied as 
drug carrier in drug delivery system due to the presence af amino group which is found in the structure 
of the amino acids which are the main component in living systems 
Preliminary experiments were carried out to assess the interaction of C-decylpyrogallol[4]arene, 
PG11, and carbamazepine, CBZ, and this is discussed in the following section 
3.16 Complexation of C-decylpyrogallol[4]arene with carbamazepine 
The complexation process has been carried out by 1H NMR in acetonitrile. It’s found that the 
macrocyclic receptor has affinity to complex with the carbamazepine and therefore the effect of the 
complexation process on the thermal behaviour of the drug will be discussed 
3.16.1 Investigation of the complexation of PG11 and CBZ by thermal analysis 
Thermal studies TG, DTG and DSC analysis have been carried out to investigate whether or not 
PG11 interacts with CBZ and if so, to investigate the effect of complexation on the physico-chemical 
properties of the drug. The CBZ was heated from 25 to 200 °C at 10 K/ min to detect the melting 
process, followed by cooling down at the same temperature range, in order to observe the drug 
crystallization. TGA analysis for the complexation between CBZ and C-decylpyrogallol[4]arene 
confirmed that the complexation process was implemented successfully, the comparison between the 
TGA thermograms obtained for the pure compounds (Fig. 3.48-3.49) and the complex formed (Fig. 
3. 50). Also, the DSC thermograms obtained for the pure compounds and the complex gives strong 
support that the complex is formed and this can be interpreted as follows, for the pure CBZ, the 
endothermic peak at 169.33 °C with the heat of 7.788 Jg-1 reflects the amorphous character of the 
drug and also can give information about the effect of the temperature on the structure. Another peak 
existed at 192.38 °C with a heat of fusion 90.75 Jg-1 which indicates the melting point of the drug. 
On cooling, an exothermic peak is observed at 170.42°C which indicates the conversion of the melted 
material to its solid state but the difference between these two peaks revealed that the phase transition 
from stable state to another occurred which means that the heat delivered to the drug induces phase 
transitions causing variations in the locations of the molecules to a new location in the molecular 
system. The thermogram of the free receptor heated from 25 °C to 250 °C to detect the melting point 
3.                                                                                                                          Results & Discussion 
 
162 
 
of the receptor was followed by cooling at the same temperature in order to investigate the 
crystallisation. The thermogram shows a broad peak at 142.65 °C which indicates the melting point 
of the host with the heat of fusion -42.23 Jg-1 and the broadening may attribute to the residual of the 
solvent used in the crystallization due to the depth of the cavity formed. There is no phase transition 
between two phases resulted from the heat delivered to the sample because of the rigidity of the 
macrocyclic host resulting from the presence of four benzene rings and the hydrgen bonding between 
these rings that can prevent the rotation and traslocation to another state which means that the 
compound has ability to work as a molecular store241. Completely different thermogram was obtained 
for the complex compared with the free host and guest as shown in Fig. 3. 36. The curve indicated 
that conformational changes in the receptor structure occurred which means that the complexation 
process led to defects in the molecular structure of the host and the guest and this is essential to 
promote the complexation process. This was reflected by the appearance of five signals in the DSC 
thermogram, and also the possibility of the macrocycle to be sufficiently flexible to achieve the 
complexation process which can lead to promote phase transition in the host structure. There are three 
endothermic peaks shifted from their free form. TG and DTG analysis of the pure compounds and 
the complex were carried out at the range of ambient temperature to 800 °C with a temperature 
increase rate 10°C/minute in a nitrogen gas atmosphere 
 
 
Fig. 3.48 TGA thermogram for the C-decylpyrogallol[4]arene receptor 
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Fig. 3.49 TGA thermogram for the CBZ  
 
 
 
Fig. 3.50 TGA thermogram of the complex formed btween CBZ and C-decylpyrogallol[4]arene 
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Fig. 3.51 DSC thermogram for the carbamazepine showing structural phase transition 
 
 
 
Fig. 3.52 DSC thermogram for C-decypyrogallol[4]arene 
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Fig. 3.53 DSC thermogram for the complex formed between C-decylpyrogallol[4]arene and CBZ 
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4.1 Meso-tetramethyl-tetrakis-(4-hydroxyphenyl ethyl)calix[4]pyrrole TTHCP 
and meso-tetramethyl-tetrakis-(4-ethylacetatophenoxyethyl) calix[4] pyrrole 
TTCP 
  Here we engineered, synthesised and characterised two novel derivatives based on calix[4]pyrrole. 
Both of them are characterised by a deep cavity with multiple functional groups and also multiple 
walls and these are first produced using a new procedure. The real progress achieved with this 
synthesis is that all of the calix[4]pyrrole derivatives  synthesised earlier rely on the addition of phenol 
groups to the meso position without a pendant arm211 like these two novel receptors. The addition of 
ethylene groups in the pendant arms could have an effect on the flexibility of the receptors to drive 
the interaction with different guests which is essential to give freedom for the conformational changes 
required in the complexation process. Also the presence of phenol ring inspired the polymerisation.  
In addition to these unique behaviour of the new receptors, the addition of ester groups is very 
important to increase the solubility of the receptor in different solvents. The receptor containing ester 
groups can act as a ditopic ion-pair receptor and may have an application as ion transporter through 
the cell membrane due to the low toxicity of calix[4]pyrrole. The chemical structures for these 
compounds are shown in Fig. 4.1 
                              
TTHCP                                                                      TTECP                                                           
Fig. 4.1 Chemical structure of novel calix[4]pyrrole derivatives (a) meso-tetramethyl-tetrakis-[2(4-
hydroxyphenyl)ethyl]calix[4]pyrrole TTHCP and meso-tetramethyl-tetrakis-[2-(4-ethylacetato-
phenoxy)ethyl] calix[4]pyrrole TTECP 
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4.1.1 Characterisation of meso-tetramethyl-tetrakis-[2-(4-hydroxyphenyl) 
ethyl]calix[4]pyrrole TTHCP 
 1H NMR data in d6-DMSO at 298 K (Fig. 4.2) confirmed that the calix[4]pyrrole derivative was 
obtained in high purity which is important for the next study. A set of peaks referring to different 
protons in different environments appear in the spectrum, the singlet peak at 9.32 ppm corresponds 
to the NH proton and that at 9.08 ppm refers to OH, the sets of doublets at 6.84 and 6.57 ppm are 
assigned to the phenyl protons. The resonance of protons of the pyrrolic ring appears as a doublet at 
5.7 ppm, the singlet peak at 3.3 ppm is due to the presence of water in d6-DMSO. The two sets of 
triplets at 2.27 and 2.06 ppm refer to the methylene protons while the singlet peak at 1.5 ppm 
corresponds to the methyl group at the meso position as shown in Fig. 4.1. Having characterised the 
receptor, solubility measurements in a variety of solvents at 298.15 were carried out. 
 
Fig. 4.2 1H NMR spectrum for meso-tetramethyl-tetrakis-(4-hydroxyphenyl ethyl) calix[4]pyrrole 
TTHCP in DMSO-d6 
4.1.2 Solubility of TTHCP in various solvents at 298.15 K 
The solvation properteries of TTHCP in various solvents can be assessed through the calculation of 
the transfer Gibbs energies from a reference solvent (acetonitrile) to other solvents. The solubility of 
the ligand in different organic solvents are reported in Table 4.1 at 298.15 K. Standard Gibbs energies 
of solution ∆sG° were calculated using the following equation  
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                                 Gº =  RT ln Ks                                                                                 eq.4.1 
                            ∆tG° (TTHCP) (s1s2) = sG (TTHCP) (s2)  sG (TTHCP) (s1)    eq.4.2 
In equation 4.1, K is the equilibrium constant which is equal to the ligand concentration in the 
saturated solution on the assumption that the activity coefficient of a low concentration non-
electrolyte in solution is equal to unity. It is not possible to calculate the Gibbs energy of solution if 
the ligand undergoes solvation as previously stated. The standard transfer Gibbs energy, ∆tG° was 
calculated using acetonitrile as reference solvent as shown in Table 4.1 
Table 4.1 Solubility data and derived standard Gibbs energies of solution of TTHCP in different 
solvents at 298.15 K. Transfer Gibbs energies from acetonitrile to other solvents is (∆tG°MeCNs2) at 
298.15 K 
         Solvent     Solubility mol dm-3     ∆sG° / kJ mol-1   ∆tG°MeCNs2 / kJ mol1 
         H2O         Not soluble                                                ----------      ----------- 
         MeCN       (1.3 ±0.1) × 10-3          16.5 ± 0.6          0.00 
         MeOH       (2.1 ± 0.4)  × 10-4          21.0 ± 2          4.5 
         EtOH       (1.8 ± 0.3) × 10-4          21.4 ± 1.7          4.5 
         DMSO       (2.0 ± 0.2) × 10-2            10 ± 1          6.5 
         DMF       (3.4±0.3) × 10-2               8 ± 1.7        8.5 
          Hexane         Not soluble          ---------           ---------- 
          Chloroform         Not soluble           ---------         ---------- 
          CH2Cl2         Not soluble          ----------         ---------- 
          Acetone       (14 ±0.1) × 10-3          14.3 ± 0.6         2.2 
 
From the standard transfer Gibbs energy of the receptor from acetonitrile (Table 4.1) it can be shown 
that among dipolar aprotic solvents, the receptor is better solvated in DMF, DMSO and acetone that 
acetonitrile. It was previously reported by Danil de Namor and Shehab that DMSO and DMF interact 
with the -NH- functionality of the pyrrole rings of the macrocycle through their basic oxygen atoms. 
As far as the alcohols are concerned, these are poor solvators of the ligand relative to acetonitrile as 
reflected in their transfer Gibbs energies (unfavourable) 
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4.1.3 Complexation of TTHCP with anions, 1H NMR studies    
1H NMR experiments reveal that the receptor interacts significantly with the fluoride anion F (Fig. 
4.3, Table 4.2) and the dihydrogen phosphate (Fig. 4.4, Table 4.2). In fact, the strong downfield shift 
change of the –NH- proton with the fluoride anion is much greater than that for the phosphate anion 
in this solvent. The result obtained for the OH proton indicates that interaction may take place with 
this proton. It is also shown for the phosphate anion that some interaction with the phenyl proton 
occurs.   
1H NMR experiments have revealed that the receptor complexed significantly with the fluoride and 
H2PO4 anions and there is significant contribution for the phenolic hydroxyl group and through the 
pyrrolic NH functional group with the complexation of these anions (Fig. 4.3). 
 
Fig. 4.3 1 H NMR spectrum of TTHCP and its fluoride complex (Bu4N
+ as counter ion) in DMSO-d6 
at 298 K. 
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Fig. 4.4 1H NMR spectrum for the complex formed between meso-tetramethyl-tetrakis-(4-  
hydroxyphenyl ethyl)calix[4]pyrrole TTHCP and tetra-n-butylammonium phosphate (Bu4NH2PO4
) 
at 298 K in DMSO-d6  
Table 4.2 1H NMR chemical shifts () and chemical shift changes () of CPD protons upon the 
addition of fluoride, phosphate, and bromide as tetra-n-butylammonium salts in DMSO-d6 at 298 K 
      
Proton 
 ppm 
 (N-H) 
ppm  
(O-H) 
ppm  
(Ar-Hmeta) 
ppm  
(Ar-Hortho) 
ppm 
 (C-H-pyrrole) 
 CPD proton      9.42      9.08       6.84      6.56       5.76 
 
 CPD + TBAF      12.9  Vanished       6.98      6.62       5.62 
 
 ∆δ ppm      3.48        0.14      0.06    − 0.14 
 
 CPD+TBAPh      9.31  Vanished       6.78      6.69       5.79 
 
 ∆δ ppm    0.14  Vanished     0.06      0.13       0.03 
 
 CPD +TBABr Overlapped Overlapped       -------      ------       ------- 
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Following 1H NMR studies on the interaction of TTHCP and the anions in DMSO-d6, conductance 
measurements were carried out in order to identify the composition of the complex. For comparison 
purposes with other calix[4]arene receptors, acetonitrile was used as the solvent for conductance and 
thermodynamic studies 
4.2 Conductometric titration of anion salts with TTHCP in MeCN at 298.15 K 
Given that the 1H NMR studies were confirmed the complexation between TTHCP and anions, 
further investigations were carried out by using conductometric measurements and it will be 
discussed next 
4.2.1 Conductance measurements of meso-tetramethyl-tetrakis-(4-
hydroxyphenyl ethyl)calix[4]pyrrole TTHCP with fluoride (tetra-n-
butylammonium as counter ion) in acetonitrile at 298.15 K 
The main goal of the conductance measurements is to corroborate further the interaction between the 
calix[4]pyrrole derivative and the fluoride anion  and to identify the stoichiometry of the interaction. 
As shown in Fig. 4.5 (plot of the molar conductance Λm (S cm2 mol-1) against [receptor]/ [anion] 
concentration ratio (Table 4.3-Appendix), the molar conductance decreases significantly upon 
addition of the receptor (A to B) until the ratio reaches a value of 0.5, at this point all the fluoride 
anions in the solution were consumed indicating the formation of a 1 [receptor]: 2 [F] complex   
[TTHCPF2]2 (eq.4.3) 
                    [TTHCP] (MeCN) + 2 F (MeCN) ⇌ [TTHCPF2]2 (MeCN)                     eq.4.3                           
The decrease in conductance is attributed to the size of the complex relative to the free anion. Further 
addition of the receptor leads to a break in the conductance (B to C) at a [receptor]/ [anion] 
concentration ratio of unity which may attributed to the transfer of one fluoride anion to the free 
receptor as shown in the following equation 
                   [TTHCPF2]
2− (MeCN) + TTHCP (MeCN) ⇌ 2 [TTHCPF] (MeCN)          eq.4.4 
From C to D the molar conductance does not change significantly                       
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Fig. 4.5 Conductometric titration of TTHCP against Bu4NH2PO4 in acetonitrile (1×10
-4 mol dm-3) at 
298.15 K.  
Conductometric measurements involving TTHCP and the dihydrogen phosphate anion in acetonitrile 
are now discussed 
4.2.2 Conductance measurements for the complexation of dihydrogen phosphate 
Bu4NH2PO4 with TTHCP in acetonitrile at 298.15 K 
As shown in Fig. 4.6 the solution of tetra-n-butylammonium phosphate monobasic in acetonitrile is 
conductive. The addition of calix[4]pyrrole solution to the phosphate anion solution has led to a 
dramatic decrease in the molar conductance as a result of the hosting of the phosphate anion by the 
receptor (A to B). A plot the molar conductance Λm (S cm2 mol-1) against [receptor] / [anion] 
concentration ratio (Table 4.4-Appendix), the stoichiometry of the reaction is found to be 2 [H2PO4]: 
1 [TTHCP] which means that one molecule of the receptor hosted two phosphate anions to form 
[TTHCP(H2PO4)2]2 as shown in eq.4.5 
               TTHCP (MeCN) + 2 H2PO4 (MeCN) ⇌ [TTHCP (H2PO4)2]2- (MeCN)                 eq.4.5 
A comparison between these results and those previously reported by Danil de Namor and Shehab32 
reveals that the parent calix[4]pyrrole interacts with only one unit of the anion. Therefore, the 
functionalization of the parent compound has increased the hosting ability of the receptor to uptake 
this anion. Furthe addition of the receptor to the phosphate solution does not lead to any significant 
change in the conductance 
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Fig. 4.6 Conductivity titration between TTHCP and tetrabutylammonium phosphate (Bu4NH2PO4) 
in acetonitrile at 298.15 K, [Bu4NH2PO4] = 9.4×10
-5 mol dm-3. 
The following section reports the thermodynamic studies on the complexation of this receptor 
TTHCP with the halides and phosphate anions (as tetra-n-butyl ammonium counter ion) by the use 
of titration calorimetry 
4.3 Thermodynamic parameters for the complexation of TTHCP with fluoride 
and phosphate anions (tetra-n-butylammonium counter ion) in acetonitrile at 
298.15 K 
The isothermal titration calorimetry was used to investigate the thermodynamic parameters of the 
complexation proceeses between the macrocyclic receptor with fluoride and phosphate anions (tetra-
n-butylammonium counter ion) in acetonitrile. The Nano-ITC cell was loaded with the receptor 
solution in acetonitrile (1 × 10-3 mol dm-3) and the injection syringe with the guest solution (fluoride 
or phosphate as tetra-n-butylammonium counter ion) in acetonitrile and the instrument was 
programmed to inject the guest solution (5.14 l) every three minutes. It seems from the 
thermodynamic data in Fig. 4.7 for fluoride and Fig. 4.8 for H2PO4 that the receptor has high affinity 
to interact with these anions (phosphate and fluoride) and stable complexes are formed with high 
stability constants as shown in Table 4.3 with stoichiometric ratios of 2: 1 guest: host. The high 
hosting ability of the receptor for these anions may be attributed to the flexibility of the receptor and 
the depth of the cavity. 
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Fig. 4.7 Isothermal titration calorimetry for the complexation of TTHCP solution in acetonitrile 
(1×10-3 mol dm-3) with fluoride (tetrabutylammonium counter ion) in acetonitrile (2×10-2 mol dm-3)  
at 298.15 K 
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Fig. 4.8 Isothermal titration calorimetry for the complexation of TTHCP in MeCN (1×10-3 mol dm-
3) with phosphate (tetrabutylammonium counter ion) in acetonitrile (2×10-2 mol dm-3) at 298.15 K. 
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Table 4.3 The thermodynamic parameters for the interaction of meso-tetramethyl-tetrakis-(4-
hydroxyphenyl ethyl) calix[4]pyrrole TTHCP  and phosphate, fluorid, chloride, as 
tetrabutylammonium counter ion in acetonitrile at 298.15 K 
 
[Guest]/ [ host] 
 
 
 
log K 
 
 
H/ kJ mol-1 
 
 
G/ kJ mol-1 
 
 
S/ J mol-1K-1 
 
 
[Fluoride]/ [CPD] 
 
 
2: 1 
 
 
K1 = 5.71 
 
 
K2 = 5.54 
 
H1 =  58.6 
 
 
∆H2 = 23  
 
G1 = - 32.59 
 
 
∆G2 = - 31.62 
 
S1 = 46 
 
 
∆S2 = 38 
[Phosphate]/ [CPD] 
 
2: 1 
K1 = 7.83 ± 0.03 
 
 
K2 = 6.55  
 
 
 
 
H1 =  32.11 
 
 
H2 =     4.9 
G1 =  44.72 
 
 
G2 =  37.45 
S1 = 42 
 
 
S2 = 142 
 
The results in Table 4.3 shows trhat highly stable complex are formed in acetonitrile, as far as the 
fluoride is concerned, the formation of the 1: 1 (receptor: anion) complex is enthalpically controlled. 
The loss of entropy is due to the conversion of 2 units (anion and receptor) into one (the complex). 
However, the formation of the 1: 2 (receptor: anion) receptor is entropically controlled and enthalpy 
destabilised. This pattern is typical of processes in which desolvation occurs upon complexation. 
Desolvation requires energy to remove the solvent either from the host or from the guest and therefore 
the reaction is endothermic and entropically favourable. As for as the H2PO4 and TTHCP is 
concerned, the 1: 1 process is favourable in enthalpic and entropic terms. As a result, a TTHCP has 
a higher affinity to complex with H2PO4
 in acetonitrile than for the fluoride anion. These results are 
relevant to Experimental Processs given that the waste processes of phosphoric acids produce 
untreated waste water containing large amounts fluoride leading to serious environmental problems 
therefore attempts to produce a material with selective properties may lead to a new approach for the 
separation of these two species. On this basis the possibility of using the phenol-formaldehyde 
reaction to synthesise a dimer or polymer was explored and the results are presented in the next 
Section  
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4.4 Polymerisation of meso-tetramethyl-tetrakis-(4-hydroxyphenyl ethyl) 
calix[4]pyrrole TTECP 
The phenol-formaldehyde polymerisation is a well known reaction in Chemistry since over a century 
ago. Here the polymerisation of the calix[4]pyrrole derivative containing phenolic hydroxyl groups 
was polymerised in acidic media. FTIR and SEM (Fig. 4.9) analysis provide further addition to the 
experimental evidence like the change in color, solubility and the viscosity which confirmed the 
formation of the polymer. The polymer formed is not soluble in any organic solvent. It has a high 
porosity according to the SEM and the BET analysis. The difference between the FTIR spectra for 
the monomer and the polymer is a further evidence for the formation of the polymer, disappearance 
of the C-H stretching of the hydrogen neighbour to the hydroxyl of the phnolic ring is the remarkable 
difference between the two IR spectrums. As shown from XR-ray diffraction analysis (Fig. 4.10) 
results obtained also confirmed the porosity of the polymer.  EDX and the microanalysis confirmed 
that the carbon C, hydrogen H and the nitrogen N, are the main elements in the polymer skeleton. It 
is found that the polymer formed contain sulphur Fig. 4.11 in addition to the main elements and this 
due to the use of sulphuric acid as a catalyst in the synthesis of the polymer and the presence of the 
catalyst as a polutant with the polymer formed is considered an ordinary case due to the porosity of 
the polymer. The results obtained from BET analysis confirmed that the obtained polymer is porous 
with a surface area = 0.9  0.1 m2 gm and the physico-chemical proterties are shown in Table 4.4 
 
 
Fig. 4.9 SEM analysis for the polymer formed showing the porosity of the structure in different 
regions a, b and c. 
 
 
 
                                                                            
a b c 
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Fig. 4.10 Shows the X-Ray diffractogram of the sample. It is characteristic of an amorphous 
compound with little or no crystal structure 
 
 
Fig. 4.11 EDS spectrum for the polymer formed 
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Table 4.4 Physical properties of the polymer obtained from BET analysis 
Properies 
 
Valu 
Sample density (g cm-3) 
 
1 g cm-3 
BET surface area (m2 g) 0.9016 ± 0.1036 m2 g 
 
Molecular cross-sectional area/ nm2 0.1620 nm2 
 
 
4.5 Charcterisation of the novel meso-tetramethyl-tetrakis-[4-(oxyethylacetato) 
phenyl] ethyl calix[4]pyrrole TTECP 
The addition of ester groups to the TTHCP is of interest due to their known affinity to complex with 
cations. It also makes the cavity of the functionalised calix[4]pyrrole deeper. The 1H NMR spectrum 
of compound (Fig.4.12) indicated that the targeted compound in addition to 13C NMR, 13C DEPT and 
the microanalysis were obtained.   It is clear from the spectrum that the compound is differs from the 
TTHCP compound which is used in the synthesis of the TTECP. The single peak at 9.27 ppm refers 
to N-H protons, two peaks at 6.95 and 6.69 ppm correspond to the aromatic protons of the benzene 
rings, the two doublets at 5.7 and 5.68 ppm are assigned to the pyrrolic protons. A single peak at 4.7 
ppm refers to the methylene next to the carbonyl group. A quartet peak at 4.14 ppm refers to the 
methylene protons and the triplet signal refers to the methyl protons (Table 4.5) 
 
Fig. 4.12 1H NMR spectrum of meso-tetramethyl-tetrakis-[4-(oxy-ethylethanoato)-phenyl]ethyl 
calix[4]pyrrole TTHCP in DMSO-d6 at 298 K 
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Table 4.5 Chemical shifts (ppm) of different protons of the meso-tetramethyl-tetrakis-(4-
ethylacetatophenoxyethyl) calix[4]pyrrole TTECP in DMSO-d6  and CD3CN at 298 K 
δ ppm (DMSO-d6) 
 
 Related proton ppm (CD3CN) 
 
     Related proton 
 
       
          1.19 Triplet (t, CH3, 12 H)       1.28 (t, O-CH2-CH3, 12 H)    0.09 
          1.58 Singlet (s, CH3)       1.53 (t, CH3, 12 H)   0.05 
          2.10 Triplet (t, C-CH2)       2.1 (t, CH2, 8 H)   0.00 
          2.30 Triplet (t, CH2-Ph)       2.3 (t, CH2, 8 H)   0.00 
          4.14 Quartet (q, O-CH2-CH3)        4.25 (q, O-CH2,8 H) - 0.11 
          4.7 Singlet (s, O-CH2-CO)       4.54 (s, O-CH2-CO, 8 H)    0.16 
          5.68, 5.78 Doublet (dd, C-H) pyrrolic       5.95 (d, C-H) pyrrole ring    0.01 
          6.7 Doublet (H-ortho phenyl ring)       6.69 (d, H-Ortho,8 H)    0.01 
           6.95 Doublet (H- phenyl ring)       6.91 (d, H- phenyl ring)    0.04 
           9.27 Doublet (N-H) pyrrole ring        7.03 (s, N-H) pyrrole ring    2.24 
 
Before proceeding with the complexation with anions and the cations it’s very important to study the 
solubility of the receptor in different organic solvents in order to select the appropriate medium for 
the complexation 
4.5.1 Solubility measurments of meso-tetramethyl-tetrakis-(4-ethylacetatopheno-
xyethyl) calix[4]pyrrole (TTECP) 
 Solubility measurements were carried out to gain information about the solvation process and to 
select the appropriate solvent for next studies. From the solubility data obtained (Table 4.6) the 
standard solution Gibbs energy in the appropriate solvent was calculated. Using acetonitrile as a 
reference solvent to calculate the standered transfer Gibbs energy from acetonitrile to other solvenet 
was calculated 
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Table 4.6 Solubility data for TTECP in different solvents at 298.15 
Solvent Solubility (mol dm-3)  ∆sG° (kJ mol-1) ∆tG°s1s2  (kJ mol-1) 
H2O Not soluble ------------- ----------- 
MeCN (1.1 ± 0.1) × 10-2 11.1±0.6 0.00 
MeOH (4.5 ± 0.4) × 10-3 13±2 1.90 
EtOH (4 ± 0.2) × 10-3 14±1 2.90 
DMSO solvation ------------ ----------- 
DMF solvation ------------ ----------- 
 
The results show that TTECP is better solvated in acetonitrile than in alcohols 
4.6 1H NMR complexation studies 
Chemical shift of the TTECP receptor and chemical shift changes by the addition of anion salts 
(BU4N as counter-ion) are shown in Table 4.7. The results shown in this Table reflect the significant 
chemical shift change observed by the addition of the fluoride salt to the receptor in a similar manner 
to that abserved with the TTHCP receptor indicating that this anion interact with the –NH-protons of 
the pyrrole rings. This is again not the case for the H2PO4anion which seems to interact with the 
ester groups. A downfield shift is found in the aromatic protons. 
Conductance measurements were carried out to identify the composition of the complex and these 
are now discussed 
Table 4.7 Chemical shifts (ppm) for the free calix[4pyrrole tetraester receptor TTECP and its 
chemical shifts changes (ppm) as a result from complexation with the fluoride, phosphate, bromide 
(as tetra-n-butylammonium salts counter ion) anions in acetonitrile at 298 K 
Related proton ppm (N-H) δppm (Ar-Hmeta) δppm (Ar-Hortho) ppm (C-Hpyrrole) 
Receptor proton 
 
     9.32      6.84     6.56    5.76 
Rceptor + TBAF 
 
∆δ ppm 
     13.2 
 
     3.78 
     6.7 
 
  − 0.14 
    6.52 
 
 − 0.04 
   5.46 
 
− 0.03 
Receptor + TBAPh 
 
∆δ ppm 
     9.31 
 
     0.01 
     6.78 
 
  − 0.06 
    6.69 
  
    0.13 
   5.79 
 
   0.03 
Recetor + TBABr 
 
∆δ ppm 
d (10.65) 
 
     1.33 
     7.4 
 
     0.56 
    6.74 
 
    0.18 
 
   5.67 
 
− 0.8 
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4.7 Conductance measurements for the complexation of meso-tetramethyl-
tetrakis-[4-(oxy-ethylaethanoato) phenyl]ethylcalix[4]pyrrole (TTECP) with the 
halides and phosphate anions( tetra-n-butylammonium counter ion) 
Given that in the 1H NMR studies overlapping was found with the addition of chloride and bromide 
salts, chloride anion was tested by conductometry  
 
4.7.1 Conductance measurements for the titration of TTECP with BU4NF in 
acetonitrile at 298.15 K  
Fig. 4.13 shows a plot of the molar conductance against the receptor: anion concentration ratio. A 
substantial decrease in conductance is observed from A to B as a result of complex formation. This 
is a size effect which decrease the mobility of the complex relative to the free anion. From B to C a 
slight increase in conductance is found due to a displacement of the equilibrium to the right in the 
presence of an exess of the receptor in this solvent. 
 
 
Fig.  4.13 Conductometric titrations of fluoride (BU4N
+ as counter-ion) in acetonitrile with TTECP 
in acetonitrile at 298.15 K, [Bu4NF] is 1×10
-4 mol dm-3 
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4.7.2 Conductometric titrations of chloride (Bu4N+ as counter-ion) with TTECP 
in acetonitrile at 298.15 K                                       
Fig. 4.14 shows a plot of the molar conductance against the receptor/ guest concentration ratios in 
acetonitrile. The pattern shown is typical of most systems involving macrocycles. The conductance 
decreases from A to B due to the lower mobility of the receptor-anion complex relative to the free 
chloride salt. The increase from B to C results from the addition of excess of TTECP which displaces 
the equilibrium to the right. The complex composition is 1: 1 (receptor: chloride). Therefore, the 
process taking place is represented by eq. 4.6 
 
                  TTECP (MeCN) + Cl (MeCN)  [TTECPCl] (MeCN)                             eq. 4.6 
 
 
 
Fig. 4.14 Conductometric titration curve of TTECP against tetra-n-butylammonium chloride 
Bu4NH2Cl solution (1.09104 mol dm-3) in acetonitrile at 298.15 K 
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4.7.3 Conductometric titration of tetra-n-butylammonium bromide (Bu4NBr) 
with TTECP in acetonitrile at 298.15 K 
It is clear from plot of changes in conductance values of Bu4NBr as a result from the addition of the 
receptor solution TTECP in the same solvent (Fig. 4.15) that there is no significant change in 
conductivity values which mean that the free receptor is unable to capture the bromide anions which 
means that the coordination of bromide with Bu4N
+ is more favourable than with the calix[4]pyrrole 
derivative 
 
 
Fig. 4.15 Conductometric titration of tetra-n-butylammonium bromide (1.48×10-4 mol dm-3) with 
TTECP in acetonitrile at 298.15 K. 
 
4.7.4 Conductometric titration of tetra-n-butylammonium phosphate    
(Bu4NH2PO4) with TTECP in acetonitrile at 298.15 K 
As shown in Fig.4.16, the sharp break in conductance is found at the [receptor]/ [H2PO4] 
concentration ratio of 0.5 which means that two anions are taking up per unit of receptor as shown in 
eq.4.7 
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               TTECP (MeCN) + 2 H2PO4
 (MeCN)  [TTECP (H2PO4)2]2 (MeCN)         eq.4.7 
 
On the basis of the conductometric studies, the hosting ability of TTECP is greater for H2PO4
 than 
for F and Cl anions 
 
Fig. 4.16 Molar conductance of Bu4NH2PO4 against the [TTECP]/ [H2PO4] in acetonitrile at 298.15 
K, [Bu4NH2PO4] is 1×10
-4 mol dm-3 
4.7.5 Thermodynamic parameters of complexation of meso-tetramethyl-tetrakis-
[4-(ethylacetatophenoxyethyl)calix[4]pyrrole TTECP with fluoride, bromide and 
anions (tetra-n-butylammonium as counter-ion) in acetonitrile at 298.15 K 
Further investigations for the complexation of the TTECP with the halides and phosphate anions 
(tetra-n-butylammonium salts) were carried out by using isothermal titration calorimetry in 
acetonitrile at 298.15 K.  
Titration calorimetry was the analytical method used to obtain the stability constant (expressed as log 
Ks) and the enthalpy of complexation of TTECP and anions (F, Cl, Br and H2PO4) in acetonitrile 
at 298.15 K. For this receptor the isothermal titration calorimeter was used. Thermograms for F, Cl, 
Brand H2PO4 and their interaction with TTECP are shown in Figs. 4.17- 4.20 respectively. Stability 
constants, standard Gibbs energies, enthalpies and entropies are listed in Table 4.8 
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As far as fluoride is concerned, the process is enthalpy and entropy favoured but enthalpy controlled. 
The strength of complexation of this receptor with chloride is approximately the same. The data 
suggest that TTECP is unable to recognise selectivity between these two anions. Again the process 
is enthalpy controlled. However, the stability of the bromide complex is lower. The enthalpy and 
entropy contribution are typical of most binding processes in that the loss of entropy results from the 
combination of two species (host and guest) to give one unit of the complex. The process is enthalpy 
controlled. 
A different picture emerges with the complexation data involving the H2PO4 anion. Thus the 
formation of the 1: 1 complex occurs with a gain in entropy, typical of processes in which strong 
desolvation, either of the host or the guest or both takes place. It seems that the entropic and enthalpic 
contribution to the stability of the complex is approximately the same. The entrance of a second anion 
to the receptor to form the 1: 2 (receptor: anion) causes conformational changes to keep the two 
anions as far apart as possible. This aspect and desolvation may be the roots of the high entropic 
contribution observed and the endothermic character of the reaction as observed from cH reported 
for this anion and this ligand in Table 4.8 
In summary, TTECP has a high affinity for phosphate relative to the halides and shows high stability 
constant compared with most of calix[4]pyrrole derivatives prepared147,245. In addition, the hosting 
ability of this receptor for the H2PO4
 is greater than that for the halides. It is therefore concluded that 
although this receptor is not able to distinguish between fluoride and chloride, in terms of the 
separation process between the former anion and phosphate, it seems to be more suitable than TTHCP 
due to the high affinity and high hosting capacity for the phosphate anion. Further experimental data 
in wastewater solutions containing both anions would be required to confirm the outcome of this 
thermodynamic study given that the kinetics of the process also play an important role in extraction 
process 
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Fig. 4.17 Interaction of fluoride (tetrabutylammonium fluoride, Bu4NF (2×10
-2 mol dm-3) as counter 
ion and CP-Tetraester in acetonitrile (1×10-3 mol dm-3) at 298.15 K  
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Fig. 4.18 Nano-isothermal titration calorimetry of the Interaction of CP-tetraester (1×10-3 mol dm-3) 
with tetrabutylammonium chloride (Bu4NCl) in acetonitrile (2×10
-2 mol dm-3) at 298.15 
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Fig. 4.19 Nano isothermal titration calorimetry for the interaction of the TTECP solution in 
acetonitrle (1×10-3 mol dm-3) and tetra-n-butylammonium bromide (Bu4NBr) in acetonitrile (2×10
-2 
mol dm-3) at 298.15 K, top, is the baseline editor, and bottom is the titration curve. 
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Fig.4.20 Nano ITC for the complexation of the Bu4NPO4 (2×10
-2 mol dm-3) and TTECP in acetonitrile 
(1×10-3 mol dm-3) at 298.15 K 
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Table 4.8 The thermodynamic parameters for the interaction of calix[4]pyrrole ester [L] and 
phosphate, fluorid, chloride, as tetrabutylammonium counter ion in acetonitrile at 298.15 K 
 
[Anion]/ [L] 
 
 
log Ks 
 
 
 
cHº/ kJ. mol-1 
 
 
cGº/ kJ mol-1 
 
 
Sº / J mol-1K-1 
 
 
[H2PO4]
-/ [L] 
 
         2: 1 
 
log Ks1 
 = 7.37  0.03 
 
log Ks2  
= 5.47  0.02 
 
 
cHº1=29.750.05 
 
cHº2 = 58.6  0.1 
 
cGº1 =  42.07  0.2 
 
cGº2 =  31.23  0.1 
 
cSº1 = 3.9×101 
 
cSº2 = 3.1×102 
 
[F]-/ [L] 
         1: 1 
 
 
log Ks  
  = 5.48  0.02 
 
cHº = 28.4 0.05 
 
cGº =  31.26  0.1 
 
cSº = 8 
 
[Cl]-/ [L] 
        1: 1 
 
 
log 
Ks = 5.79 ± 0.02 
 
cHº= −33.8 ± 0.06 
 
cGº = −33.09 ± 0.05  
 
∆cSº = 1.99 
 
[Br]-/ [L]       
       1: 1 
 
 
log 
Ks = 3.6  0.01 
 
∆cHº =  27.90.05 
 
∆cGº =  21.11 0.06 
 
∆cSº =  23 
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FINAL CONCLUSIONS 
From the above discussion the following conclusions are drawn 
A number of macrocycles have been synthesised and characterised by 1H NMR and microanalysis. 
These are based on modified naturally occurring receptors such as cyclodextrins (heptakis-(6-chloro-
6-deoxy)-β–cyclodextrin and heptakis-( 2, 3 , 6-tri-O-benzoyl)-ß-cyclodextrin) and synthetic 
macrocycles such as calix[4]arenes (5, 11, 17, 23- tert-butyl-25, 26, 27, 28-
(ethylacetatoethoxy)calix[4]arene, 5, 11, 17, 23 tetra-p-tert-butyl, 25, 27- bis[aminoethoxy], 26, 28 
dihydroxycalix[4]arene,25, 27-dihydroxy-26-28-(dioxypropargyl)  tert-butylcalix[4]arene , 4-tert-
butyl-azidocalix[4]arene,25, 26, 27, 28-(diethylamino) ethoxycalix[4]arene), calix[4]pyrroles (meso-
tetramethyl-tetrakis-(4-hydroxyphenyl ethyl) calix[4]pyrrole, meso-tetramethyl-tetrakis-(4-
ethylacetatophenoxyethyl) calix[4]pyrrole ), resorc[4]arene (C-pentyl-resorcin[4]arene ,C-
pentylresorci[4]arene ester) and pyrogallol[4]arene (C-decyl pyrogallol[4]arene and C-4-
aminophenyl pyrogallol[4]arene). 
The solution properties (solubility and derived Gibbs energies of solution) for some drugs (sodium 
diclofenac and carbamazepine) have been investigated and the transfer Gibbs energies from a 
reference solvent (acetonitrile) to other solvents have been calculated in an attempt to obtain 
information regarding the differences in the solvation of these drugs in moving from one solvent to 
another. In the derivation of solution Gibbs energies particular attention was paid to the speciation 
present in solution. Thus sodium diclofenac was treated as a fully dissociated electrolyte in water and 
fully associated in solvents of low permittivity. Carbamazepine was considered to be fully associated 
in non-aqueous solvents.  Partition coefficients were determined for diclofenac, clorofibric acid and 
carbamazepine in the water-1-octanol solvent system at 298.15 K and the results were compared with 
literature data. For new receptors such as meso-tetramethyl-tetrakis-(4-hydroxyphenyl ethyl) 
calix[4]pyrrole and meso-tetramethyl-tetrakis-(4-ethylacetatophenoxyethyl) calix[4]pyrrole the 
solution properties showed that as for other calix[4]pyrrole derivatives these are not water soluble. 
From all receptors synthesised, per-benzoylated cyclodextrin and calix[4]arene ester were selected 
for interaction with sodium diclofenac. The latter receptor was selected for interaction with sodium  
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diclofenac, due to the selectivity of the calix[4]arene ester derivative for the sodium cation. Given 
that this is a neutral receptor, cation and anion are taken simultaneously, to keep the neutrality of the 
system. Thermal analysis was the approach taken to assess the stability of the receptor, the drugs and 
the complex. 
P-tert-butylcalix[4]arene amine CA-(NH2)2 was the receptor selected for further studies involving 
drugs ( aspirin, clofibric acid, diclofenac, sodium diclofenac and ibuprofen).  The 3–aminopropyl 
functionalised silica gel was used for the removal of aspirin from water. 
Extraction experiments involving a solid phase (the free receptor) and the drug in aqueous medium 
were accomplished under different experimental conditions to determine the optimal conditions for 
the removal of the drug from water. It was found that the calix[4]arene ester was able to remove 0.2 
mmol of the drug from aqueous solution per gram of receptor. As far as the modified cyclodextrin is 
concerned, the stability constant of the receptor-drug (sodium diclofenac) interaction was relatively 
low and the receptor have showed high hydrophobicity and the aggregation of the compound in the 
aqueous media prevent the progress with the extraction process. As far as clofibric acid, diclofenac, 
aspirin and ibuprofen are concerned, the presence of carboxylic groups in their structure led to the 
choice of the partially functionalised calix[4]arene amine derivative (5, 11, 17, 23 tetra-p-tert-butyl, 
25, 27- bis[aminoethoxy], 26, 28 dihydroxycalix[4]arene) as a suitable receptor for these drugs. 
Several techniques were used to determine qualitatively and quantitatively the extent of interaction 
of these drugs with this receptor. Striking results were obtained. Thus the receptor was able to host 
two units of the drug per unit of receptor in the case of clofibric acid and diclofenac, while the 
capacity of the receptor was lower for aspirin, only a unit of this drug was taken up per unit of 
calix[4]arene amine. The selectivity behaviour of the calix[4]arene amine derivative for the drugs 
was demonstrated through the thermodynamics associated with protonation process. 
.It is concluded that the receptor is able to recognise selectively these drugs in the following sequence 
based on the formation of host 1- complexes 
Clofibric acid > Diclofenac > aspirin 
Therefore this receptor has an enhanced capacity for clorofibric acd and diclofenac but in addition it 
fulfils the concept of selectivity, one of the main features of Supramolecular Chemistry. The 
application of this receptor for the removal of some drugs from water was investigated showing that 
0.2 mmol of clofibric acid can be removed from water. Given that the removal of aspirin from water 
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by the calix[4]arene amine derivative was rather low,  the 3 –aminopropyl functionalised silica gel 
was used for the removal of aspirin from water.The optimal extraction conditions were determined.  
For carbamazepine, the receptor found to interact with this drug was C-decylpyrogallol[4]arene and 
significant changes in the phisico-chemical properties was observed. 
For the novel calix[4]pyrrole receptor TTHCP affinity to complex with the fluoride and phosphate  
(tetrabutylammonium counter ion)  and stable complexes were formed and high value for stability 
constant with phosphate was determined compared with fluoride. 
Also the functionalisation of TTHCP with ester groups led to the production of a new receptor, 
TTECP, which shows a higher hosting affinity for the dihydrogen phosphate anion as well as a higher 
affinity for this anion relative to fluoride.  
In real water samples, the materials need to be tested and some of the steps to be taken are briefly 
addressed (i) Sampling: sampling should be representative of the source of water under study. Several 
sampling methodologies have been reported in the literature, including frequency of sampling. 
Storage of samples needs to be considered and this would depend on the type of the analysis to be 
carried out (microbiological or physico-chemical analysis). Within the context of this work, physico-
chemical analysis is the issue to address and it is important to emphasise that this this type of analysis 
requires the availability of properly collected and stored samples otherwise the results are not 
meaningful. The amount of residual chlorine. pH and the turbidity should be determined immediately 
after sampling otherwise changes are found with time, (ii) Physico-chemical analysis: This process 
include: (a) Chlorine removal 
Treatment with chlorine is the main disinfecting agent employed. Chlorine has low cost, it is efficient 
and easy to measure in the laboratory or “in situ”. Samples should be analysed for chlorine by the 
recommended methods 
(b) pH measurements  
Disinfection by chlorine requires a pH lower than 8, otherwise, disinfection is not effective. The pH 
can be measured ‘in situ’ with the appropriate electrodes     
(c) Turbidity 
Visual methods employing extinction are adequate 
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d. Analysis of samples 
 Analysis to test the presence of health pollutants such as heavy metals, fluoride as well as pesticides 
and pharmaceuticals should be carried out. For the determination of heavy metals, atomic absorption 
and ICP/ MS techniques can be used. Anions can be analysed by ion chromatography. For pesticides 
and pharmaceuticals, spectrophotometric techniques can be used. Interfering anions and cations may 
be removed. Materials reported in this thesis are to be tested for the removal of drugs from water 
under several experimental conditions discussed in this thesis (mass of the receptor, temperature, 
concentration of the pharmaceutical, pH, presence of interfering ionic and neutral species)
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Suggestions for further work 
 Suggestions for further research include 
A comprehensive study on calix[4] resorcarene derivatives covering interactions with neutral and 
ionic species in solution using NMR technique, electrochemical and thermal techniques. On the basis 
of fundamental studies attempts should be made to immobilise these receptors into solid supports and 
to proceed with an investigation of their extraction properties with the aim of obtaining easily 
recyclable materials for decontamination purposes as well as the use of these receptors for the design 
of ion selective electrodes. In this area significant advances have been already made with the use of 
calix[4] pyrrole derivatives as recently discussed by Danil de Namor and co-workers  
Further research is required on the receptors discussed in this thesis, mainly on the calix[4]pyrrole 
derivatives and their interactions  with cations particularly for those  ligands for which preliminary 
work has demonstrated that cation-ligand interactions take place in solution 
Expansion of this work by the use of Scanning Electron Microscopy to get insight on the surface 
characteristics of materials based on these receptors as well as Energy Dispersive X- ray Analysis to 
find the composition of membranes used for the design of ion selective electrodes. There is already 
work undergoing in the Thermochemistry Laboratory as well as in other Laboratories linked to 
Thermochemistry regarding the use of these techniques. 
Testing these compounds under real situations is another issue which needs to be addressed
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A-Calibration Curves 
 
 
Fig. 1- A Calibration curve of sodium diclofenac in water 
 
Fig. 2-A Calibration curve of NaDF in methanol at 298 K 
 
 
 
 
 
 
 
Fig. 3-A Calibration curve of NaDF in acetonitrile at 298 K 
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Fig. 4. A Calibration curve of NaDF in DMSO 
 
Fig. 5-A Calibration curve of NaDF in 1- Butanol at 298 K 
 
 
 
 
 
 
 
 
Fig. 6-A Calibration curve of NaDF in ethylacetate at 298 K 
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Fig. 7-A Calibration curve of sodium diclofenac in DMF 
 
Fig. 8-A Calibration curve of sodium diclofenac in THF at 298 K 
 
 
Fig.  9–A: Calibration curve of carbamazepine in water at 298 K 
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Fig. 10-A Calibration curve of carbamazepine in DCM at 298  
 
Fig. 11-A Calibration curve of carbamazepine in acetonitrile at 298 K 
 
 
Fig. 12-A Calibration curve of CBZ in DMSO at 298 K
0
0.5
1
1.5
2
0 0.00002 0.00004 0.00006 0.00008 0.0001 0.00012 0.00014 0.00016
A
b
so
r
b
a
n
c
e
Concentration mol dm-3
y = 1002.7x
R² = 0.9962
0
0.5
1
1.5
2
2.5
0 0.0005 0.001 0.0015 0.002
A
b
so
r
b
a
n
c
e
 
Concentration mol dm-3
y = 10484x
R² = 0.999
0
0.5
1
1.5
2
2.5
0 0.00005 0.0001 0.00015 0.0002
A
b
so
r
b
a
n
c
e
Concentration
8.                                                                                                                                             Appendix 
 
222 
 
 
Fig. 13-A Calibration curve of clofibric acid in water 
 
 
Fig. 14-A Calibration curve of carbamazepine in water 
 
 
Fig. 15-A Calibration of carbamazepine in DCM at 298 K 
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Fig. 16-A Calibration curve of carbamazepine in acetonitrile  
 
 
 Fig. 17-A Calibration curve of carbamazepine in DMSO 
 
 
Fig. 18-A Calibration curve of carbamazepine in DMF 
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Appendix-B 1 H NMR Spectrum 
 
Fig. 1-B:  1H NMR spectrum for monochlorinated -cyclodextrine in DMSO-d6 
 
 
Fig. 2-B: 13C NMR spectrum for mono chlorinated--cyclodextrine in DMSO-d6 at 298 K
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Fig. 3-B:  1H NMR spectrum of per-benzoylated-ß-cyclodextrine in DMSO-d6 at 298 K 
 
 
Fig. 4-B: 1H NMR spectra for p-tert-buylcalix[4]arene tetraethylethanoate in CDCl3 at 298 K. 
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Fig. 5-B: 1H NMR spectrum of 5, 11, 17, 23 tetra- tert -butyl, 25, 27 bis (2-cyanomethox) methoxy-  
26, 28 -dihydroxycalix[4]arene at 298 K 
 
Fig. 6-B 1H NMR spectrum of 5, 11, 17, 23 tetra-tert-butyl, 25, 27-bis (aminoethoxy)-26, 28 
dihydroxycalix[4]arene at 298 K
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Fig. 7-B 1H NMR spectrum for 25, 26, 27, 28-tetrahydroxycalix[4]arene in CDCl3 at 298 K 
 
Fig. 8-B 1H NMR spectra for 5-tert-butyl-2-hydroxybenzaldehyde in CDCl3 at 298 K 
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Fig. 9-B 1H NMR spectra for 5-tert-butyl-3-chloromethyl-2-hydroxy benzaldehyde In CDCl3 at 
 
 298 K 
 
 
 
 
Fig. 10-B 1H NMR spectroscopy for 5-tert-butyl-3-(azidomethyl)-2-hydroxyBenzaldehyde in 
CDCl3 at 298 K 
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Fig. 11-B 1NMR spectrum of 25, 27-dihydroxy-26-28-(dioxypropargyl) tert-butylcalix[4]arene  
(ArCH) in CDCl3 at 298 K 
 
 
Fig. 12-B 1H NMR spectrum of p-tert-butyl-azidocalix[4]arene   in CDCl3 298 K  
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Fig. 13-B 1 H NMR spectrum of 2-azidoacetamide in CDCl3 at 298 K 
 
 
Fig. 14-B 1H NMR spectrum of 25, 26, 27, 28-(diethylamino) ethoxy calix[4]arene in CDCl3 at 
 298 K 
8.                                                                                                                                             Appendix 
 
231 
 
 
Fig. 15-B 1H NMR spectrum of TTHCP in DMSO-d6 at 298 K 
 
 
 
Fig. 16-B 13C NMR of TTHCP in DMSO at 298 K 
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Fig. 17-B 1H NMR spectrum of TTECP in DMSO-d6 at 298 K 
 
 
Fig. 18-B 1H NMR spectrum of calix[4]pyrrole derivative TTECP in CD3CN at 298 K 
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Fig. 19-B Appendix H NMR spectrum of C-pentyl-resorcin[4]arene in CDCl3 at 298 K 
 
 
Fig. 20-B 1H NMR spectrum of PG6 in cdCl3 at 298 K 
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Fig. 21-B 1 H NMR spectrum of PG11 in CDCl3 at 298 K
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Table 3.1 1H NMR titration experiment and the chemical shift changes from the addition of   
increasing amounts of diclofenac to a fixed concentration of calix[4]arene amine in CD3CN at 298 
K. 
DF/[(CANH2)2] H1  H2  H3  H4  H5  H6  H7  H8  N-H 9 
Free L  1.2  1.16  7.24  7.17  3.39  4.32  4.01  3.22  2.17  
0.16  0.00  1.16  0.00  0.00  0.00  -0.01  0.01  0  0.14  
0.32  0.00  1.16  0.00  0.00  0.00  -0.03  0.02  0.02  0.21  
0.48  0.00  -0.01  -0.01  0.00  0.00  -0.05  0.04  0.04  0.24  
0.64  0.00  -0.01  -0.01  -0.01  0.01  -0.08  0.06  0.06  0.26  
0.8  0.01  -0.01  -0.01  -0.01  0.01  -0.1  0.07  0.07  0.27  
0.96  0.01  -0.01  -0.01  -0.02  0.01  -0.12  0.08  0.09  0.27  
1.12  0.01  -0.01  -0.01  -0.02  0.01  -0.14  0.09  0.1  0.27  
1.28  -0.01  -0.01  -0.01  -0.01  0  -0.15  0.1  0.11  0.27  
1.44  -0.01  -0.01  -0.01  -0.01  0.01  -0.16  0.11  0.12  0.26  
1.6  -0.01  -0.01  -0.01   0.0  0.01  -0.17  0.12  0.12  0.25  
1.76  -0.01  -0.01  -0.01  -0.01  0.01  -0.18  0.13  0.13  0.25  
1.92  -0.01  -0.01  -0.01  0.00  0.01  -0.2  0.14  0.14  0.24  
2.08  -0.01  -0.01  -0.01  0.00  0.00  -0.21  0.13  0.15  0.23  
2.24  -0.01  -0.01  -0.01  0.00  0.01  -0.21  0.14  0.15 0.22  
2.56  -0.01  -0.01  -0.01  0.00  0.01  -0.22  0.14  0.17  0.21  
 
In Table 3.13 [CA-(NH2)2] and [DF] are the receptor and diclofenac concentrations in mol dm
-3 
[CAE] = 2  10-3 mol dm-3, [DF]  4  10-3 mol dm-3, 0.04 cm3 for each addition  
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Table 3.2 Chemical shift changes for the receptor [(CA-(NH2)2] as a result from the addition of 
increasing concentrations of clofibric acid in CD3CN at 298 K 
[CLF]/[L] H1  H2  H3  H4  H5  H6  H7  H8  N-H  
Free L  1.2  1.16  7.24  7.14  3.37  4.32  4.01  3.21  2.17  
0.16  -  -  -  7.14  0.02  -0.01  0.01  0.01  0.02  
0.32  -  -  -  0.01  0.03  -0.02  0.03  0.03  0.12  
0.48  -  -  -  0.01  0.03  -0.05  0.04  0.05  0.14  
0.64  -  -  -  0.02  0.03  -0.07  0.06  0.06  0.18  
0.8  -  -  -  0.02  0.04  -0.09  0.07  0.07  0.21  
0.96  -  -  -  0.02  0.04  -0.11  0.08  0.09  0.23  
1.12  -  -  -  0.02  0.04  -0.13  0.09  0.1  0.26  
1.28  -  -  -  0.02  0.06  -0.15  0.1  0.12  0.26  
1.44  -  -  -  0.02  0.05  -0.16  0.11  0.13  0.27  
1.6  -  -  -  0.02  0.05  -0.17  0.12  0.13  0.29  
1.76  -  -  -  0.02  0.05  -0.18  0.12  0.14  0.30  
1.92  -  -  -  0.02  0.05  -0.20  0.12  0.14  0.30  
2.08  -  -  -  0.02  0.06  -0.21  0.12  0.15  0.32  
2.24  -  -  -  0.02  0.06  -0.22  0.12  0.16  0.32  
 
In the table 3.14 [CA-NH2)2] and [CLF] are the receptor and clofibric acid concentrations in mol dm
-
3 units, [L] = 2 ×10-3 mol dm-3, [CLF] = 4 ×10-3 mol dm-3, 0.04 ml for each addition 
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Table 3.3 Conductance  measurements  for the Diclofenac   
Volume added Vol (acc) [CA(NH2)2] [Diclofenac] [CA(NH2)2]/ [DF] m 
0.00 0.00 0.00 1.60 ×10-3 0.00 1.20 
0.25                                                                                                                                                                     0.25 1.59 ×10-4 1.58 ×10-3 0.10 2.10 
0.25 0.50 3.15 ×10-4 1.57 ×10-3 0.20 3.07 
0.25 0.75 4.68 ×10-4 1.55 ×10-3 0.30 3.88 
0.25 1.00 6.18 ×10-4 1.54 ×10-3 0.40 4.55 
0.25 1.25 7.65 ×10-4 1.52 ×10-3 0.50 5.20 
0.25            1.50 9.09 ×10-4 1.51 ×10-3 0.60 5.87 
0.25 1.75 1.05 ×10-3 1.49 ×10-3 0.70 6.37 
0.25 2.00 1.19 ×10-3 1.48 ×10-3 0.80 6.93 
0.25 2.25 1.33 ×10-3 1.47 ×10-3 0.90 7.47 
0.25 2.50 1.46 ×10-3 1.45 ×10-3 1.00 8.00 
0.25 2.75 1.59 ×10-3 1.44 ×10-3 1.10 8.60 
0.25 3.00 1.72 ×10-3 1.43 ×10-3 1.20 9.11 
0.25 3.25 1.85 ×10-3  1.41 ×10-3 1.31 9.55 
0.25 3.50 1.97 ×10-3 1.40 ×10-3 1.41 10.27 
0.25 3.75 2.09 ×10-3 1.39 ×10-3 1.51 10.82 
0.25 4.00 2.21 ×10-3 1.38 ×10-3 1.61 11.40 
0.25 4.25 2.33 ×10-3 1.37 ×10-3 1.71 12.03 
0.25 4.50 2.45 ×10-3 1.35 ×10-3 1.81 12.49 
0.25 4.75 2.56 ×10-3 1.34 ×10-3 1.91 13.11 
0.25 5.00 2.67 ×10-3 1.33 ×10-3 2.01 13.64 
0.25 5.25 2.78 ×10-3 1.32 ×10-3 2.11 14.30 
0.25 5.50 2.89 ×10-3 1.31 ×10-3 2.21 15.03 
0.25 5.75 3.00 ×10-3 1.30 ×10-3 2.31 15.71 
0.25 6.00 3.10 ×10-3 1.29 ×10-3 2.41 16.63 
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Table 3.4 Conductivity values for the titration of clofibric acid solution in MeCN (1.96×10-3 mol dm-
3) with the CA-(NH2)2 receptor in MeCN (1. 59×10
-2 mol dm-3) at 298.15 K                                                                                                                                                                                                   
Volume added Volume accum CA-(NH2)2 [CLF] CA-(NH2)2/ [CLF]          m 
0.00 0.00 0.00 1.96 ×10-3 0.00 1.52 
0.25 0.25 1.59 ×10-4 1.94 ×10-3 0.08 2.29 
0.25 0.50 3.15 ×10-4 1.92 ×10-3 0.16 3.07 
0.25 0.75 4.68 ×10-4 1.90 ×10-3 0.25 3.77 
0.25 1.00 6.18 ×10-4 1.88 ×10-3 0.33 4.32 
0.25 1.25 7.65 ×10-4 1.87 ×10-3 0.41 4.85 
0.25 1.50 9.09 ×10-4 1.85 ×10-3 0.49 5.32 
0.25 1.75 1.05 ×10-3 1.83 ×10-3 0.57 5.84 
0.25 2.00 1.19 ×10-3 1.81 ×10-3 0.66 6.15 
0.25 2.25 1.33 ×10-3 1.80 ×10-3 0.74 6.54 
0.25 2.50 1.46 ×10-3 1.78 ×10-3 0.82 6.93 
0.25 2.75 1.59 ×10-3 1.76 ×10-3 0.90 7.31 
0.25 3.00 1.72 ×10-3 1.75 ×10-3 0.98 7.70 
0.25 3.25 1.85 ×10-3 1.73 ×10-3 1.07 8.06 
0.25 3.50 1.97 ×10-3 1.72 ×10-3 1.15 8.49 
0.25 3.75 2.09 ×10-3 1.70 ×10-3 1.23 8.88 
0.25 4.00 2.21 ×10-3 1.69 ×10-3 1.31 9.30 
0.25 4.25 2.33 ×10-3 1.67 ×10-3 1.39 9.76 
0.25 4.50 2.45 ×10-3 1.66 ×10-3 1.48 10.18 
0.25 4.75 2.56 ×10-3 1.64 ×10-3 1.56 10.54 
0.25 5.00 2.67 ×10-3 1.63 ×10-3 1.64 11.06 
0.25 5.25 2.78 ×10-3 1.62 ×10-3 1.72 11.47 
0.25 5.50 2.89 ×10-3 1.60 ×10-3 1.80 11.94 
0.25 5.75 3.00 ×10-3 1.59 ×10-3 1.88 12.45 
0.25 6.00 3.10 ×10-3 1.58 ×10-3 1.97 13.09 
0.25 6.25 3.21 ×10-3 1.56 ×10-3 2.05 13.46 
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Table 3.5 Conductometric titration of aspirin with CA-(NH2)2 in acetonitrile at 298.15 K 
Vol(add) Vol(acc) CA-(NH2)2 [Aspirin] CA-(NH2)2/[Aspirin]  m 
0.00 0.00 0.00 1.79×10-4 0.00 2.84 
0.200 0.20 1.44×10-5 1.78 ×10-4  0.08 5.78 
0.200 0.40 2.85 ×10-5 1.76 ×10-4 0.16 9.13 
0.200 0.60 4.24 ×10-5 1.75 ×10-4 0.24 12.48 
0.200 0.80 5.61 ×10-5 1.73 ×10-4 0.32 15.63 
0.200 1.00 6.95 ×10-5 1.72 ×10-4 0.40 18.89 
0.200 1.20 8.28 ×10-5 1.71 ×10-4 0.48 22.29 
0.200 1.40 9.58 ×10-5 1.69 ×10-4 0.57 25.40 
0.200 1.60 1.09 ×10-4 1.68 ×10-4 0.65 28.58 
0.200 1.80 1.21 ×10-4 1.67 ×10-4 0.73 31.86 
0.200 2.00 1.34 ×10-4 1.66 ×10-4 0.81 34.86 
0.200 2.20 1.46 ×10-4 1.64 ×10-4 0.89 38.37 
0.200 2.40 1.58 ×10-4 1.63 ×10-4 0.97 42.43 
0.200 2.60 1.70 ×10-4 1.62 ×10-4 1.05 45.68 
0.200 2.80 1.82 ×10-4 1.61 ×10-4 1.13 48.66 
0.200 3.00 1.94 ×10-4 1.60 ×10-4 1.21 51.87 
0.200 3.20 2.05 ×10-4 1.59 ×10-4 1.29 55.66 
0.200 3.40 2.16 ×10-4 1.57 ×10-4 1.37 59.37 
0.200 3.60 2.27 ×10-4 1.56 ×10-4 1.45 64.84 
0.200 3.80 2.38 ×10-4 1.55 ×10-4 1.54 67.2 
0.200 4.00 2.49 ×10-4 1.54 ×10-4 1.62 71.32 
0.200 4.20 2.60 ×10-4 1.53 ×10-4 1.70 76.85 
0.200 4.40 2.70 ×10-4 1.52 ×10-4 1.78 79.44 
0.200 4.60 2.81 ×10-4 1.51 ×10-4 1.86 82.04 
0.200 4.80 2.91 ×10-4 1.50 ×10-4 1.94 85.85 
0.200 5.00 3.01 ×10-4 1.49 ×10-4 2.02 88.69 
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Table 3. 6 Absorbance values change of diclofenac resulting from the addition of increasing 
concentration of CA-(NH2)2 in acetonitrile at 298 K 
Vadd Vacc Vt  [DCF] [CA(NH2)2] [CA(NH2)2]/[DCF] Absorbance 
0.00 0.00 0.00 1.12×10-4 0.000               0.000 0.112 
0.05 0.05 1.05 1.07×10-4 5.00×10-5               0.469 0.387 
0.05 0.10 1.10 1.02×10-4 9.55×10-5               0.938 0.600 
0.05 0.15 1.15 9.74×10-5 1.37×10-4               1.406 0.731 
0.05 0.20 1.20 9.33×10-5 1.75×10-4               1.875 0.780 
0.05 0.25 1.25 8.96×10-5 2.1×10-4               2.340 0.850 
0.05 
0.05                    
0.30 
0.35 
1.30 
1.35 
8.62×10-5 
8.30×10-5 
2.42×10-4 
2.72×10-4 
 
              2.800 
              3.20 
0.879 
 
 
In Table 3.3 Vadd is the volume of the receptor added into UV cell, Vt, is the total volum of the receptor 
and the drug accumulated in the UV cell, [D] and [L] is the drug and receptor concentration, the 
receptor concentration is 1.05 × 10-3 mol dm-3 
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Table 3.7 Absorbance values change values of clofibric acid solution in acetonitrile as a result from    
the gradual addition of calix[4]arene amine solution in the same solvent. 
[CA-(NH2)2] = 1×10
-3 mol dm-3       Volume of the drug in the UV cell = 1ml 
Amount added Vacc VT Acc [Drug] [CA-(NH2)2] [CA-(NH2)2]/[Drug] Abs 
0.00 0.00 0.00 3.35×10-4 0.000 0.000 0.36 
0.05 0.05 1.05 3.19×10-4 4.76×10-5 0.149 0.51 
0.05 0.10 1.10 3.05×10-4 9.09×10-5 0.299 0.69 
0.05 0.15 1.15 2.91×10-4 1.30×104 0.448 0.80 
0.05 0.20 1.20 2.79×10-4 1.67×104 0.597 0.92 
0.05 0.25 1.25 2.68×10-4 2.00×10-4 0.746 1.03 
0.05 0.30 1.30 2.58×104 2.31×10-4 0.896 1.10 
0.05 0.35 1.35 2.48×10-4 2.59×10-4 1.045 1.15 
0.05 0.40 1.40 2.39×10-4 2.86×10-4 1.194 1.19 
0.05 0.45 1.45 2.31×10-4 3.10×10-4 1.343 1.23 
0.05 0.50 1.50 2.23×10-4 3.33×10-4 1.493 1.24 
0.05 0.55 1.55 2.16×10-4 3.55×10-4 1.642 1.24 
0.05 0.60 1.60 2.09×10-4 3.75×10-4 1.791 1.27 
0.05 0.65 1.65 2.03×10-4 3.94×10-4 1.940 1.28 
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Table 3.8 Absorbance values change of aspirin solution in dry acetonitrile as a result from gradual 
addition of calix[4]arene amine at 298 K 
The concentration of the L [CA-(NH2)2] = 1.0×10
-3 mol dm-3, 
 The initial volume of drug [D] in the UV cell = 1ml with the concentration 2.99×10-4 
 
Volumeadded Vaccumulated Vtotal  [D] mol dm
-3 [L] [L]/[D] Absorbance 
 0.0                   0.0 0.0 2.99×10-4   0 0 0.27 
 0.1 0.10 1.1 1.42×104 4.76×105 0.334 0.538 
0.1 0.20 1.2 1.36×104 9.09×105 0.669 0.733 
0.1 0.30 1.3  1.30×104 1.30×10
-4 1.003 0.835 
0.1 0.40 1.4 1.25×104 1.67×10
-4 1.338 0.9 
0.1 0.50 1.5 1.20×104 2.00×10
-4 1.672 0.94 
0.1 0.60 1.6 1.15×104 2.31×104 2.007 0.96 
0.1 0.7 1.7 1.11×10-4 2.59×10-4 2.341 0.98 
0.1 0.8 1.8 1.07×104 2.86×104 2.676 0.98 
0.1 0.9 2.9 1.03×10-4 3.10×104 3.010 0.98 
 
 
 
 
 
